Aluminium and group IV metals for polymerisation of lactide by Janeway, Felix David
Aluminium and group IV metals for polymerisation of lactide 
 
 
Felix David Janeway 
 
 
 
Submitted in accordance with the requirements for the 
degree of  
Doctor of Philosophy 
 
The University of Leeds 
 
School of Chemistry 
 
 
December 2015 
 
  
2 
 
The candidate confirms that the work submitted is his own, except where work 
which has formed part of jointly authored publications has been included. The 
contribution of the candidate and the other authors to this work has been explicitly 
indicated below. The candidate confirms that appropriate credit has been given within 
the thesis where reference has been made to the work of others. 
 
This copy has been supplied on the understanding that it is copyright material and 
that no quotation from the thesis may be published without proper acknowledgement 
 
© 2016 The University of Leeds and Felix David Janeway 
 
The right of Felix David Janeway to be identified as Author of this work has been asserted 
by him in accordance with the Copyright, Designs and Patents Act 1988. 
 
  
3 
 
0. CONTENTS 
 Table of Contents 
0. Contents ..........................................................................................................................3 
0.1. Table of Contents ..................................................................................................................... 3 
0.2. Table of Figures ......................................................................................................................... 6 
0.3. Table of Schemes ................................................................................................................... 11 
0.4. Table of Tables ........................................................................................................................ 11 
0.5. Table of Compounds ............................................................................................................. 12 
0.6. List of abbreviations ............................................................................................................... 13 
0.7. Acknowledgements .............................................................................................................. 15 
1. Introduction ...................................................................................................................16 
1.1. Project Aims ............................................................................................................................. 16 
1.2. Polymers ................................................................................................................................... 16 
1.2.1. Types of Polymer ..................................................................................................................... 16 
1.2.2. History of Catalysed Polymerisation .................................................................................... 17 
1.2.3. Catalysed Polymerisation Mechanisms.............................................................................. 18 
1.2.4. Poly(lactic acid) ..................................................................................................................... 20 
1.2.5. Polymerisation of lactide in solution and dry melt conditions ........................................ 22 
1.2.6. Proposed ROP of lactide mechanism ................................................................................ 25 
1.2.7. Polymers for drug delivery .................................................................................................... 25 
1.3. Cancer ..................................................................................................................................... 26 
1.3.1. Cancer ..................................................................................................................................... 26 
1.3.2. Titanium anti-cancer drugs................................................................................................... 27 
1.3.3. Cancer Specific Drug Delivery Systems ............................................................................. 28 
1.4. Summary .................................................................................................................................. 29 
1.5. Chapter One References ..................................................................................................... 31 
2. Aluminium Complexes ................................................................................................38 
2.1. Acetylacetonate ligands ...................................................................................................... 38 
2.2. Aluminium complexes ........................................................................................................... 42 
2.3. Chloride Bridged Aluminium Dimers ................................................................................... 43 
2.3.1. Attempted synthesis of bis-(acetylacetonate)aluminium chloride (Compound 1) .. 44 
2.3.2. Attempted synthesis of bis-(phenylacetyacetonate)aluminium chloride ................... 46 
4 
 
2.3.3. Attempted syntheses of bis-(4’chlorophenylacetylacetonate)aluminium chloride 
(Compound 3) .......................................................................................................................................... 47 
2.3.4. Synthesis of alkoxide compounds from aluminium chloride precursors ....................... 49 
2.3.5. Polymerisation attempts using crude aluminium chloride mixtures .............................. 50 
2.4. Synthesis of bis-(acetylacetonate)aluminium sec-butoxide  [Al(acac)2(sBuO)2]2 
(Compound 4) .......................................................................................................................................... 51 
2.4.1. Crystallographic analysis of bis-(acetylacetonate)aluminium sec-butoxide  
[Al(acac)2(sBuO)2]2 (Compound 4) ....................................................................................................... 53 
2.4.2. NMR spectroscopic analysis of bis-(acetylacetonate)aluminium sec-butoxide  
(Compound 4) .......................................................................................................................................... 58 
2.4.3. Polymerisation of lactide by bis-(acetylacetonate)aluminium sec-butoxide  
(Compound 4) .......................................................................................................................................... 63 
2.5. Conclusion ............................................................................................................................... 66 
2.6. Further Work............................................................................................................................. 66 
2.7. Chapter 2 References ........................................................................................................... 67 
3. Titanium chloride complexes for polymerisation of lactide ...................................72 
3.1. Titanium chloride complexes as anti-cancer drugs ......................................................... 72 
3.1.1. In solution polymerisations .................................................................................................... 73 
3.1.2. Dry Melt Polymerisations........................................................................................................ 74 
3.2. NMR Spectroscopy For Polymer Analysis ............................................................................ 79 
3.3. In situ polymerisation kinetics ............................................................................................... 86 
3.4. Conclusion ............................................................................................................................... 88 
3.5. Further Work............................................................................................................................. 88 
3.6. Chapter Three References ................................................................................................... 90 
4. Titanium ethoxide complexes ....................................................................................92 
4.1. Titanium complexes in the McGowan group ................................................................... 92 
4.2. Synthesis of bis-(4-fluorophenylacetylacetonate)titanium(IV) ethoxide [Ti(4’F-
Phacac)2(OEt)2] (Compound 5) ............................................................................................................ 94 
4.2.1. Crystallographic analysis of bis-(4-fluorophenylacetylacetonate)titanium(IV) 
ethoxide  (Compound 5) ........................................................................................................................ 95 
4.2.2. NMR spectroscopic analysis of bis-(4-fluorophenylacetylacetonate)titanium(IV) 
ethoxide  (Compound 5) ...................................................................................................................... 101 
4.3. Synthesis of bis-(4-bromophenylacetylacetonate)titanium(IV) ethoxide [Ti(4’Br-
Phacac)2(OEt)2]  (Compound 6) ......................................................................................................... 104 
4.3.1. Crystallographic analysis of bis-(4-bromophenylacetylacetonate)titanium(IV) 
ethoxide  (Compound 6) ...................................................................................................................... 105 
5 
 
4.3.2. NMR spectroscopic analysis of bis-(4-bromophenylacetylacetonate)titanium(IV) 
ethoxide  (Compound 6) ...................................................................................................................... 110 
4.3.3. Variable temperature studies of bis-(4-bromophenylacetylacetonate)titanium(IV) 
ethoxide  (Compound 6) ...................................................................................................................... 116 
4.4. Synthesis of bis-(4-iodophenylacetylacetonate)titanium(IV) ethoxide [Ti(4’I-
Phacac)2(OEt)2]  (Compound 7) ......................................................................................................... 119 
4.4.1. NMR spectroscopic analysis of bis-(4-iodophenylacetylacetonate)titanium(IV) 
ethoxide (Compound 7) ....................................................................................................................... 119 
4.5. Synthesis of bis-(di-1,3-methoxyphenylpropan-1,3-diketonate)titanium(IV) ethoxide 
[Ti(4’OEtPhacacPh4’OEt)2(OEt)2] (Compound 8) ............................................................................ 123 
4.5.1. NMR spectroscopic analysis of bis-(di-1,3-methoxyphenylpropan-1,3-
diketonate)titanium(IV) ethoxide (Compound 8) ............................................................................ 124 
4.6. Titanium(IV) Ethoxide complexes for polymerisation of lactide .................................. 130 
4.7. In vitro cell line testing of para-substituted budotitane derivatives ............................ 132 
4.8. Mechanistic studies of the interconversion of isomers of the titanium ethoxide 
complexes ............................................................................................................................................... 135 
4.9. Mechanism of interconversion of titanium ethoxide complexes ................................ 135 
4.9.1. Attempted polymerisation with reduced titanium (IV) species................................... 139 
4.10. Possible oxygenated products .......................................................................................... 139 
4.11. Attempted syntheses ........................................................................................................... 141 
4.11.1. Synthesis of bis-(4-methylphenylacetylacetone)Titanium(IV) ethoxide 
[Ti(4’MePhacac)2(OEt)2] - compound 10 ........................................................................................... 142 
4.11.2. Crystallographic analysis of bis-(1,3-diphenylpropan-1,3-diketonate)titanium(IV) 
ethoxide [Ti(1,3-diphenylpropan-1,3,diketonate)2(OEt)2] (Compound 11) ................................. 145 
4.12. Dimeric analogues of bridging aluminium sec-butoxide dimers ................................. 149 
4.13. Conclusion ............................................................................................................................. 149 
4.14. Further Work........................................................................................................................... 150 
4.15. Chapter Four References ................................................................................................... 151 
5. Experimental .............................................................................................................. 154 
5.1. Apparatus .............................................................................................................................. 154 
5.2. Analysis and instrumentation ............................................................................................. 154 
5.3. Aluminium Complexes......................................................................................................... 155 
5.3.1. Attempted synthesis of bis(acetylacetonate)aluminium chloride – (Compound 1)155 
5.3.2. Attempted synthesis of bis(acetylacetonate)aluminium chloride – (Compound 1)
 ……………………………………………………………………………………………………...155 
6 
 
5.3.3. Attempted synthesis of bis-(phenylacetylacetonate)aluminium chloride dimer – 
(Compound 2) ........................................................................................................................................ 156 
5.3.4. Attempted synthesis of bis(acetylacetonate)aluminium chloride dimer – (Compound 
3) …………………………………………………………………………………………………….156 
5.3.5. Successful Synthesis of bis-(acetylacetonate)aluminium secbutoxide dimer - 
(Compound 4) ........................................................................................................................................ 157 
5.3.6. Polymerisation of L-Lactide using bis-(acetylacetonate)aluminium chloride dimer – 
(Compound 2) ........................................................................................................................................ 157 
5.3.7. Polymerisation of L-Lactide using bis-(acetylacetonate)aluminium secbutoxide - 
(Compound 4) ........................................................................................................................................ 158 
5.4. Titanium Complex Synthesis ............................................................................................... 158 
5.4.1. Bis-(4-fluorophenylacetylacetonate)titanium(IV) ethoxide - compound 5............... 158 
5.4.2. Bis-(4-bromophenylacetylacetonate)titanium(IV) ethoxide  (Compound 6) .......... 159 
5.4.3. Bis-(4-iodophenylacetylacetonate)titanium(IV) ethoxide (Compound 7) ............... 160 
5.4.4. Synthesis of Bis-(1,3-di-4-methoxyphenylpropan-1,3-diketonate)titanium(IV) ethoxide 
(Compound 6) ........................................................................................................................................ 160 
5.5. Bulk polymerisations ............................................................................................................. 161 
5.5.1. Bulk polymerisation of lactide with bis-(acetylacetonate)titanium chloride 
(Compound 2) ........................................................................................................................................ 161 
5.5.2. Bulk polymerisation of lactide with bis-(4’methoxyphenylacetylacetonate) 
titanium(IV) chloride............................................................................................................................... 162 
5.5.3. In situ polymerisation of lactide with bis-(4’methoxyphenylacetylacetonate) 
titanium(IV) chloride............................................................................................................................... 162 
5.5.4. In-Situ polymerisation studies of lactide with compound 5 .......................................... 163 
5.6. Chapter Five References .................................................................................................... 164 
6. Appendices ............................................................................................................... 165 
6.1. Crystallographic information for compound 4 ............................................................... 165 
6.2. Crystallographic information of compound 5 ................................................................ 175 
6.3. Crystallographic information of compound 6 ................................................................ 177 
6.4. Crystallographic data of compound 11 .......................................................................... 181 
6.5. Crystallographic information for compound 8 ............................................................... 187 
6.5.1. Experimental ......................................................................................................................... 196 
6.5.1.1. Crystal structure determination of bis-(1,3-diphenylpropan-1,3-
diketonate)titanium(IV) ethoxide ........................................................................................................ 196 
6.6. Maple calculation methods of EC50 from the logarithmic fitting of data presented in 
section 4.6 ................................................................................................................................................ 196 
7 
 
 
 Table of Figures 
Figure 1.2-1 A representation of an isotactic polymer .............................................................18 
Figure 1.2-2 A representation of a syndiotactic polymer ........................................................18 
Figure 1.2-3 A representation of an atactic polymer ...............................................................18 
Figure 1.2-4 The Cossee-Arlman mechanism of a Ti polymerisation[7] ...................................19 
Figure 1.2-5 Mechanism of a metallocene polymerisation[8] ..................................................19 
Figure 1.2-6 L-Lactic Acid Structure ............................................................................................20 
Figure 1.2-7 Polymerisation of Lactic Acid .................................................................................20 
Figure 1.2-8 An iron alkoxide complex used for ROP of lactide .............................................21 
Figure 1.2-9 Zinc ethoxide dimer complex.................................................................................21 
Figure 1.2-10 Yttrium containing catalyst for ROP of lactide...................................................21 
Figure 1.2-11 – Sodium polyamine aryloxide structures for polymerisation of lactide .........22 
Figure 1.2-12 – Industrial stannous octoate catalyst for polymerisation of lactide ..............22 
Figure 1.2-13 – Synthesis of poly(lactic acid) from raw lactic acid ........................................22 
Figure 1.2-14 – Chiral enantiomers of lactic acid and their corresponding diastereomers of 
lactide ............................................................................................................................................23 
Figure 1.2-15 – Stereotacticity in chains of poly(lactic acid) ..................................................24 
Figure 1.2-16  Possible Mechanism Of ROP of the Lactide Dimer ..........................................25 
Figure 1.3-1 – MTT assay ................................................................................................................27 
Figure 1.3-2 – Structure of Budotitane ........................................................................................27 
Figure 1.3-3 -  Anti-cancer drugs of interest in nanoparticle delivery systems ......................28 
Figure 2.1-1 – Tautomers of acetylacetone ligands .................................................................38 
Figure 2.1-2 – Delocalised electron system of a free acetylacetone molecule ..................39 
Figure 2.1-3 – Typical 1H NMR spectrum of an acetylacetonate ligand showing likely solvent 
contaminants ................................................................................................................................40 
Figure 2.1-4 – Typical 13C NMR spectrum for an acetylacetonate ligand ............................41 
Figure 2.3-1 - 1H NMR spectrum comparison of tris-(acetylacetonate)aluminium (top) and 
crude reaction mixture of attempts to form compound 1 (bottom) collected at 500MHz 
and 298 K in CDCl3 ........................................................................................................................45 
Figure 2.3-2 – Comparative 1H NMR spectrum of crude (top) vs recrystallised (bottom) 
reaction mixtures resulting from the attempted synthesis of compound 2 collected at 500 
MHz at 298 K in CDCl3 ...................................................................................................................47 
Figure 2.3-3- 1H NMR spectrum of crude product of attempted synthesis of bis-4-
chlorophenylacetylacetonate aluminium chloride collected at 500 MHz and 223 K in 
CDCl3 ..............................................................................................................................................48 
Figure 2.3-4 – Comparative 1H NMR spectrum showing the spectrum of 
4’chlorophenylacetylacetone (top) against crude reaction mixture of attempted synthesis 
of compound 3 using the synthesis described in Scheme 2.3-2, collected at 500 MHz and 
298 K in CDCl3. ...............................................................................................................................50 
8 
 
Figure 2.4-1 - ORTEP diagram of the asymmetric unit of compound 4 with ellipsoids 
displayed at the 50% probability level, (hydrogen atoms omitted for clarity) .....................53 
Figure 2.4-2 – Capped stick diagram showing the sec-butoxide bridging ligand plane 
(blue) ..............................................................................................................................................54 
Figure 2.4-3 – Selected bond lengths and angles in the structure of compound 4 (atoms 
omitted for clarity) ........................................................................................................................54 
Figure 2.4-4 – Space filling diagram of compound 4 ...............................................................55 
Figure 2.4-5 – Crystal packing of compound 4 viewed down the c-axis of the crystal 
structure.          Left – Capped Stick Diagram                        Right – Space filling diagram .57 
Figure 2.4-6 – Assigned 1H NMR spectrum of compound 4 collected at 500 MHz, 298 K in 
CDCl3 ..............................................................................................................................................60 
Figure 2.4-7 – Variable temperature 1H NMR spectrum of compound 4 collected at 500 
MHz in CDCl3 ..................................................................................................................................61 
Figure 2.4-8 – 13C {1H} NMR spectrum of compound 4 (bottom) and DEPT 135 13C{1H} 
spectrum (top) collected at - 50 °C in CDCl3 at 125 MHz .......................................................62 
Figure 2.4-9 - Possible mechanism of polymerisation of lactide .............................................63 
Figure 2.4-10 – 1NMR spectra showing in situ polymerisation of lactide using compound 4 
over 24 hours, collected at 500 MHz, 298 K  in CDCl3 ..............................................................65 
Figure 3.1-1 – Proposed mechanism of the ring opening polymerisation of lactide ...........73 
Figure 3.1-2– Titanium chloride complexes investigated for polymerisation of lactide.......73 
Figure 3.1-3 – Example integration of unreacted lactide quartet (right) against polymer 
chain signals (left) .........................................................................................................................74 
Figure 3.1-4 – 1H NMR spectrum of resulting polymer/lactide mixture after stirring at 150 °C 
for two days. ..................................................................................................................................75 
Figure 3.1-5 – Mass spectrum of polymer mixture of compound 2 with 200 equivalents of 
rac-lactide. ....................................................................................................................................77 
Figure 3.1-6 – Isotopic pattern calculated (top) and found (bottom) for a fragment of 
poly(lactic acid) chain containing a chlorine atom. ..............................................................78 
Figure 3.2-1 – Figure showing the isotactic and syndiotactic naming system for a hexad of 
lactic acid repeating units. Note that ‘iisss’ would also give describe a hexaad with where 
the sequence of configuration of chiral centres is “S,S,S,R,S,R” .............................................80 
Figure 3.2-2 – 1H spectrum of reaction mixture of dry melt of 200 equivalents of lactide with 
1 equivalent of compound 2 collected at 298 K at 500 MHz in CDCl3 .................................82 
Figure 3.2-3 – 13C{1H} spectrum of reaction mixture of 48 hour dry melt of 200 equivalents of 
lactide with 1 equivalent of compound 2. ................................................................................84 
Figure 3.2-4 – Expected chemical shifts of poly(rac-lactic acid) tetramers and pentamers 
(top) with observed peaks (bottom)[24] .....................................................................................85 
Figure 3.2-5 – Comparison of the observed signals to 1-chloro-2-methyl-1-oxopropan-2-yl 
acetate[25] ......................................................................................................................................85 
Figure 3.3-1 – Graph of % conversion against time for polymerisation of 200 equivalents of 
lactide with one equivalent of compound 3 in tumbling vials dry melt polymerisation. ....87 
9 
 
Figure 4.1-1 – General structure of titanium (IV) complexes synthesised by the McGowan 
group. .............................................................................................................................................92 
Figure 4.1-2 – Possible structural isomers of β-diketonate ethoxide complexes ...................93 
Figure 4.2-1 – Structure of compound 5 .....................................................................................94 
Figure 4.2-2 – ORTEP diagram of compound 5 with displacement ellipsoids showing 50% 
probability ......................................................................................................................................95 
Figure 4.2-3 – Capped stick diagram showing the distorted octahedral geometry of the 
titanium centre of compound 5 .................................................................................................96 
Figure 4.2-4 – Space filling diagram showing the Van der Waals radii of the ligands around 
the titanium centre of compound 5. Hydrogen atoms omitted for clarity. ..........................99 
Figure 4.2-5 – Capped stick representation of compound 5 showing the planes of the 
acetylacetonate backbone (lighter grey layer) and the plane of the 4’fluorophenyl ring 
(darker blue layer) ........................................................................................................................99 
Figure 4.2-6 - Hydrogen bonding of the fluorophenyl fluorine atom with the adjacent 
hydrogen atom of the nearest molecule ................................................................................100 
Figure 4.2-7 – Crystal packing of compound 5 viewed down the a axis of the crystal 
structure ........................................................................................................................................100 
Figure 4.2-8 – Labelled structure of compound 5 ...................................................................101 
Figure 4.2-9 - 500MHz 1H NMR spectrum of compound 5 in CDCl3 showing chemical shifts 
and integrals at 300K ..................................................................................................................101 
Figure 4.2-10 – 500MHz 1H-1H COSY spectrum in CDCl3 collected at room temperature .102 
Figure 4.3-1- Structure of compound 6 ....................................................................................104 
Figure 4.3-2 – ORTEP diagram of the asymmetric unit only of compound 6 with ellipsoids 
displayed at the 50% probability level .....................................................................................105 
Figure 4.3-3 – Space-filling representation of the structure of compound 6 showing a Z-
shape arrangement of the ethyl chains of the ethoxide ligand ..........................................106 
Figure 4.3-4 – Capped stick diagram of compound 6 showing the distorted octahedral 
geometry of the titanium metal centre (hydrogen atoms omitted for clarity) ..................108 
Figure 4.3-5 – Capped stick representation of compound 6 showing the planes of the 
acetylacetonate backbone (light grey layer) and the plane of the 4’bromophenyl ring of 
the ligand. ....................................................................................................................................108 
Figure 4.3-6 – Crystal packing of compound 6 viewed down the a-axis of the crystal 
structure. .......................................................................................................................................109 
Figure 4.3-7 – Labelled structure of compound 6 ...................................................................110 
Figure 4.3-8 – 500MHz 1H NMR spectrum of compound 6 in CDCl3 showing chemical shifts 
and integrals at 300K ..................................................................................................................110 
Figure 4.3-9 – 500 MHz 1H-1H COSY spectrum in CDCl3 ..........................................................112 
Figure 4.3-10 – 500 MHz HMQC spectrum of compound 6 collected in CDCl3 at 298 K...113 
Figure 4.3-11 – 500 MHz HMBC spectrum of compound 6 collected at 253 K ...................114 
Figure 4.3-12 – 500 MHz NOESY spectrum of compound 6 collected at 253 K ..................115 
10 
 
Figure 4.3-13 – Variable temperature 500 MHz 1H NMR spectra of compound 6 in CDCl3. 
Expansions provided (right) Temperatures listed against the spectra. ................................117 
Figure 4.3-14 – 175 MHz 13C{1H} NMR spectra of compound 6 collected in CDCl3 at 298 K 
(top) and at 253 K (bottom) ......................................................................................................118 
Figure 4.4-1 - Structure of compound 7 ...................................................................................119 
Figure 4.4-2 – Labelled structure of compound 7 ...................................................................119 
Figure 4.4-3 – 500 MHz 1H NMR spectrum of compound 7 collected at 298 K in CDCl3....120 
Figure 4.4-4 – 175 MHz 13C{1H} NMR spectrum collected at 298 K in CDCl3. The CDCl3 peak 
has been truncated....................................................................................................................122 
Figure 4.5-1 - Structure of compound 8 ...................................................................................123 
Figure 4.5-2 – Labelled structure of compound 8 ...................................................................124 
Figure 4.5-3 – Possible isomers of compound 8 .......................................................................125 
Figure 4.5-4 - 500 MHz 1H NMR spectrum of compound 8 collected at 298 K in CDCl3 ....126 
Figure 4.5-5 – 500 MHz 1H COSY NMR spectrum of compound 8 collected at 298K in CDCl3
 .......................................................................................................................................................128 
Figure 4.5-6 – DEPT-135 (top) and 13C{1H} (bottom) NMR spectra of compound 8 collected 
at 298 K on a 175 MHz spectrometer. ......................................................................................129 
Figure 4.6-1 – Logarithmic curves of best fit showing degree of polymerisation of samples 
of lactide at 150 °C, 160 °C, 170 °C, 185 °C and 200 °C with a 1:210 equivalents catalyst 
loading of compound 5. ............................................................................................................131 
Figure 4.6-2 – Change in the rate of polymerisation with varying temperature of compound 
5 with 210 equivalents of lactide. .............................................................................................132 
Figure 4.9-1 – Ligand exchange reactions of bis-(acetylacetonate) titanium chloride 
complexes. Bis-(4-chlorophenylacetylacetonate)titanium(IV) chloride (top left) and bis-
(phenylacetylacetonate)titanium(IV) chloride (bottom left) are mixed together in 
deuterated chloroform to form a cross-product  (right) .......................................................136 
Figure 4.9-2 – In situ 1H NMR spectroscopy mechanistic study of a mixture of compound 5 
and compound 9 ........................................................................................................................138 
Figure 4.9-3 - 1H NMR spectrum of a UV exposed mixture of compound 5 and lactide 
(bottom) and 1H NMR spectrum of lactide (top) in CDCl3 collected at 300 MHz .............139 
Figure 4.10-1 – Structure solution of the oxygenated product of compound 8. (Hydrogen 
atoms omitted for clarity) ..........................................................................................................140 
Figure 4.10-2 – Truncated view of the Ti-O-Ti ring of the oxygenated product of compound 
8. Titanium – light grey   Oxygen - red ......................................................................................141 
Figure 4.11-1 - Structure of compound 10 ...............................................................................142 
Figure 4.11-2 - ORTEP diagram of the asymmetric unit of with ellipsoids displayed at the 50% 
probability level ...........................................................................................................................143 
Figure 4.11-3 – Capped stick model of compound 10 with annotated bite angles of the 
acetylacetonate ligand ............................................................................................................143 
Figure 4.11-4 - Crystal packing of compound 10 viewed down the a-axis of the crystal 
structure. .......................................................................................................................................144 
11 
 
Figure 4.11-5 – Structure of bis-(1,3-diphenylpropan-1,3-diketonate)titanium(IV) ethoxide
 .......................................................................................................................................................145 
Figure 4.11-6 – ORTEP diagram of compound 11 with displacement ellipsoids showing 50% 
probability ....................................................................................................................................146 
Figure 4.11-7 – Space filling diagram showing the Van der Waals radii of the atoms of the 
ligands around the complex and showing significant bowing of the acetylacetonate 
ligand. ...........................................................................................................................................148 
Figure 4.11-8 – Capped stick representation of compound 11 showing the planes of the 
acetylacetonate ligand (grey) and the plane of the twisted phenyl ring of the ligand (blue)
 .......................................................................................................................................................148 
Figure 4.12-1 – Target bridged titanium dimer compounds ..................................................149 
Figure 5.3-1 – Lettered structure of compound 2 used for the assignment of 1H NMR peaks
 .......................................................................................................................................................156 
 
 Table of Schemes 
Scheme 2.1-1 – Synthesis of acetylacetone ligands ................................................................38 
Scheme 2.2-1 – ‘Disproportionation’ reactions of aluminium dimer structures ....................42 
Scheme 2.3-1 – Synthesis of bis-(acetylacetonate)aluminium chloride dimer structures ...43 
Scheme 2.3-2 – Attempted synthesis of bis-(4’chlorophenylacetylacetonate)aluminium 
chloride dimer ...............................................................................................................................49 
Scheme 2.4-1 – Synthesis of bisacetylactonate aluminium sec-butoxide ............................52 
Scheme 2.4-2 – Possible interconversion of aluminium dimers into two aluminium monomers
 .........................................................................................................................................................58 
Scheme 3.1- General preparation of titanium halide complexes .........................................72 
Scheme 4.1-1 – Synthesis of titanium ethoxide complexes .....................................................92 
Scheme 4.5-1 – Synthesis of symmetrical bis-(acetylacetonate)titanium(IV) ethoxide 
complexes. ...................................................................................................................................124 
Scheme 4.9-1 – Ligand exchange reactions of bis-(acetylacetonate) titanium ethoxide 
complexes. Bis-(4-fluorophenylacetylacetonate)titanium(IV) ethoxide (left) and bis-
(phenylacetylacetonate)titanium(IV) chloride (right) are mixed and no reaction is 
observed ......................................................................................................................................137 
 
 
 Table of Tables 
Table 2.4-1 – Selected bond lengths for compound 4 with standard uncertainties listed in 
parentheses. (a)/(b) – Indicates a symmetry generated atom in the second half of the 
molecule ........................................................................................................................................56 
Table 2.4-2 – Bond angles for compound 4 with standard uncertainties listed in parentheses 
(a)
 – Indicates a symmetry generated atom in the second half of the molecule .................57 
12 
 
Table 3.1-1 – Major peaks from the mass spectrum of dry melt of 3 equivalents of lactide 
with 1 equivalent of compound 2. (L) = phenylacetylacetonate .........................................78 
Table 3.1-2 - Major peaks from the mass spectrum of dry melt of 10 equivalents of lactide 
with 1 equivalent of compound 2. (L) = phenylacetylacetonate .........................................79 
Table 4.2-1 – Interatomic distances for compound 5 with standard uncertainties listed in 
parentheses ...................................................................................................................................97 
Table 4.2-2 – Selected bond angles for compound 5 with standard uncertainties listed in 
parentheses ...................................................................................................................................98 
Table 4.2-3 – NMR spectroscopic assignments for compound 5 .........................................103 
Table 4.3-1 – Average bond lengths of compound 6 with standard uncertainties listed in 
parentheses .................................................................................................................................106 
Table 4.3-2 – Bond angles of compound 6 with standard uncertainties listed in parentheses
 .......................................................................................................................................................107 
Table 4.3-3 – NMR spectroscopic assignments of compound 6...........................................111 
Table 4.4-1 – 1H and 13C{1H} assignments of compound 7 ....................................................121 
Table 4.5-1 – NMR spectroscopic assignments of the 1H and 13C{1H} spectra of compound 
8 .....................................................................................................................................................127 
Table 4.6-1 – EC50 Time taken for a 1:200 equivalents catalyst loading of compound 5 to 
lactide to reach 50% conversion at a range of temperatures. ............................................131 
Table 4.7-1 – IC50 values of a series of para-substituted Budotitane derivatives. ...............134 
Table 4.11-1 - Interatomic distances for compound 10 with standard uncertainties listed in 
parentheses .................................................................................................................................145 
Table 4.11-2 – Selected interatomic distances for compound 11 with standard 
uncertainties listed in parentheses ...........................................................................................147 
Table 4.11-3 – Selected bond angles for compound 11 with standard uncertainties listed in 
parentheses .................................................................................................................................147 
Table 6.5-1 - Crystal data and structure refinement for bis-(1,3-diphenylpropan-1,3-
diketonate)titanium(IV) ethoxide .............................................................................................188 
Table 6.5-2 - Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement 
Parameters (Å×103) for dc150. Ueq is defined as 1/3 of of the trace of the orthogonalised 
UIJ tensor. ......................................................................................................................................190 
Table 6.5-3 - Anisotropic Displacement Parameters for dc150. The Anisotropic 
displacement factor exponent takes the form: -2π2[h2a*2U11+2hka*b*U12+…]. .................191 
Table 6.5-4 - Bond Lengths for bis-(1,3-diphenylpropan-1,3-diketonate)titanium(IV) 
ethoxide. ......................................................................................................................................193 
Table 6.5-5 - Bond Angles for bis-(1,3-diphenylpropan-1,3-diketonate)titanium(IV) ethoxide
 .......................................................................................................................................................194 
Table 6.5-6 - Hydrogen Atom Coordinates (Å×104) and Isotropic Displacement Parameters 
(Å2×103) for bis-(1,3-diphenylpropan-1,3-diketonate)titanium(IV) ethoxide. ......................196 
 
 
13 
 
 Table of Compounds 
Compound 1 – bis-(acetylacetonate)aluminium chloride .....................................................44 
Compound 2 – bis-(phenylacetylacetonate)aluminium chloride dimer ..............................46 
Compound 3 – bis-(4-chlorophenylacetylacetonate)aluminium chloride dimer ...............47 
Compound 4 – bis-acetylacetonate aluminium sec-butoxide ..............................................52 
Compound 5 - bis-(4’fluoroacetylacetonate)titanium(IV) ethoxide .....................................94 
Compound 6 - bis-(4-bromophenylacetylacetonate)titanium(IV) ethoxide .....................104 
Compound 7 - bis-(4-iodophenylacetylacetonate)titanium(IV) ethoxide .........................119 
Compound 8 - bis-(di-1,3-methoxyphenylpropan-1,3-diketonate)titanium(IV) ethoxide 123 
Compound 9 – Budotitane ........................................................................................................133 
Compound 10 - bis-(4-methylphenylacetylacetone)Titanium(IV) ethoxide ......................142 
Compound 11 - bis-(1,3-diphenylpropan-1,3-diketonate)titanium(IV) ethoxide ...............145 
 
 List of abbreviations 
 
Symbol Definition 
σ Chemical shift 
[M]+ Molecular Ion 
{1H} Nucleus decoupled from nucleus of interest 
ºC Degrees Celcius 
Å Angstrom 1 x 10-10  m 
ad Apparent doublet 
Ar Aromatic 
Ar Aryl 
as Apparent singlet 
bd Broad doublet 
bs Broad singlet 
DNA Deoxyribonucleic acid 
ES Electrospray 
et al. and others 
etc. et cetera 
g Grams 
HIV Human Immunodeficiency Virus 
HT-29 Colon adenocarcinoma cell line 
Hz Hertz 
iPr Iso-propyl 
xJ Spin-spin coupling constant over x bonds 
J Joules 
K Degrees Kelvin 
kJ Kilojoules 
14 
 
L General ligand 
m Multiplet 
m/z Mass per charge ratio 
Me Methyl 
ml Millilitre 
mol Mole  
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
Ph Phenyl ring 
ppm Parts per million 
q Quartet 
R General group 
s Singlet 
s Second 
sBuO Sec-butoxide 
t Triplet 
tBu Tert-butyl 
UV Ultra Violet 
μg Microgram 
  
15 
 
 Acknowledgements 
I would like to acknowledge the hard work of Dr Aida Basri and Dr Rianne Lord, both of 
whom were involved in completing the cell-line work in the 4th chapter of this work at the 
University of Bradford. I would also like to acknowledge Dr Ben Crossley for establishing the 
synthetic pathways which I have used for this work.  
I would like to offer Dr Rianne Lord a second thank you for collecting a crystal structure for 
me at very short notice when the new X-ray diffractometer was delivered and for 100 
favours throughout the years. I would also like to thank Dr Christopher Pask who also 
collected, solved and resolved a crystal structure for me. 
I would also like to thank Mr. Ian Blakeley, Mr. Simon Barrett and Ms. Tanya Marinko-Covell 
for their excellent work running the analytical, mass spectrometry and NMR facilities 
respectively. I would also like to thank Mr. Colin Kilner for teaching me the secrets of the 
diffractometer.  
Patrick, I can’t thank enough for all of his help, advice and recommendations during the 
happy times and the hard times. Your unending perseverance has helped more than you 
know and I hope I can return the favour somehow.  
In no particular order (except always Chris first) I want to thank Chris, Stephie, Andrew, 
Aunty Rannie, AnTHrea, Ben, the Carlo, Tom, Jonathan, Laurence, Adi, Laura, Kakie, Laura 
and Maxamullion for making the lab a happy place to be even when Radio 1 was on. For 
putting up with my inanity and giving me an excuse to go to pizza hut once in a while. I 
would also like to thank Pamela Thorne for giving me a theatrical and musical outlet when 
I felt the science getting on top of me.  
A huge thank you to mum and dad for putting up with me for the last few years. I know I 
have not been fun to live with for a while now. I’ll do the dishwasher tomorrow.   
16 
 
1. INTRODUCTION 
 Project Aims 
The overall aim of this project is to broaden the understanding of the polymerisation of lactide to 
make poly(lactic acid). 
The major uses of poly(lactic acid) are in the household, replacing petroplastics to make disposable 
items such as plastic bags. During this project, new catalysts for the polymerisation of lactide will be 
synthesised, with both electron poor and electron precise target molecules being identified in order 
to discover useful replacements for current catalysts. 
Study of the mechanism of the polymerisation of lactide will be achieved by variation of the steric 
and electronic properties of the catalysts, as insights into the mechanism of the polymerisation may 
also give ideas as to how to better design viable industrial alternatives to those compounds already 
established. 
Target molecules will be tested for their ability to polymerise lactide to discover motifs which are 
efficient at synthesising poly(lactic acid), as well as exploring those motifs which are traditionally 
avoided for polymerisation of lactide. 
The nature of the polymers obtained will be investigated, and qualifications of what makes a useful 
polymer for industrial use defined. The project will investigate the possible products formed after 
polymerisation, and attempts will be made to exploit the structure of a catalyst to impart 
functionality into the polymer chain itself. 
Some of the target molecules of this project are also expected to have anti-cancer properties, so 
their anti-cancer activity will be assessed in vitro, and polymers made using anti-cancer active 
catalysts will be tested for anti-cancer activity.  
 Polymers 
1.2.1. Types of Polymer 
A polymer is a long chain molecule consisting of repeating units joined by covalent bonds. The first 
synthetic polymer was Bakelite, discovered in 1907 by Leo Baekeland.[1] The polymer was 
synthesised by subjecting phenol and formaldehyde mixtures to high temperatures and pressures 
to form a large phenolic network of arene rings. Bakelite was a synthetic analogue of a shellac resin 
harvested from insects.  
The invention of a synthetic method of preparing materials with the properties of plastics allowed 
for a rapid increase in production volume of synthetic materials, despite the high energetic cost of 
preparing the polymer. Since then, metal and radical catalysts have been used to greatly reduce 
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the amount of energy required to perform a polymerisation reaction and to control the nature of 
the polymer itself. 
The synthesis of polymers necessitates covalent bonding of many molecules together. This process 
can be metal-mediated, radical or chemical, with each method allowing a different degree of 
control of the properties of the final polymer including chain length, degree of branching of the 
polymer chain and the arrangement of any chiral centres within the polymer.  
Polymers commonly used today are separated into polymers synthesised by carrying out addition 
reactions - addition polymers, and those formed by chemical condensation reactions - 
condensation polymers. 
Common addition polymers include those made by the addition of alkene molecules together - 
poly(ethene), poly(propylene), poly(vinyl chloride) and poly(trifluoroethene) (PTFE, Teflon). 
Common condensation polymers include polymers with ester or amide repeating units. Examples 
of these polymers include Kevlar®, nylon and polyethylene terephthalate (PET).  
1.2.2. History of Catalysed Polymerisation  
The first organometallic polymerisation catalyst was discovered by Karl Ziegler and used to produce 
a stereoregular polymer by Giulio Natta. For this reason they were jointly awarded the Nobel Prize 
in 1963. The catalyst was prepared by performing a ligand exchange reaction with α-TiCl3 and 
[AlCl(Cp)2]2.[2]  Due to the nature of the cyclopentadienyl (Cp) ligands around the titanium 
coordination sphere, alkenes are restricted by which path they can approach and must coordinate 
with a certain geometry. In this way the tacticity of the resultant polymers can be controlled by 
varying the nature of the ligands surrounding the catalysing metal. These particular catalysts have 
been used to produce long chain polymers for industrial production of poly(ethene), 
poly(propylene), poly(acetylene) and several others with carefully controlled crystalline properties. 
[3-5] 
One way to control the properties of a polymer is to carefully control the ratio of monomer, or source 
chemical, to catalyst in the mixture. This can limit the length of the chains formed. Desirable 
catalysts are ones which produce polymer mixtures where most of the chains are of similar length. 
A commonly used measure of similarity of length of a polymer is the PDI, the polydispersity index, 
however the recognised IUPAC terminology is simply “dispersity”.[6] To calculate the dispersity the 
Mw (weight average molecular mass) is divided by the Mn (number average molecular mass). A 
polymer mixture that contains only one length of polymer chain would have a dispersity of 1. A 
mixture with a wide range of chain lengths would have a number larger than 1 with the most 
disperse mixtures usually having a dispersity around 2. 
Another feature of a polymer is the position of any groups which are attached to the polymer but 
are not part of the primary backbone of the polymer. 
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Isotactic: 
 
Figure 1.2-1 A representation of an isotactic polymer 
 
In an isotactic polymer all ancillary, or ‘R groups’, are attached to the same face of the polymer. 
This is usually the resultant product of a polymerisation reaction using a Ziegler-Natta catalyst or 
other metal catalyst with significant steric bulk around the metal centre. These types of polymer 
tend to pack together more closely and form dense and rigid polymers than the other types of 
polymer. 
Syndiotactic: 
 
Figure 1.2-2 A representation of a syndiotactic polymer 
Syndiotactic polymers have ‘R groups’ on alternating faces of the polymer chain. This type is also 
usually made by more complex organometallic catalysts. These chains will pack much less densely 
and will tend to be less crystalline. 
Atactic: 
 
Figure 1.2-3 A representation of an atactic polymer 
   
Atactic polymers have ‘R groups’ randomly dispersed across the faces. Due to their random nature 
these chains pack even less closely than syndiotactic polymers and tend to be much more 
amorphous. This leads to a more flexible polymer with a lower melting point. These types of polymers 
result from most radical polymerisations and polymerisations performed by catalysts without 
reasonable steric bulk or chiral ligands. 
1.2.3. Catalysed Polymerisation Mechanisms 
The mechanisms of many polymerisation reactions are not fully understood but the following have 
been proposed to explain the tacticity of the polymers they produce. Most of these mechanisms 
are based on alkyl insertion reactions. 
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Figure 1.2-4 The Cossee-Arlman mechanism of a Ti polymerisation[7] 
Figure 1.2-4 shows the coordination-insertion mechanism of propene, and addition polymer, at a 
titanium centre. As there is no restriction to the way the propene molecule approaches the metal 
centre in this complex the poly(propene) yielded by this catalyst has no ‘R group’ ordering and as 
such a random atactic polymer is yielded.  
 
 
Figure 1.2-5 Mechanism of a metallocene polymerisation[8] 
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Figure 1.2-5 shows how catalyst design can be used to yield isotactic polymers. By using two 
tethered cyclopentadienyl ligands with bulky side groups the complex is shaped into a 
structure which dictates the orientation by which the propene coordiates to the zirconium 
centre and holds the propene in place during the alkyl insertion step.  
1.2.4. Poly(lactic acid) 
 
Figure 1.2-6 L-Lactic Acid Structure 
Lactic acid is a biological acid which can be produced by fermentation industrially using 
lactobacillus bacteria on starch or dextrose sources such as corn, rice, wheat, sugar beets and 
sweet potatoes. This means that the product can be produced using a renewable material, rather 
than a petrochemical source. This makes it an excellent source material to be used in industrial 
procedures. The polymer produced is also compostable. The molecule has a chiral centre, but 
99.5% of the raw lactic acid produced by fermentation is the L-isomer. Poly(lactic acid) (PLA) is a 
polyester based on lactic acid prepared by a condensation step to make a cyclic di-ester and 
then a ring-opening polymerisation step to make the polymer.  
 
Figure 1.2-7 Polymerisation of Lactic Acid 
This polymerisation process is an example of a living polymerisation and as such, chain length can 
be controlled by controlling the concentration of lactide in the reacting solution. Most research in 
this field has focussed on the synthesis of high molecular weight polymer chains suitable for use as 
an alternative plastic in the consumables market and in controlling the tacticity of the polymer to 
tune the required properties of the final polymer.  
Many different metal sources have been used to catalyse the polymerisation of lactide. The ring-
opening polymerisation can be crudely carried out with metal oxides or simple metal salts, with one 
recent paper reporting successful polymerisation of lactide using Pepto-Bismol, an over the counter 
dietary relief aid.[9]  
While simple iron oxide has had some success with lactide polymerisation, much more complicated 
iron complexes have been synthesised and reported to initiate lactide polymerisation by Gibson et 
al.[10] 
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Figure 1.2-8 An iron alkoxide complex used for ROP of lactide 
Other transition metal complexes reported to polymerise lactide include a dimeric zinc complex 
reported by Williams et al.[11] 
 
Figure 1.2-9 Zinc ethoxide dimer complex 
While alkoxide groups are popular in catalysts for the ROP of lactide other ligands can be included 
which are displaced with an alcohol initiator before addition of lactide as in this yttrium complex 
also reported by Williams et al. whereby N(SiMe3)2 is displaced from the complex on activation.[12] 
 
Figure 1.2-10 Yttrium containing catalyst for ROP of lactide 
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Alkali metals have also been used to conduct ring-opening polymerisation reactions. Complicated 
structures based on lithium have been found to polymerise lactide rapidly at room temperature, 
though undergo a series of side reactions due to their basic nature which makes them inefficient as 
catalysts and the resulting mixture difficult to purify. [13] 
More recent reports of very well defined polyamine-stabilised sodium complexes have been 
reported to polymerise 300 equivalents of lactide in CH2Cl2 at 25 °C in 5 minutes.[14]  
 
Figure 1.2-11 – Sodium polyamine aryloxide structures for polymerisation of lactide 
Industrial polymerisation of lactide is performed using stannous octoate, which performs well in 
solution and dry-melt conditions, however concerns about tin oxide products leeching from the 
plastic into food and drinks contained within commercial plastics have stimulated research into less 
toxic metal catalysts for the production of poly(lactic acid).[15] 
 
Figure 1.2-12 – Industrial stannous octoate catalyst for polymerisation of lactide 
When used industrially stannous octoate requires an alcohol initiator in order to activate the 
complex towards polymerisation of lactide.[16] 
 
1.2.5. Polymerisation of lactide in solution and dry melt conditions 
 
Figure 1.2-13 – Synthesis of poly(lactic acid) from raw lactic acid 
 
There are two synthetic routes to poly(lactic acid), PLA. The first a direct method to catalyse a 
condensation reaction between lactic acid molecules. This method tends to yield polymers of low 
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molecular weight, i.e. less than 100,000 gmol-1, as the catalyst is deactivated by the formation of 
water in the reaction.[17, 18] Another synthetic method is the ring-opening polymerisation of a dimer 
of lactic acid, lactide.  
 
Figure 1.2-14 – Chiral enantiomers of lactic acid and their corresponding diastereomers of lactide 
Lactide has two chiral carbon atoms in its structure, leading to several diasetreomers available for 
use in polymerisation reactions. (Figure 1.2-14) As lactic acid is sourced by fermentation of biomass 
a vast majority of the lactide produced industrially is L-lactide. However, D-lactide, meso-lactide 
and a racemic mixture of the two RR and SS enantiomers, rac-lactide, are also available.  
Lactide is formed in a multi-step process by synthesising short oligomers of lactic acid, usually using 
a tin catalyst, then performing a cyclic deoligomerisation also using stannous salt.[19] The resulting 
cyclic diester is then able to undergo ring-opening polymerisation anhydrously, allowing the 
formation of polymers with much higher molecular weights and with narrower polydispersity indices. 
(Figure 1.2-13) 
Polymerisations can be conducted in solution at various temperatures or under dry melt conditions 
where the lactide monomer is melted to act as a solvent. Lactide melts at 100 °C and therefore dry 
melt polymerisations tend to be carried out at temperatures exceeding 150 °C. The properties of 
the final plastic are dependent upon several factors; the length of the polymer, the polydispersity 
and the tacticity of the polymer. While these properties are dependent upon the action of the 
catalyst in the case of tacticity the chirality of the monomer is also important. The structure of 
isotactic poly(lactic acid) contains chiral carbons all with the same configuration, either R or S 
(Figure 1.2-15). As such the chain has a regular 3D shape and is able to pack closely with other 
chains. This increases the plastic’s crystallinity, strength and melting point as well as increasing the 
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amount of time the polymer takes to degrade.[20] Isotactic polymers can only be synthesised using 
a diasteromer of lactide with both chiral carbons in the same S or R configuration, or using a catalyst 
capable of differentiating and catalysing the polymerisation of one diasteromer in a racemic 
mixture.  
 
 
Figure 1.2-15 – Stereotacticity in chains of poly(lactic acid) 
The tacticity of the final polymer is one property that a chemist may wish to control. They may also 
be interested in the colour of the polymer. The tacticity can vary properties of the polymer such as 
melting point, solubility and speed of breakdown of the plastic.[21a] The colour of the polymer is 
largely aesthetic, and can depend on the efficiency of the catalyst, as the reaction occurs the 
extra heat created must be dissipated or the polymer can easily burn as the monomer undergoes 
a series of thermolytic reactions. The ideal commercial polymer would be white so that the polymer 
can be coloured appropriately for the desired application. 
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1.2.6. Proposed ROP of lactide mechanism 
In the case of lactide polymerisation the mechanism is unknown but could be based around the 
following steps. 
 
Figure 1.2-16  Possible Mechanism Of ROP of the Lactide Dimer 
The carbonyl oxygen of the lactide coordinates to the metal centre via donation of a lone pair of 
electrons. This means that an active catalyst must have labile ligands capable of detaching from 
the centre and freeing up a coordination site. Dimers are ideal for this function as they can break 
apart into monomers yielding two metal centres each with a vacant binding site. 
A pre-complexed alcohol initiating group inserts into the carbonyl double bond and allows the 
lactide ether oxygen to coordinate to the metal centre into the now vacant binding site.[21b]  
The four membered transition state formed allows rearrangement and reforms the carbonyl double 
bond leaving the lactide ether oxygen complexed to the metal centre and ready to act as an 
initiating group for the next lactide molecule to complex. 
1.2.7. Polymers for drug delivery 
There has been interest in the literature in drug-delivery techniques using a wide variety of tailored 
nanoparticles as drug delivery matrices. Though there are many types of nanoparticle; non-metal, 
carbon allotropes, semiconducting metalloids and metal containing particles including magnetic 
particles, by far the most researched are ones made of polymeric materials. One way of forming a 
drug delivery system is to use water-soluble or degradable plastics in some combination of 
polyesters,[29-31] amides, urethanes,[[32, 33]] ethers, phosphorylcholines,[34] celluloses[35, 36] and more 
exotic cross-linked and unlinked block co-polymers to protect drugs from the aqueous environment 
of the blood plasma, control timed drug release,[37] and even tune drug release to chemical 
environments such as areas of specified pH[38] or temperature.[38, 39] This is achieved by forming 
chains of each of the monomers in a specific sequence in order to form domains of hydrophilic 
polymer, so-called ‘blocks’, and domains of hydrophobic polymer. These specifically designed 
polymers go on to form micelles, as the hydrophobic parts of the polymers form intermolecular 
attractions preferentially over interacting with an aqueous solvent, and vice versa in an organic 
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solvent. The results are structures such as spheres, rods or bi-layers of polymeric material providing 
an anhydrous area in which to store drugs protected from aqueous conditions. With careful design 
of the length and chemistry of the domains of the polymer it is possible to loosen the intermoleculear 
interactions in specific pH environments and allow targeted delivery of drugs to affected areas. 
A more simple delivery matrix can be made by forming water soluble polymers or block co-polymers 
with hydroxyl or groups similarly amenable to condensation or addition reactions as terminals or 
side chains on the polymer. The number of hydroxyl groups on the chain can be controlled by 
regulating the stochiometry of the monomers used to make the polymers. These functional groups 
can then been used to covalently add drugs,[40, 41] fluorescent tags[42] and structural property 
modifiers[43] to the polymer to affect its properties in vivo. In this way small loadings of functional 
molecules can be loaded onto the plastic while retaining biodegradability. 
 Cancer 
1.3.1. Cancer 
‘Cancer’ is an umbrella term which covers a series of diseases caused by mutations in cells causing 
the cell to be unable to terminate. Cells which are unable to terminate are effectively immortal 
while there is supply of ATP and oxygen. The cells may also have other defects which make them 
no longer able to perform the specific task of the tissue. There are over 200 different types of cell in 
the human body, and so there are over 200 different types of cancer, ranging from cancers of 
specific organs or organ systems, isolated or ‘alien’ teratomas growing in tissues of different types 
to those in the tumour, or as a secondary result of another disease or virus such as Kaposi’s sarcoma 
caused by human herpesvirus 8 and other HIV-related viruses.[22a]  
The first step towards clinical use of an anti-cancer drug is to perform in vitro studies of the drug with 
isolated lines of human cancer cells. The efficacy of the drug in vitro gives some indication of its 
potential efficacy in vivo and so is a humane, comparatively inexpensive and high-throughput 
method of screening candidates for anti-cancer activity. The method is not without disadvantages, 
however, as in vitro methods are unable to model the responses of the whole organ system or tissue 
of a mammal might have to the drug. Using a single cell-focussed method does not model how the 
drug might be metabolised and converted within the body into an active drug, or deactivated by 
cells which are non-cancerous such as liver or kidney cells.[22b] 
During cell line testing, human cancer cells are distributed evenly in a 96-well plate and different 
concentrations of drug are added to each lane of wells. The cells are allowed to incubate in a 3 
day cycle. The fraction of cells alive after exposure to the drug is measured using the MTT-assay 
(Figure 1.3-1). Cells are exposed to a tetrazolium bromide salt which is yellow in colour. Wells 
containing cells which are alive will change colour to purple as the cells convert the tetrazolium salt 
into a purple coloured formazan.[23] The degree of conversion of the tetrazoium is studied using 
UV/visible spectroscopy and correlates with the fraction of cells alive in the wells. 
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Figure 1.3-1 – MTT assay 
 
The standard method to describe the activity of a cancer drug is to state the IC50 and compare this 
to the action of a cis-platin standard which is measured in parallel on the same batch of cells. The 
IC50 is the concentration of drug required to kill 50% of cells in a given medium. This standard allows 
us to assess drugs which do not reach 100% cell-death and will be used as a standard to compare 
efficacy of drugs in this work. 
1.3.2. Titanium anti-cancer drugs 
Budotitane (Figure 1.3-2) was discovered and reported by Keppler et al in 1986. [24] The drug was 
found to be a potent anti-cancer agent, undergoing Phase I trials for use in humans in 1983 and 
again in 1996. The first trial reported increased anti-cancer activity over cis-platin and lower 
observed toxicity.[25] The second study was conducted with 18 patients receiving doses between 
180 mg/m2 and 230 mg/m2. The dose limiting side effect was found to be cardiac arrhythmia. 
Preliminary pharmacokinetic analysis found maximum concentrations of the drug in the 
bloodstream to be the same, within error, at both extremes of the dosages with values of 2.9 ± 1.2 
μg and 2.2 ± 0.8 μg respectively.[26] 
 
Figure 1.3-2 – Structure of Budotitane 
During Phase I trials the drug was dispersed in a micellular formulation of glycerine polyethylene-
glycolericinoleate and 1,2-propylene glycol with anhydrous ethanol in order to help stabilise the air 
and moisture sensitive drugs. The drug was found to have a fairly long half-life of 59.3 ± 12.1 hours 
and 78.7 ± 24 hours for the highest and lowest doses respectively.[27, 28] However, at this point clinical 
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trials were halted due to difficulties fully characterising the active species in the micellular 
formulation. 
1.3.3. Cancer Specific Drug Delivery Systems 
Cancer specific polymeric drugs and imaging agents have been developed, patented,[44] 
published[45] and reviewed.[46-48] Encapsulation of organic drugs such as doxorubicin,[49] paclitaxel[50] 
and plasmid DNA (Figure 1.3-3) has been investigated.[51] Several encapsulated metallodrugs have 
also been studied for their cytotoxic effect and use in medical imaging. The most focus has been 
on the well-defined Pt(II) species cis-platin[52, 53], and carboplatin[54], which have shown improved 
cytotoxicity against the free drug when delivered using dual membrane carbon nanotube 
morphologies and reduced cytotoxicity when using a herringbone morphology of carbon as the 
nanoparticle retains around 90% of the loaded drug. More recent developments have shown more 
improvements; Zhi et al have reported selective pH release of cis-platin using nanodiamond 
particles[55] and Shi et al have found that both cis-platin and trans-platin can be more active against 
breast and cervical cancers when bound to silica nanoparticles than the equivalent free drug.[56] 
Polymeric drug delivery matrices have received the most attention for metallodrugs and Phase I 
trials have begun for some cis-platin delivery systems.[57-59] Cis-platin has also been used as a co-
drug in a synergistic medicine containing cis-platin and doxorubicin, the combination of which 
showed dramatic enhancements to the cytotoxicity of the drug mixture compared to the drugs 
separately.[60] 
 
Figure 1.3-3 -  Anti-cancer drugs of interest in nanoparticle delivery systems 
There has also been interest in encapsulated Pt(IV) species, with the intention that the platinum will 
be reduced to the active Pt(II) species in vivo. In this way the Pt(IV) drug acts as a prodrug and also 
allows extra coordination sites for addition of targeting molecules.[61-65] 
 Other metals have also been studied for drug delivery. Magnetic Rh(II) complex nanoparticles 
have shown specific toxicity for cancerous breast cells over healthy breast cells.[66] A series of 
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ferrocenyl,[67, 68] Ru(III)[69] and Ni(II)[70] complexes have shown increased activity when delivered as 
micelles or in liposomes rather than as a free drug. There have also been reports of the use of 
chromium and ruthenium metal complexes with a nitrosyl ligand to act as a source of NO gas by 
irradiating cancer cells with UV or visible light to promote the release of NO in the cell and 
encourage apoptosis.[71-73] 
Despite progress in the field there has only been one recent report of the use of titanium containing 
nanoparticles for treatment of cancer[74] and no reports in the literature of using micellular and 
nanoparticle techniques to overcome the problems inherent in delivery of Budotitane, and other 
titanium drugs based on the structure of Budotitane. 
DFT calculations conducted by Šponer et al suggested that the identity of the active titanium 
species in the cell may be the same for all titanium complexes. The group found a correlation 
between the IC50 of several titanocene drugs and the Gibb’s energy of acid catalysed dissociation 
of the Cp ligands.[75] As the Gibb’s free energy becomes more negative, the dissociation becomes 
more favourable and the compound becomes more cytotoxic. Šponer suggests, therefore, that 
the active species for all titanium drugs may be a maximally hydrolysed [Ti(H2O)6]+4 species, as the 
activity of Budotitane is very similar to that of titanocene dichloride, despite the drugs having very 
different modes of coordination.[27]  
 Summary 
Poly(lactic acid) is a medically and industrially useful polymer formed from lactide which can be 
synthesised by fermentation of waste plant materials. The feedstock for the plastic can be entirely 
synthesised without the use of petrol products and, as such, can be considered somewhat 
renewable. The polymer can be formed using direct condensation or by ring-opening 
polymerisation. While there are many examples of active catalysts for the ring-opening 
polymerisation of lactide, the mechanism of the polymerisation is still somewhat unknown, and this 
project seeks to add to the library of known active catalysts, quantify their ability to polymerise 
lactide, and seek structure-activity relationships where possible.  
Cancer is an umbrella term describing a series of conditions caused by mutations of cells which 
causes those cells to malfunction. Some mutations of these cells prevent the cell from being able 
to perform apoptosis, a process by which a cell terminates, and so these ‘faulty’ cells continue to 
reproduce in the body. Medicinal attempts to deactivate cancerous cells focus on disrupting the 
DNA so that the cell is unable to replicate, form proteins necessary for its continued survival and this 
causes the cell to die. One method of disrupting the DNA within the cell is to add a Lewis acid which 
is able to form dative bonds with the nitrogen atoms in the nucleobases, and thus disrupt the double 
helix of the DNA. Titanium (IV) complexes are promising candidates for the treatment of cancer in 
patients, with one example of a titanium (IV) drug, Budotitane, having undergone Phase I and II 
trials in humans.[24] These trials were abandoned due to the difficulty in preparing a safe and suitable 
formulation of the drug. Recent developments in the production of polymer-based delivery systems 
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using a wide array of polymers suggests that polymer-based drug delivery systems might be of use 
for the delivery of titanium metallodrugs.[29-36] In order to prepare Ti(IV)-dispersed polymer 
preparations, the metal’s ability to conduct the ring-opening polymerisation of lactide to form 
poly(lactic acid) could be exploited. 
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2. ALUMINIUM COMPLEXES 
 Acetylacetonate ligands 
In order to study the mechanism of the polymerisation of lactide by the complexes of interest to this 
project, a ligand system which is tunable for sterics and electronics was required.  Acetylacetonate 
ligands are an excellent candidate for this application as symmetrical or asymmetrical 
acetylacetone ligands can be synthesised easily via Claisen condensation reactions. (Scheme 
2.1-1) 
 
Scheme 2.1-1 – Synthesis of acetylacetone ligands  
Asymmetrical ligands where R = substituted phenyl group and R’ = methyl group can be prepared 
by refluxing the relevant acetophenone, or ketone, with base in ethyl acetate. The ligand is 
acidified and extracted in chloroform from an aqueous solution of the solid obtained in step 1. 
 
Figure 2.1-1 – Tautomers of acetylacetone ligands 
Asymmetrical ligands such as those in Figure 2.1-1 have three possible tautomers, whereas protons 
labelled Ha in symmetrical acetylacetone molecules are equivalent to one another. In the solid 
state, the acetylacetone ligands have been found by X-ray crystallography to adopt a delocalised 
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configuration (Figure 2.1-2), with the C=O bond lengths usually being approximately equal, within 
error, with an average bond length of 130 pm, half way between a double and single bond.[1-7]  
 
Figure 2.1-2 – Delocalised electron system of a free acetylacetone molecule 
The free ligand appears to retain this delocalised structure in solution, with the methinine proton 
usually appearing between 6.0 – 7.0 ppm in the 1H NMR spectra (Figure 2.1-3). The DEPT 135 
experiment offers further evidence that the β-diketonate form is not observed in solution as no 
significant –ve CH2 peak is observed in the DEPT 135 13C NMR spectra (Figure 2.1-1). 
Complexes of β-diketonates are synthesised by mixture with a metal source and, if necessary, a 
base. In the case of the syntheses in this thesis all complexations are ligand substitution reactions 
where the substituted ligand from the metal acts as a base, removing the extra proton from the 
free acetylacetone ligand. 
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Figure 2.1-1 – Typical 1H NMR spectrum of an acetylacetonate ligand showing likely solvent contaminants   
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Figure 2.1-2 – Typical 13C NMR spectrum for an acetylacetonate ligand 
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 Aluminium complexes 
Aluminium is well known to the McGowan group to proficiently polymerise lactide. The 
group has used aluminium complexes to covalently attach functional molecules to 
poly(lactic acid) chains, allowing the group to synthesise functional plastics which can be 
spun into fibres for use in garments. [8] 
An ideal catalyst for the polymerisation should have a vacant coordination site or should 
be capable of producing one with little energy input. In this case a dimer structure is ideal, 
as a dimeric structure can break into two monomeric structures with a vacant 
coordination site in the presence of a lewis acid. Additionally, aluminium is an ideal metal 
to form dimeric structures without forming polymeric structures as the metal centre is the 
smallest of the p-block metals. Trimethylaluminium and triethylaluminium are known to 
have a dimeric structure in the solid phase.[9, 10] In the case of triethylaluminium there is also 
evidence the structure can break into monomeric form in the gaseous phase.[10] 
Ethylaluminium structures have also been explored and a lithium tetraethyl aluminium salt 
monomer has also been reported.[11] Electron poor structures such as trimethylaluminium 
and triethylaluminium are known to be pyrophoric, and rapidly react with oxygen in the 
air, indicating an extremely fragile structure and very reactive metal centres. 
It is also possible to synthesise electron precise aluminium dimers using bridging ligands 
containing lone pair electrons such as halides or alkoxides. Even these types of complex 
are known to be extremely air sensitive, but not pyrophoric.[12, 13] Some examples using 
bridging alkoxide ligands have been synthesised in the literature, with examples having 
been reported by Wengrovius et al.[14, 15] and many others.[16-27] However bridged 
acetylacetonate aluminium dimers have not yet been crystallised, with the closest 
examples being the malate complexes reported by Seubert et al. in 2007 and the 
aluminium β-diketonate alkoxide trimers reported by Wengrovius. [12, 28] 
One of the reasons that the dimer structures may not have yet been elucidated is the 
fragility of the structure. Additional to the air sensitivity of the compound, dimer structures 
of these sort are also known to ‘disproportionate’ (though there is no change in oxidation 
number of the elements in the compound) into the more stable tris-acetylaceonate 
complexes with relatively small inputs of heat.[12] 
 
Scheme 2.2-1 – ‘Disproportionation’ reactions of aluminium dimer structures 
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Initial attempts to synthesise aluminium dimers focussed on investigating and rationalising 
the methods used by Wrengrovius et al, and considering possible synthetic pathways for 
making halide bridged analogues of alkoxide bridged compounds previously reported. 
 Chloride Bridged Aluminium Dimers 
Chloride bridged dimer structures are electron precise. The ligand exchange reaction 
seems to proceed quickly, driven by the formation of hydrochloric acid and, in this case 
using bidentate ligands, also driven by the chelate effect. 
 
Scheme 2.3-1 – Synthesis of bis-(acetylacetonate)aluminium chloride dimer structures 
As aluminium chloride is a salt, it was necessary to identify a solvent which allowed full 
dissolution of the aluminium chloride. If the aluminium chloride was reacted as a solid in 
suspension, aluminium centres at the surface of the solid crystal lattice may have reacted 
with a non stoichiometric number of acetylacetonate ligands. Toluene was found to be a 
good solvent for this reaction as aluminium trichloride readily dissolved in the toluene. 
However, isolating the product without overheating later became a problem, and a new 
solvent was sought out which could be removed in vacuo at much lower temperatures. 
Initial reactions of this type were performed using excess acetylacetonate ligands to 
investigate the reaction times and suitable solvents. It was found that dissolving aluminium 
chloride in dichloromethane and adding a solution of the acetylacetonate ligand in petrol 
60 - 80° yielded a uniform white solid. When recrystallised by diffusion of pentane into 
chloroform solution of the solid, hexagonal crystals were isolated, which were found to be 
tris-acetylacetonate aluminium. 
Further attempts to identify a reasonable synthetic method followed the method outlined 
in Scheme 2.3-1. Attempts to synthesise chloride bridged dimers were made with 
acetylacetonate and substituted phenylacetylacetonate ligands. 
To a stirred solution of aluminium (III) chloride in dichloromethane, a solution of 
acetylacetone in petrol 60-80° was added dropwise with stirring under a dynamic 
atmosphere of N2 in Schlenk apparatus. 1H NMR spectra were collected in deuterated 
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chloroform which had been distilled over calcium hydride and stored in Young’s tapped 
ampoules under N2. 
In the 1H NMR spectrum, complexation can be measured by measuring the shift downfield 
of the methine proton in the acetylacetonate ligand, labelled ‘Hb’ in Figure 2.1-4. Shifts of 
this signal downfield by around 0.1 ppm indicate some complexation. 
The number of methine proton signals present in the 1H NMR spectrum between 5.5 -6.5 
ppm of an aluminium dimer prepraration is also indicative of the number of products which 
may have been formed, with tris-acetylacetonate aluminium having fewer electrons 
withdrawn from the methine proton than any form of acetylacetonate aluminium chloride 
derivative, and expected to have the most upfield shift. 
2.3.1. Attempted synthesis of bis-(acetylacetonate)aluminium chloride 
(compound 1) 
 
Compound 1 – bis-(acetylacetonate)aluminium chloride 
Attempts to synthesise compound 1 using the synthetic method laid out in Scheme 2.3-1 
were made. 
In all syntheses but one using 1, 1.5 and 2 equivalents of acetylacetonate per molecule of 
aluminium (III) chloride in toluene and dichloromethane/petrol 60-80° mix, a single white 
product was formed during recrystallisation at - 20 °C from pentane. This product was 
found to be tris-acetylacetonate aluminium by 1H NMR spectroscopy and microanalysis 
which showed very little chlorine contained within the substance (13.7% expected, 0.35% 
found). 
In one instance where the reaction was performed with two equivalents of  acetylacetone 
with aluminium chloride in pentane and dichloromethane at - 20 °C a crude mixture was 
formed which suggested some formation of a product with a downfield shift of the 
methine proton around 0.3 ppm compared to the free ligand. This finding suggests 
formation of bis-acetylacetonate aluminium chloride (compound 1). The NMR spectrum 
showed that the compound was impure, with some tris-acetylacetonate aluminium also 
present in the mixture. (Figure 2.3-1) 
Attempts to crystallise the product from a chloroform/pentane mixture at 0 ºC yielded a 
crystal suitable for x-ray crystallography, however, midway through solving the compound 
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was found to be trisacetylacetonealumninium, and the mother liquor changed colour to 
a light grey on opening the vessel under a flow of N2. 
 
 
Figure 2.3-1 - 1H NMR spectrum comparison of tris-(acetylacetonate)aluminium (top) and 
crude reaction mixture of attempts to form compound 1 (bottom) collected at 500MHz and 
298 K in CDCl3 
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2.3.2. Attempted synthesis of bis-(phenylacetyacetonate)aluminium chloride  
 
Compound 2 – bis-(phenylacetylacetonate)aluminium chloride dimer 
Attempts to synthesise bis-phenylacetylactonate aluminium chloride using the synthetic 
method outlined in Scheme 2.3-1 were made. During one reaction a green precipitate 
was formed. The precipitate was collected by filtration and the crude mixture showed 
several methine peaks in the 1H NMR spectrum (Figure 2.3-2). The mixture was recrystallised 
from pentane diffusion into chloroform solution of the crude compound. Recrystallisation 
had a minor effect on the 1H NMR spectrum (Figure 2.3-2), which showed significant 
removal of tris-phenylacetylacetonate aluminium as the tallest peaks in the crude 1H NMR 
spectrum are reduced in intensity at 6.45 ppm and 2.31 ppm. As this is the largest expected 
impurity the method has promise. 
Additionally only a single methine proton signal, Hb, remains in the spectrum. This is 
diagnostic of only a single product formed, as there is only one magnetic environment. If 
there were a series of products, some monomers, some dimers, some including several 
chloride ions and some including none, each of these changes should cause significant 
effects on the aromaticity of the acetylacetonate ligand, and so the magnetic 
deshielding of the methine proton. However, the overlapping signals of the aromatic 
protons, Hc, Hd and He suggest that there may still be several stereoisomers within the 
structure, which causes the aromatic protons to experience different magnetic 
environments as they are forced closer to and further away from the bridging chloride ions 
in some arrangements of the dimers. This recrystallised product was by far the cleanest 
and most promising aluminium dimer with bridging chloride product formed during this 
project. Additional attempts to characterise the complex failed, and attempts to obtain 
elemental analyses were unsuccessful, possibly due to the extremely air sensitive nature of 
the complex. 
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Figure 2.3-2 – Comparative 1H NMR spectrum of crude (top) vs recrystallised (bottom) reaction 
mixtures resulting from the attempted synthesis of compound 2 collected at 500 MHz at 298 K 
in CDCl3 
2.3.3. Attempted syntheses of bis-(4’chlorophenylacetylacetonate)aluminium 
chloride (compound 3) 
 
Compound 3 – bis-(4-chlorophenylacetylacetonate)aluminium chloride dimer 
In other attempted syntheses using substituted phenylacetylacetonate ligands, a similar 
pattern emerges, with the 4’Cl, 2’Cl and 4’OMe phenylacetylacetonate ligands also 
forming tris(acetylacetonate)aluminium derivatives, products with single methine peaks in 
the 1H NMR spectrum.  
The exception is attempted syntheses of compound 3 using 4’chlorophenylacetylacetone 
in dichloromethane and petrol 60 – 80 ° which yielded a slightly green product. The 
product was recrysallised by pentane diffusion into a chloroform solution of the crude 
product under N2. 
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Figure 2.3-3- 1H NMR spectrum of crude product of attempted synthesis of bis-4-
chlorophenylacetylacetonate aluminium chloride collected at 500 MHz and 223 K in CDCl3 
The 1H NMR spectrum of the solid (Figure 2.3-3) showed that the recrystallised solid 
contained many different methine proton environments, with seven signals showing 
between 6.17 and 6.30 ppm, suggesting either several products or several non-
magnetically equivalent stereoisomers.  
The mass spectrum of the solid suggested some formation of the [Al(4-Cl’acac)3]2 dimer, 
showing a major peak of 1249.1 gmol-1 which corresponds to [C60H50Al2Cl6NaO12]. Other 
major peaks corresponding to Al(4-ClPhacac)2 with a major peak representing 
[C20H16AlCl2O4]+ at 417.0 gmol-1  and, Al(4-ClPhacac)3Na; 635 gmol-1, [C30H24AlCl3NaO6]+. 
Attempts to grow crystals under N2 from pentane, chloroform, dichloromethane and 
diffusion of pentane into chloroform at - 20 °C yielded very small amounts of solid which 
were unsuitable for analysis. 
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2.3.4. Synthesis of alkoxide compounds from aluminium chloride precursors  
 
Scheme 2.3-2 – Attempted synthesis of bis-(4’chlorophenylacetylacetonate)aluminium 
chloride dimer 
In one attempted synthesis of compound 3, ethanol was used as a solvent using the 
scheme outlined in Scheme 2.3-2. As alkoxide bridged compounds were also a target of 
this investigation, if the chloride ions were able to suitably act as a base to form ethoxide 
bridging ligands, this would have also been of interest. 
The crude product of the reaction was analysed by 1H NMR spectrum (Figure 2.3-4) and 
shows a shift of the methine peak from 6.09 ppm in the uncomplexed 
4’chlorophenylacetylacetone ligand to 6.29 ppm in the crude reaction mixture, 
suggesting complexation of the ligand to the aluminium centre as expected. 
 Additionally there is a broadening of the peaks corresponding to the CH2 protons of the 
ethanol changing from a doublet at 3.35 ppm to a single broad peak at 3.91 ppm. This 
large upfield shift of 0.56 ppm suggests that there has been some complexation of ethanol 
to the metal centre. Downfield there is a large change in the signals, with a new broad 
signal appearing at 1.29 ppm which may indicate complexation of the ethanol as the 
usual CH3 signal appearing around 1.25 ppm of the ethanol shifts significantly. There are 
additional new peaks at 0.87 ppm which could not be identified. 
This method was also thought to have promise as a possible method to form alkoxide 
complexes as aluminium (III) chloride is not particularly oxygen sensitive, though it is 
hygroscopic and will react with water if exposed to the atmosphere.[29] 
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Figure 2.3-4 – Comparative 1H NMR spectrum showing the spectrum of 
4’chlorophenylacetylacetone (top) against crude reaction mixture of attempted synthesis of 
compound 3 using the synthesis described in Scheme 2.3-2, collected at 500 MHz and 298 K in 
CDCl3. 
The compound was found to be thermally unstable and degraded in the spectrometer 
awaiting long run collections. 
2.3.5. Polymerisation attempts using crude aluminium chloride mixtures 
Polymerisation attempts were made with all aluminium compounds synthesised in the most 
forcing conditions to ascertain whether the acetylacetonate ligands ‘turned off’ the 
metal’s catalytic ability, and whether the acetylacetonate ligands were able to act as 
initiators to the polymerisation reaction. 
The most forcing polymerisation conditions possible for the polymerisation of lactide is to 
dry-melt together the lactide and potential catalyst in a ratio of 200:1 lactide to catalyst. 
51 
 
Lactide melts around 100 °C, but can withstand temperatures of 150 °C before thermal 
decomposition occurs. Using this method the moltern lactide acts as its own solvent for the 
reaction mixture. A stirrer bead is added to ensure reasonable mixing of the reaction 
mixture, and the reaction is conducted in a suba-sealed round bottomed flask under 
nitrogen and submerged in hot oil. 
A successful polymerisation results in a solid at the bottom of the round-bottomed flask at 
150 °C. Degree of polymerisation is measured by 1H NMR spectrum (see Chapter 3) 
The major impurity formed during the synthesis, tris-acetylacetonate aluminium, was found 
not to polymerise lactide in these forcing conditions. Aluminium (III) chloride was also found 
not to polymerise lactide during control studies to ensure there were no impurities within 
the purchased samples of the starting materials which may be active for the 
polymerisation of lactdie. Lactide was found not to self-polymerise in these forcing 
conditions, establishing the control methods for testing the catalytic ability of the polymers. 
All of the tris-acetylacetonate compounds tested were found not to polymerise lactide in 
dry-melt conditions, with 1H NMR spectroscopy confirming no change in the lactide 
monomer after polymerisation attempts. 
However, the impure substance which resulted from attempts to synthesise compound 2 
was found to polymerise lactide efficiently in dry melt conditions and 1:200 equivalents of 
lactide per aluminium centre, to yield a spongy, slightly yellow, solid plastic at 150 °C. This 
crude reaction mixture represented the most successful attempts to synthesise a chloride 
bridged aluminium dimer, which acted as a reasonably successful catalyst for the 
polymerisation of lactide. The ability for aluminium chloride complexes to polymerise 
lactide has not yet been reported in the literature, although some examples of complexes 
containing chloride ligands have.[30, 31] This result led to further investigations of the ability 
of chloride ligands to act as initiating groups to polymerise lactide which are discussed in 
Chapter 3. 
 Synthesis of bis-(acetylacetonate)aluminium sec-butoxide  
[Al(acac)2(sBuO)2]2 (Compound 4) 
Many attempts at synthesising alkoxide bridged compounds were made during this 
project. Due to the severely air sensitive nature of these compounds, as well as their heat 
sensitivity, synthesis and purification of these compounds is extremely challenging. While 
Wrengrovius et al report synthesis of very simple alkoxide bridged dimers, the challenge of 
crystallisation of the most simple compounds remains. The simplicity of the compounds is 
of extreme importance. 
Examples of large substituted ligands and pheyl bridging alkoxide compounds exist in the 
literature,[16, 17, 32-37] however these complexes have unrealistic industrial applications. 
Chapter 1 discusses the current industrial synthetic methods of poly(lactic acid), which 
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uses a simple catalyst of stannous octoate. Any proposed substitute must be as simple to 
handle and as cheap as stannous octoate unless that catalyst confers vastly improved 
synthetic properties such as rate of polymerisation or control of chain length. If an initiator 
is involved, this should be a common solvent. Some catalysts in the literature require 
benzoyl alcohol or more expensive compounds still as an initiator, making these catalysts 
undesirable for industrial use.[38, 39] While the synthesis and purification of the compound 
described in this section is difficult if the chemist wishes to isolate and characterise the 
compound, the synthesis is incredibly simple if they are interested only in creating some of 
the compound in situ to use in polymerisation. 
In order to investigate more closely the mechanism of action of the catalysts, it is necessary 
to have an idea of the structure of the compound in the solid state, for further confirmation 
that the structure of the compound is following the models the mechanism of the 
polymerisation of the plastic is suspected to be. 
This section reports the full synthesis and characterisation of a novel simple alkoxide-
bridged aluminium dimer which acts as an efficient catalyst for the polymerisation of 
lactide at room temperature in solution without the need for an initiator, which is made by 
simple addition of aluminium (III) sec-butoxide and acetylacetone. 
Bis-acetylacetonate aluminium sec-butoxide (compound 4) was synthesised under N2 by 
slow addition of a solution of acetylacetone in chloroform to a stirred solution of 
aluminium(III) sec-butoxide at - 78 °C. The mixture was stirred for three hours at - 78 °C then 
allowed to warm up to 0 °C under dynamic nitrogen flow.  
 
 
Scheme 2.4-1 – Synthesis of bisacetylactonate aluminium sec-butoxide 
The solution was allowed to partially evaporate slowly at 0 °C under nitrogen flow and 
small colourless crystals suitable for X-ray crystallography were obtained. The crystals were 
isolated by filtration and were found to be pure by microanalysis.  
On further cooling a second crop of large cloudy plates were obtained. These plates were 
later found to be tris-acetylacetonate aluminium by 1H NMR spectroscopy.  
 
Compound 1 – bis-acetylacetonate aluminium 
sec-butoxide 
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2.4.1. Crystallographic analysis of bis-(acetylacetonate)aluminium sec-butoxide  
[Al(acac)2(sBuO)2]2 (Compound 4) 
 
Figure 2.4-1 - ORTEP diagram of the asymmetric unit of Compound 4 with ellipsoids displayed 
at the 50% probability level, (hydrogen atoms omitted for clarity) 
Compound 4 crystallised in a tetragonal unit cell in the space group I41. The asymmetric 
unit contains two half-molecules with a total of eight molecules in the unit cell. Bond angles 
and lengths are included in Table 1.4-1 and Table 1.4-2 respectively. 
Each symmetry generated molecule contains only one of the half molecules shown in the 
asymmetric unit, giving rise to Al(1)-Al(1) molecules and Al(2)-Al(2) molecules in the crystal 
structure. The two molecules are equivalent within error. The dimer structure contains two 
octahedral aluminium centres, with bridging sec-butoxide O-Al bond lengths measuring 
1.882(6) Å and 1.870(6) Å, and an average interatomic Al-Al inter-atomic distance 
measuring 2.91 Å. This further confirms the electron precise nature of the complex as this 
bond length is very similar to the bond lengths found in simple aluminium oxide hydroxide 
minerals such as diaspore of 1.86 Å.[40, 41] The aluminium-acetylacetonate oxygen 
interactions are all equidistant, within error, measuring an average of 1.90 Å. The bridging 
centre is sterically strained and there is a significant pinching effect between the 
aluminium atoms and the bridging oxygen atoms reducing the O(6)-Al(1)-O(6) bond angle 
to 78.25(3)° (Figure 2.4-3). The bond angles around the sec-butoxide oxygen atom  seem 
to exhibit a trigonal planar geometry, with the outside C(13)-O(5)-Al(1) angles measuring 
129.6(8)°, and the strained angle inside the bridging structure Al(1)-O(5)-Al(1) measuring 
101.5(2)°.  
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Figure 2.4-2 – Capped stick diagram showing the sec-butoxide bridging ligand plane (blue)  
 
     
  
Figure 2.4-3 – Selected bond lengths and angles in the structure of compound 4 (atoms 
omitted for clarity) 
 
The sec-butoxide ligand was shown to have a 2D planar carbon backbone (Figure 2.4-2) 
which was not expected. The sec-butoxide C(13)-O(5) bond measures 1.412(9) Å, 
indicating a single  C-O bond, and sp3 hybridised oxygen atom, rather than the sp2 C=O 
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which is suggested by the planar arrangement of the sec-butoxide chain.  This planarity 
may be a result of average motion of the chain, which is supported by the large ellipsoids 
of the sec-butoxide carbon atoms (Figure 2.4-1). This thermal motion leads to an odd 
placement of the hydrogen atom of the sec-butoxide carbon. The other carbon-carbon 
bond lengths within the sec-butoxide carbon backbone are anomalous measuring: C(13)-
C(12) 1.223(19)Å, C(13)-C(14) 1.72(2)Å and C(11)-C(12) 1.222(13)Å. Other angles around 
the aluminium centres were as expected all measuring approximately 90° (Figure 2.4-3 
and Figure 2.4-4) 
           
Figure 2.4-4 – Space filling diagram of compound 4 
The crystal structure gives us some insight into the reason why the methyl protons of the 
acetylacetonate ligand might be observed as two separate peaks in the 1H NMR 
spectrum in Figure 2.4-6. Figure 2.4-4 shows a space filling diagram of compound 4. Due 
to the sterically strained nature of the bridging structure the acetylacetone methyl groups 
are forced together into a very close arrangement, with a methyl carbon - methyl carbon 
distance measuring 4.89 Å. A 1996 study of observed Van der Waals radii of carbon-
hydrogen bonds from crystal structures conducted by Taylor et al. was found to be 3.02 
Å.[42] With the methyl – methyl distances being so short compared to an expected C-H 
bond length, it is possible at this distance that the Van der Waals radii of the methyl protons 
are able to interfere, causing a change in magnetic environment enough for these 
interacting methyl groups to be differentiated in an NMR spectrum.   
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 Al(1)-Al(1)(a) 2.915(5)Å   Al(1)-O(5) 1.882(6)Å 
 Al(1)-O(5)(a) 1.883(6)Å   Al(1)-O(2) 1.902(7)Å 
 Al(1)-O(3) 1.889(6)Å   Al(1)-O(4) 1.908(7)Å 
 Al(1)-O(1) 1.902(5)Å   O(5)-Al(1)(a) 1.883(6)Å 
 O(5)-C(13) 1.412(9)Å   O(2)-C(4) 1.283(11)Å 
 O(3)-C(7) 1.288(9)Å   O(4)-C(9) 1.241(10)Å 
 O(1)-C(2) 1.263(10)Å   C(1)-C(2) 1.481(11)Å 
 C(9)-C(10) 1.527(11)Å   C(9)-C(8) 1.393(12)Å 
 C(2)-C(3) 1.390(11)Å   C(7)-C(8) 1.384(11)Å 
 C(7)-C(6) 1.494(12)Å   C(4)-C(3) 1.372(13)Å 
 C(4)-C(5) 1.531(11)Å   Al(2)-Al(2)(b) 2.923(5)Å 
 Al(2)-O(6) 1.888(6)Å   Al(2)-O(8) 1.895(7)Å 
 Al(2)-O(10)(b) 1.875(6)Å   Al(2)-O(10) 1.870(6)Å 
 Al(2)-O(7) 1.898(8)Å   Al(2)-O(9) 1.902(6)Å 
 O(6)-C(16) 1.288(9)Å   O(8)-C(21) 1.288(11)Å 
 O(10)-Al(2)(b) 1.875(6)Å   O(10)-C(27) 1.447(11)Å 
 O(7)-C(18) 1.249(10)Å   O(9)-C(23) 1.254(9)Å 
 C(24)-C(23) 1.507(10)Å   C(19)-C(18) 1.499(11)Å 
 C(23)-C(22) 1.389(11)Å   C(16)-C(17) 1.369(11)Å 
 C(16)-C(15) 1.523(11)Å   C(18)-C(17) 1.408(12)Å 
 C(22)-C(21) 1.382(13)Å   C(21)-C(20) 1.513(11)Å 
 C(28)-C(27) 1.72(3)Å   C(11)-C(12) 1.222(13)Å 
 C(27)-C(26) 1.228(19)Å   C(13)-C(12) 1.223(19)Å 
 C(13)-C(14) 1.72(2)Å   C(26)-C(25) 1.264(14)Å 
      
 
Table 2.4-1 – Selected bond lengths for Compound 4 with standard uncertainties listed in 
parentheses. (a)/(b) – Indicates a symmetry generated atom in the second half of the molecule 
 
           
 O(5)-Al(1)-Al(1)(a) 39.28(16)°   O(5)(a)-Al(1)-Al(1)(a) 39.27(16)° 
 O(5)-Al(1)-O(5)(a) 78.5(2)°   O(5)-Al(1)-O(2) 94.6(3)° 
 O(5)(a)-Al(1)-O(2) 90.5(3)°   O(5)(a)-Al(1)-O(3) 95.9(3)° 
 O(5)-Al(1)-O(3) 174.3(3)°   O(5)(a)-Al(1)-O(4) 94.6(3)° 
 O(5)-Al(1)-O(4) 90.2(3)°   O(5)(a)-Al(1)-O(1) 174.5(3)° 
 O(5)-Al(1)-O(1) 96.0(3)°   O(2)-Al(1)-Al(1)(a) 93.08(19)° 
 O(2)-Al(1)-O(4) 173.6(3)°   O(2)-Al(1)-O(1) 89.2(2)° 
 O(3)-Al(1)-Al(1)(a) 135.1(2)°   O(3)-Al(1)-O(2) 86.6(3)° 
 O(3)-Al(1)-O(4) 89.1(3)°   O(3)-Al(1)-O(1) 89.6(3)° 
 O(4)-Al(1)-Al(1)(a) 93.4(2)°   O(1)-Al(1)-Al(1)(a) 135.2(2)° 
 O(1)-Al(1)-O(4) 86.1(3)°   Al(1)-O(5)-Al(1)(a) 101.5(2)° 
 C(13)-O(5)-Al(1) 129.6(8)°   C(13)-O(5)-Al(1)(a) 128.2(8)° 
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 C(4)-O(2)-Al(1) 128.3(5)°   C(7)-O(3)-Al(1) 129.3(5)° 
 C(9)-O(4)-Al(1) 129.5(6)°   C(2)-O(1)-Al(1) 130.3(5)° 
 O(4)-C(9)-C(10) 114.6(9)°   O(4)-C(9)-C(8) 124.0(8)° 
 C(8)-C(9)-C(10) 121.3(8)°   O(1)-C(2)-C(1) 117.9(7)° 
 O(1)-C(2)-C(3) 122.7(8)°   C(3)-C(2)-C(1) 119.5(8)° 
 O(3)-C(7)-C(8) 122.6(7)°   O(3)-C(7)-C(6) 115.3(7)° 
 C(8)-C(7)-C(6) 121.9(8)°   C(7)-C(8)-C(9) 123.3(8)° 
 O(2)-C(4)-C(3) 124.2(8)°   O(2)-C(4)-C(5) 115.4(9)° 
 C(3)-C(4)-C(5) 120.4(8)°   C(4)-C(3)-C(2) 123.5(8)° 
      
 
Table 2.4-2 – Bond angles for  compound 4 with standard uncertainties listed in parentheses 
(a)
 – Indicates a symmetry generated atom in the second half of the molecule 
 
 
Figure 2.4-5 – Crystal packing of  compound 4 viewed down the c-axis of the crystal structure.  
        Left – Capped Stick Diagram                        Right – Space filling diagram 
Figure 2.4-5 shows the crystal packing of compound 4 when viewed down the c-axis. The 
compound shows an interesting structure where the aluminium bridges of the compound 
stack on top of each other to form an interesting square lattice, and forming tiny channels 
running down the structure when viewed in the space filling mode are too small for 
possible hosting applications. 
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2.4.2. NMR spectroscopic analysis of bis-(acetylacetonate)aluminium sec-
butoxide  (Compound 4) 
The 1H NMR spectrum of the isolated product shows broad peaks belonging to the 
aluminium sec-butoxide dimer (compound 4) and sharp peaks identified as belonging to 
an aluminium tris-acetylacetonate. The full 1H NMR spectrum is displayed in Figure 2.4-6.  
At room temperature the 1H NMR spectrum is complex. The usual diagnostic peak for the 
methine proton of the β-diketonate (Hb Figure 2.4-6) is split into two distinct signals at 5.38 
ppm and 5.33 ppm which coalesce to a single signal at 5.36 ppm as the sample is heated 
to 60 °C (Figure 2.4-7).  
It is possible that increasing the temperature pushes the formation of tris-acetylacetonate 
aluminium. If this were the case only two products would be formed, tris-acetylacetonate 
aluminium and aluminium (III) sec-butoxide. As tris-acetylacetonate aluminium is already 
present in the spectrum, the product formed at 60 °C must be different, otherwise the 
methine proton labelled b in Figure 2.4-7 would join the signal downfield at 5.15 ppm. 
Aluminium is known to form 5 co-ordinate trigonal bipyramidal structures. [43, 44] One 
possibility is that, at room temperature, the interconversion between the dimeric structure 
and the monomeric structure as shown in Scheme 2.4-2 is reasonably rapid, and both 
forms can be seen in the 1H NMR spectrum. As the sample is heated the kinetic product is 
formed and only one of these forms is seen. As the dimer is known to be the 
thermodynamic product, forming at - 78 °C, it may be the monomer which predominates 
in the 60 °C spectrum. 
 
Scheme 2.4-2 – Possible interconversion of aluminium dimers into two aluminium monomers 
This mirrors the observations of the methyl group signals of the β-diketonate ligand (Ha) 
which also displays two separate signals at room temperature which coalesce into one 
signal on heating to 60 °C.  
As the sample is cooled to - 50 °C the methine peak separates into a large number of 
signals, with three major signals emerging, all displaying significant movements of 
chemical shift. Again this effect is reflected by the methyl proton signals of the β-
diketonate ligand, which also separate into a complex set of peaks. Due to the symmetry 
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of the aluminium dimer it seems unlikely that the peaks which emerge at - 50 °C could arise 
from stereochemical isomers of the complex, and must instead arise from structural isomers 
of the dimer, but at this time it is unclear what these structures may be. 
It was unclear whether the aluminium tris-acetylacetonate is formed spontaneously on 
dissolution or if it exists as an impurity in the isolated solid. Attempts to further purify the 
compound by techniques other than recrystallisation were made. The air-sensitive and 
electronically deficient nature of the compound made column chromatographic 
separating methods infeasible, and so sublimation was chosen as a possible method for 
purification. 
Several experiments were conducted to find suitable conditions to purify compound 4 by 
sublimation. The compound was found to melt at 172 °C under nitrogen while 
aluminiumtris-acetylacetonate is known to have a melting point above 190 °C.  The 
sublimation was performed under static vacuum at 160 °C, however it was found that the 
compound was thermally unstable with NMR analysis of the resulting sublimate showing 
several decomposition products. 
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Figure 2.4-1 – Assigned 1H NMR spectrum of compound 4 collected at 500 MHz, 298 K in CDCl3 
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Figure 2.4-7 – Variable temperature 1H NMR spectrum of compound 4 collected at 500 MHz in CDCl3
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Figure 2.4-8 – 13C {1H} NMR spectrum of compound 4 (bottom) and DEPT 135 13C{1H} spectrum (top) collected at - 50 °C in CDCl3 at 125 MHz
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2.4.3. Polymerisation of lactide by bis-(acetylacetonate)aluminium sec-butoxide  
(Compound 4) 
Compound 4 was found to polymerise 400 equivalents of lactide at 150 °C in dry melt 
conditions in 5 minutes to yield a white polymer giving a turnover number of 1.32 
molecules/s. The compound was also found to polymerise lactide in toluene at 80 °C in 
under one hour. Compound 4 was synthesised with aluminium tris-acetylacetonate as the 
major impurity, which is known to be inactive to ring opening polymerisation in solution, so 
the polymerisation activity is assumed to be as shown in Figure 2.4-9.[45] 
 
Figure 2.4-9 - Possible mechanism of polymerisation of lactide 
The first step of normal polymerisation is thought to be coordination of the lactide molecule 
to the metal centre. The following step is an alkoxide insertion into the coordinated lactide 
carbonyl bond. This step allows the migratory group to be covalently bonded into the 
chain of the polymer, which then acts as a migratory group to insert into the next molecule 
of lactide.[46]  
Compound 4 was added to two equivalents of lactide in CDCl3 (one molecule of lactide 
per metal centre) and a 1H spectrum taken at intervals over 24 hours in an attempt to 
study the first step of the polymerisation (Figure 2.4-10). As time elapses the broad signal at 
3.70 ppm labelled as He becomes more defined with a slight upfield shift as the flexible 
R2HC-O proton of the sec-butoxide (labelled He in Figure 2.4-10) moves from an α-position 
to a Lewis acidic oxygen atom to a well-defined proton in an α-position to an ester. The 
peaks labelled Hf and Hd at 1.37 ppm and 0.88 ppm respectively also become a defined 
triplet and doublet confirming the original assignment, however, the final protons 
belonging to the sec-butoxide bridging group, Hc, does not become defined at all. 
Furthermore the protons Ha and Hb which belong to the acetylacetonate ligand appear 
to be diminishing as some intermediate structure is formed with singlet peaks at 1.89 ppm, 
2.08 ppm and 5.43 ppm.  During the experiment there is a slow reduction in peak height 
of the protons belonging to the lactide ring labelled Hi at 5.04 ppm. This change in intensity 
suggests that as this is the most acidic proton on the molecule it may be removed by the 
sec-butoxide acting as a base. If this is so an upfield shift would be expected as sec-
butanol is formed and the oxygen no longer binds to the metal centre, however in this 
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experiment we observe the opposite occurring as the more defined protons He move 
downfield and become more defined. 
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Figure 2.4-10 – 1NMR spectra showing in situ polymerisation of lactide using compound 4 over 24 hours, collected at 500 MHz, 298 K  in CDCl3
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 Conclusion 
A route to synthesis and characterisation of a very fragile novel sec-butoxide bridged aluminium 
dimer complex has been found, and structural information for a simple β-diketonate dimer has 
been reported for the first time. The simplicity of synthesising this catalyst in situ makes it an ideal 
candidate for industrial use, and the structural information reported will contribute to further study 
into the mechanism of the ring opening polymerisation of aluminium alkoxide complexes. The 
complex was found to have good activity as a catalyst for the ring opening polymerisation, with 
catalytic turnover of over one molecule per second at 150 °C yielding an industrially useful colourless 
polymer. This is somewhat comparable to catalysts used in industry which report turnover numbers 
between 5-10 molecules per second. 
Some attempts to synthesise chloride-bridged aluminium dimers have been made and crude 
mixtures containing aluminium chloride complexes have been found to polymerise lactide. The 
synthetic evidence included in this chapter may be enough to put chloride-bridged dimers to use 
as a catalyst for polymerisation by forming the complex in situ if the aluminium chloride complexes 
are more air and water stable than the aluminium sec-butoxide complexes, this may prove a 
significant industrial advantage. 
 Further Work 
Further work in this field should be to continue to attempt to crystallise substituted bridged aluminium 
sec-butoxide bridged β-diketonate complexes and study structure -activity relationships with the 
ability to polymerise and rate of polymerisation as electron withdrawing and electron donating 
groups are incorporated into the complex. 
Further investigation into the industrial applicability of compound 4 to large scale polymerisation 
experiments may bring the project towards commercial viability as a replacement for toxic tin 
impurities in commercial beverage plastics. 
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3.  TITANIUM CHLORIDE COMPLEXES FOR 
POLYMERISATION OF LACTIDE 
 Titanium chloride complexes as anti-cancer drugs 
Previous work in the McGowan group by Dr. James Mannion, Dr Andrew Hebden and Dr. Benjamin 
Crossley have reported the anti-cancer activity of Budotitane derivatives featuring monodentate 
halide ligands.[1-3] The general preparation is detailed in Scheme 3.1. Compounds with a cis-chloride 
or cis-bromide motif were found to be cytotoxic with some IC50 values comparable to those of cis-
platin, and most within an order of magnitude on the A2780 ovarian carcinoma and MCF-7 breast 
cancer cell lines.  
 
Scheme 3.1- General preparation of titanium halide complexes 
 
It is well known that titanium is able to act as a catalyst for the ring opening polymerisation of lactide 
with titanatranes,[4] titanium alkoxide complexes[5-7] titanium oxide clusters[8] and amidotitanium[9] 
complexes all reported to be active. Titanium has also been used in conjunction with other metals 
in bimetallic complexes and on its own to polymerise lactide.[10] Usually, when titanium complexes 
are used for this purpose an alkoxide group is included in the complex, or an alcohol initiator is used 
to add an alkoxide group to the complex.[11, 12] A small number of examples of titanium chloride 
complexes have been found to polymerise lactide without initiator.[5, 13, 14] The mechanism for the 
ring opening polymerisation of lactide is not yet well characterised, but is assumed to proceed by 
a coordination-insertion mechanism in which the lactide first coordinates, then a labile group inserts 
into the ester C-O bond, causing the lactide ring to open and the addition of the labile group into 
the chain of the polymer (Figure 3.1-1). 
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Figure 3.1-1 – Proposed mechanism of the ring opening polymerisation of lactide 
The anti-cancer active titanium chloride complexes were synthesised and tested for ability to 
polymerise lactide. Attempts were made to assess whether the titanium species retains anti-cancer 
ability after the polymerisation and kinetic information about the rate of polymerisation was also 
collected. 
3.1.1. In solution polymerisations 
Polymerisations were conducted using three titanium chloride complexes previously synthesised by 
Dr James Mannion.[3] These complexes were chosen as they have structures well defined by the 
McGowan group with crystal structures of all three having been collected. The steric bulk of the 
ligand increases in the order 1 < 2 < 3 and also has electron withdrawing properties increasing in 
the same order. 
 
Figure 3.1-2– Titanium chloride complexes investigated for polymerisation of lactide 
Bis-acetylacetonate titanium(IV) chloride complexes were synthesised by the slow addition of two 
equivalents of the relevant acetylacetone to titanium(IV)chloride with vigorous stirring in 
chloroform. After 16 hours a red precipitate was formed and the solvent removed by filtration. The 
red solid was dried in vacuo and purity was assessed by microanalysis. 
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Polymerisations in solution were investigated using Schlenk line techniques in dry toluene. Solutions 
of 1, 2 and 3 with 200 equivalents of rac-lactide were heated at 70 °C and refluxed at 110 °C with 
vigorous stirring in all cases. The solutions were precipitated in ice after 24 hours, reduced in vacuo 
and the resulting pink solids were found to be unchanged from initial mixtures of catalyst and lactide 
by 1H NMR spectroscopy. This suggests that titanium (IV) chloride complexes are inactive catalysts 
for the ring opening polymerisation of lactide in solution, or at low temperatures. 
3.1.2. Dry Melt Polymerisations 
A preliminary study was conducted by preparing mixtures of titanium complexes 1, 2 or 3 and rac-
lactide in a ratio of 1:200 respectively under anhydrous glove box conditions. The flask was closed 
with a suba seal, and release of expanding gas was allowed through a pin hole in the seal. The 
body of the flask was submerged in oil and heated to 150 °C while stirring for 2 days. As the 
polymerisation was found not to proceed in solution there was no need for addition of a specific 
quenching agent before analysing the polymers in CDCl3. If any residual active species were 
present they would be quenched by exposing the plastic to air and with addition of wet deuterated 
chloroform. The degree of polymerisation was measured by integration of 1H NMR signals of the 
ester proton of the lactide molecule against the downshifted ester proton of the poly(lactic acid) 
chain. The spectra of poly(L-lactic acid) or poly(D-lactic acid) are fairly simple with only one 
polymer environment. As the enantiomeric environment becomes more complicated so does the 
NMR spectrum.[15]  
 
Figure 3.1-3 – Example integration of unreacted lactide quartet (right) against polymer chain signals 
(left) 
Compounds 1, 2 and 3 were found to polymerise rac-lactide under dry melt conditions (200 eq 
lactide, 150 °C, N2 atmosphere, 2 days) giving poly(lactic acid) with varying degrees of conversion 
to polymers (1 = 80% conversion 2 = 54% conversion, 3 = 14% conversion). In all three cases the 
polymer mixture was brown in colour.  
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This data correlates as expected with the ring opening mechanism described in Figure 3.1-1. The 
first step of the polymerisation involves the coordination of lactide to the metal centre. The more 
electron donating the β-diketonate ligand on the catalyst the slower this preliminary step and each 
additional coordination of lactide will be afterwards. The order of degree of electron withdrawing 
of the ligand from the metal is 1 > 2 > 3 which correlates with the conversions, the largest conversion 
observed when compound 1 is used as a catalyst and smaller observed conversions when a more 
withdrawing methoxy substituted catalyst is used.  
 
Figure 3.1-4 – 1H NMR spectrum of resulting polymer/lactide mixture after stirring at 150 °C for two days. 
It could be argued that the larger the electronic withdrawal to the metal centre, the more likely a 
C=O lone pair of the lactide will form a dative coordination to the metal centre, and so more likely 
the monodentate ligand is to insert into the π* of the C=O of a coordinated lactide molecule. If this 
is the case this data may provide some argument to the idea that the coordination of the lactide 
to the metal centre is the rate determining step of the polymerisation. A variation of the catalyst 
loading may offer additional insight into the mechanism. 
Several studies probing the mechanism of the polymerisation were undertaken. Compound 2 was 
reacted with 3, 5, 10 and 200 equivalents of rac-lactide under anhydrous conditions. The mixtures 
were stirred at 150 °C for 2 days under partial vacuum. Sublimed lactide was returned to the 
reaction mixture by heating the body of the flask periodically. Mass spectrometry was utilised to 
analyse the polymers.  The mass spectra of all of the polymerisations followed the expected pattern 
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of peaks separated by a gap of 72 gmol-1, corresponding to a single repeating lactic acid unit. 
(Figure 3.1-5) 
In an attempt to identify whether the ligand itself is acting as an initiating group for the ring opening 
reaction or the chloride, the mass spectra were studied in detail to identify chains of poly(lactic 
acid) with an additional chloride atom.  
Table 3.1-1 and Table 3.1-2 show assignments of the major peaks of the mass spectra of the mixtures 
of 3 and 10 equivalents of lactide to catalyst respectively. Solutions of polymer in dry chloroform 
were compared against sodium formate calibrant. The sample was subjected to electrospray 
ionisation. Each peak found was matched to the closest possible ion or adduct found by 
calculation of all possible values of Tin(C3H4O2)mClx(C10H9O2)y+Naz up to the detection limit of the 
instrument, 2000 gmol-1. Phenylacetonate has been shortened to (L) for clarity. Each spectrum 
shows some evidence of chloride inclusion into a lactide chain (peaks 9, 17, 25 and 27) however 
there is as much evidence for inclusion of the ligand into the chain before ionisation (peaks 10, 18, 
22 and 26). As the polymer/catalyst mixture is fairly complex the spectrum features many 
overlapping peaks, making isotopic matching more difficult, however some examples of short 
oligomers of lactic acid with possible acylchloride terminals were found with matching isotopic 
patterns, showing there was at least some initiation by the chloride moieties.  Figure 3.1-6 shows one 
such isolated peak representing 5 repeating units of lactic acid, with an additional chloride atom. 
The observed peak has excellent correlation with the predicted isotopic abundances and may be 
the acylchloride species the mechanism predicts. However, as always with mass spectrometry, it is 
possible that the observed species is simply an ionisation product formed in the instrument. Further 
evidence was sought using NMR spectroscopy.  
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Figure 3.1-1 – Mass spectrum of polymer mixture of compound 2 with 200 equivalents of rac-lactide. 
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Figure 3.1-6 – Isotopic pattern calculated (top) and found (bottom) for a fragment of 
poly(lactic acid) chain containing a chlorine atom. 
 
Peak 
number 
m/z Assignment Chemical Formula 
1 429.1 0.5(lactide)Cl(L)2 C23H22O6Cl 
2 483.1 1.5(lactide)Ti(L) + Na C19H21O8TiClNa 
3 511.2 0.5(lactide) Ti(L)2Cl2 – H C23H23O6TiCl2 
4 527.1 3.5(lactide) + Na C21H28O14Na 
5 589.2 2(lactide)TiCl2(L) + Na C22H24O10TiCl2Na 
6 684.4 2.5(lactide)TiCl2(L) + 2Na C25H29O12TiCl2Na2 
7 701.2 3.5(lactide)Cl (L) C31H37O16Cl 
8 815.2 5.5(lactide)Na C33H44O22Na 
9 971.3 6.5(lactide)Cl C39H52O26Cl 
10 999.3 5.5(lactide)(L) + 2Na C43H53O24Na2 
 
Table 3.1-1 – Major peaks from the mass spectrum of dry melt of 3 equivalents of lactide with 1 
equivalent of compound 2. (L) = phenylacetylacetonate 
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Peak 
number 
m/z Assignment Chemical Formula 
11 327.1 0.5(lactide) Ti (L) + 2Na C13H13O4TiNa2 
12 387.1 1(lactide) Cl (L) + 2Na +H C16H18O6ClNa2 
13 429.1 0.5(lactide) Cl (L)2 C23H22O6Cl 
14 483.1 1.5(lactide) Ti Cl (L) + Na C19H21O8TiClNa 
15 511.2 0.5(lactide) Ti Cl2 (L)2 -H C23H21O6TiCl2 
16 527.1 3.5(lactide) +Na C21H28O14Na 
17 611.1 4(lactide) Cl C24H32O16Cl 
18 689.2 3.5(lactide) (L) +Na +H C31H38O16Na 
19 795.1 3.5(lactide) Ti Cl (L) + 2Na + H C34H38O16TiClNa2 
20 815.2 5.5(lactide) + Na C33H44O22Na 
21 897.2 3.5(lactide) Ti (L)2 + Na C41H46O18TiNa 
22 999.3 5.5(lactide) (L) + 2Na C43H33O24Na2 
23 1091.6 7(lactide) Ti Cl C42H56O28TiCl 
24 1181.2 6.5(lactide) Ti Cl (L) + H C49H62O28TiCl 
25 1283.3 8.5(lactide) Cl + Na + H C51H69O34ClNa 
26 1353.4 7(lactide) (L)2 Na C62H74O32Na 
27 1449.7 9.5(lactide) Cl + 2Na C57H76O38ClNa2 
 
Table 3.1-2 - Major peaks from the mass spectrum of dry melt of 10 equivalents of lactide with 
1 equivalent of compound 2. (L) = phenylacetylacetonate 
 
  NMR Spectroscopy For Polymer Analysis 
Several papers on the proton NMR environments of polymers of lactide are available in 
the literature.[16-23] The two chemical environments in L-lactide are identical to those in D-
lactide; upfield, around 1.68 ppm, there is a doublet arising from methyl protons in β 
arrangement with a carbonyl group. Downfield there is a quartet at 5.05 ppm arising from 
a methine proton in the α arrangement to the ester carbonyl. On polymerisation the 
methyl protons shift upfield around 0.11 ppm, while the α proton shifts downfield around 
0.12ppm. However, the spectra of the polymer formed by these catalysts are more 
complex.  
As the polymerisation of rac-lactide proceeds in the presence of catalyst it is assumed to 
be equally likely that a D-lactide molecule or L-lactide will complex to the catalyst and 
join into a polymer chain. As each monomer is added it can be described as being either 
isotactic with the last molecule, i.e. having the same stereochemistry, or as syndiotactic 
with the last monomer, i.e. having opposite stereochemistry. An isotactic diad of lactic 
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acid repeating units could be –RR- or –SS-, both of which would be expected to have 
equivalent signals by NMR spectroscopy (Figure 3.2-1). 
 
Figure 3.2-1 – Figure showing the isotactic and syndiotactic naming system for a hexad of 
lactic acid repeating units. Note that ‘iisss’ would also give describe a hexaad with where the 
sequence of configuration of chiral centres is “S,S,S,R,S,R” 
A syndiotactic diad would have configurations of either –RS- or –SR-, again these would 
be expected to be equivalent in the 1H NMR spectra. A diad of lactic acid units with 
opposite chirality can therefore be described simply as ‘s’, and two acid units with the 
same arrangement would be described as ‘i’.  
Chains of units can be denoted by describing each one as ‘i’ or ‘s’ to the one preceding, 
for example a chain containing perfectly alternating –RSRSRS- stereocentres would be 
described as having each stereocentre in the opposite configuration to the last, the first 
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pair (-RS-) is syndiotactic, the pair starting on the second stereocentre (-SR-) is syndiotactic. 
So the –RSRSRS- hexad could be described as sssss. All five diads in syndiotactic 
arrangements. More stereoirregular chains can also be described. -RSRR- can be 
described as ssi, and -RRRSRS- would be described as iisss (Figure 3.2-1).  
Each set of unique chiral tetrads and hexads of the lactic acid repeating unit are 
distinguishable, having unique chemical shifts in both 1H and 13C spectra due to having 
different magnetic environments. This nomenclature of the lactic acid chain allows us to 
assign peaks to chiral environments, regardless of whether the chiral environment is left 
handed or right handed. While ssi represents the -RSRR- string mentioned earlier, it also 
represents the chemically and magnetically identical tetrad –SRSS-.  
However there has been discussion in the literature about which chemical shifts represent 
which stereochemical assignment. Preliminarily Kriechldorf et al. performed Bernoullian 
statistical analyses of the outcomes of polymerisations of meso-lactide and rac-lactide 
and correlated integrations from homonuclear decoupled experiments to assign the 
peaks to the relevant tetrads to each peak.[19] Later Chisholm et al. performed HETCOR 
experiments to correlate 13C signals to their corresponding 1H signals. The Chisholm group 
found a correlation between 1H signals suggested to arise from reported sis tetramers (-
RSSR-, or –SRRS-) and 13C signals for iss/ssi configurations of lactic acid units, suggesting that 
one of these assignments was incorrect, prompting the group to propose a new 
assignment of the peaks.[23]  Further discussion from Thakur et al. suggested that the 
chemical shift differentiation between chiral tetrads arises asymmetrically; i.e. two stereo 
units in one direction and only one unit in the other, and that the direction of asymmetry 
in the case of 13C NMR and 1H NMR spectroscopy were opposite, leading to confusion 
from the HETCOR experiments. Most recently Kasperczyk conducted high resolution 
HETCOR experiments and agreed with the original assignments reported by Kriechldorf.[24] 
In the case of polymers of rac-lactide stereocentres can only join in pairs with chain 
configurations following a pattern of –RRRR- or –RRSS- and their opposites. It is, therefore, 
impossible for an ss triad to appear as this would represent a fragment such as –RSR- or –
SRS-. It is possible for one of the stereocentres to undergo nucleophilic attack and be 
inverted during the reaction, or undergo transesterification reactions, but this effect is 
expected to be rare and not observed in these spectra as the titanium atoms act as lewis 
acids, preventing formation of large concentrations of free nucleophiles. 
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Figure 3.2-1 – 1H spectrum of reaction mixture of dry melt of 200 equivalents of lactide with 1 equivalent of compound 2 collected at 298 K 
at 500 MHz in CDCl3 
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Figure 3.2-2 shows the 1H NMR spectrum of the resulting polymer from mixture of compound 
2 and 200 equivalents of rac-lactide in CDCl3. The major peaks in this spectrum are well 
defined, belonging to unreacted lactide at 5.05 ppm and 1.68 ppm.  The multiplet at 5.16 
ppm arises from the stereoisomers of the polymer chain. At least two overlapping quartets 
can be observed, one at 5.16 ppm and the other at 5.20 ppm. Neither peak is well defined 
with additional peaks appearing on the left and right of the multiplet, suggesting several 
overlapping peaks. 
Similarly the expected doublet at 1.58ppm representing the poly(lactic acid) shows at 
least two overlapping doublet signals with smaller signals at 1.49 ppm  and 1.54 ppm. 
The chemical shifts of each of the peaks of the polymer in the spectrum are obscured by 
the splitting patterns of the proton peaks. A much clearer picture of the stereochemical 
environments of the polymer can be obtained using decoupled spectra. Figure 3.2-3 
shows a 14,000 scan 13C{1H} spectrum of the resulting bulk polymers of mixture of 200 
equivalents of lactide with one equivalent of compound 2, with the peaks labelled ‘d’, 
arising from the carbon next to the ester carbonyl, which is typically used to deduce 
whether the polymer is atactic as expected and whether the catalyst is capable of 
distinguishing between specific diastereomers of lactide as they are included. Figure 3.2-4 
shows the expected shift and approximate areas of the two possible carbon environments 
of polymers of rac-lactide, assuming random incorporation of diastereomers of lactide to 
the polymer chain as described by Kasperczyk.[24] The major peaks of the 13C{1H} NMR 
spectra show good agreement with the predicted spectra, with both major peaks at the 
correct chemical shift. The peak height ratio of the calculated spectrum is 1:3 for isi:iii 
peaks. In the real spectrum the peak areas have a ratio of 1:2.5, which given the noise in 
the signal, as well as the nuclear Overhauser enhancement used in the process of 
acquiring decoupled spectra, is close enough to say that the catalyst has no diastereo 
preference as expected.   
Figure 3.2-4 also shows a comparison between the calculated 1H NMR spectrum and the 
experimental spectrum. The pattern of having a larger area in the upfield isis, isii, iii and siiii 
signal region of the polymer quartet around 5.16 ppm and areas of expected lower signal 
around 5.20 ppm representing iiis, iisi and sisi tetrads is observed in the 1H NMR spectrum, 
however the signal overlap does not allow us to take meaningful measurements of the 
comparative size ratios of those signals. 
  
 
 
Figure 3.2-2 – 13C{1H} spectrum of reaction mixture of 48 hour dry melt of 200 equivalents of lactide with 1 equivalent of compound 2. 
  
 
 
 
 
Figure 3.2-4 – Expected chemical shifts of poly(rac-lactic acid) tetramers and pentamers (top) 
with observed peaks (bottom)[24] 
 
A 13C DEPT 135 experiment shows the signals a, d, e and f to belong to quaternary carbon 
atoms, and agreement with the literature led to the assignments of the peaks given in 
Figure 3.2-3.[17, 19, 23, 24] 
 
Figure 3.2-5 – Comparison of the observed signals to 1-chloro-2-methyl-1-oxopropan-2-yl 
acetate[25] 
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Further analysis of the 13C{1H} NMR spectrum shows evidence of an acylchloride group 
outside of the vigorous conditions of the electrospray ionising source. The peak labelled 
‘a’ at 174.99 ppm was found to correlate very closely with the chemical shift of an 
analogous molecule, 1-chloro-2-methyl-1-oxopropan-2-ylacetate, reported in the 
literature.[26] (Figure 3.2-5) 
 In situ polymerisation kinetics 
As the previously described bulk method introduced errors of unknown size, a new method 
for investigating the activity of the titanium chloride complexes was sought to eliminate 
removal of lactide from the polymerisation mixture by sublimation and to ensure a 
thoroughly anaerobic atmosphere throughout the reaction. It was decided that the 
samples should be prepared in a glove box to ensure environments of O2 concentrations 
<5 ppm and H2O concentrations <1ppm. Bulk samples were prepared and crushed with a 
pestle and mortar to ensure homogenicity. HPLC vials were prepared with approximately 
equal amounts of lactide/catalyst mixtures and sealed using a PTFE/rubber/aluminium 
crimp cap. The vials were then submerged in oil at the desired temperature with vigorous 
stirring to ensure continuous tumbling and, therefore, complete mixing of the mixture inside 
the vials. Preliminary experiments showed the degree of conversion to be much higher 
using this method than stoppered flasks. Control vials charged with only L-lactide and 
stirred using this method were found to be unchanged after stirring for 24 hours. 
In situ polymerisation studies were carried out by submerging several vials at the same time 
and removing vials at the appropriate time. Each vial was analysed by NMR spectroscopy 
with wet CDCl3 and percentage conversion calculated by integration of the unreacted 
lactide quartet against the PLA quartet. To simplify this measurement L-lactide was used 
as it has only one stereo environment in the NMR spectrum, that of the iii tetrad. Three 
separate proton acquisitions were run on each HPLC vial. A sample of compound 3 was 
prepared with 200.06 equivalents of L-lactide. Several sample vials were prepared and a 
graph of % conversion against time was plotted.  
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Figure 3.3-1 – Graph of % conversion against time for polymerisation of 200 equivalents of 
lactide with one equivalent of compound 3 in tumbling vials dry melt polymerisation. 
The most suitable line of best fit seemed to be a log dose response line of best fit giving 
curves with the general formula represented in Equation 3.3-1, where A1, A2, x0 and p 
were all constants found by the best-fitting algorithm of Origin Pro 8.0. 
𝑦 = 𝐴2 +
(𝐴1 − 𝐴2)
(1 + (
𝑥
𝑥0)
𝑝
)
 
Equation 3.3-1 – General formula of a logarithmic line of best fit for % conversion curves 
against time for the polymerisation of lactide by titanium chloride complexes. 
 
For each data point, a standard deviation was calculated and is also plotted on the 
graph.  
As the curve of best fit is essentially straight for the first portion of the graph the initial slope 
can be calculated from the time it takes to reach 50% conversion.  
Rearrangement of Equation 3.3-1gives: 
𝑥 = 𝑒
ln⁡(−
−𝑦+𝐴1
−𝑦+𝐴2
)
𝑝
𝑥0
 
Equation 3.3-2 – Rearrangement of Equation 3.3-1 for x 
Inserting the values from the equation calculated for the line of best fit and inserting y = 50 
the time taken for the polymerisation to reach 50 % (EC50) conversion is 79.9 ± 1.3 minutes. 
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The gradient is dy/dx and is calculated to be 0.62 %min-1 or 0.010 %s-1. As the catalyst has 
been added in a ratio 1:200 the turnover number for the catalyst is 0.021 molecules/s and 
the maximum conversion is 96% at 150 °C. 
A second experiment was performed by heating, under dry melt conditions at  
150 °C, 1 equivalent of compound 3 with 2000 equivalents of L-lactide.  The experiment 
showed that compound 3 has an EC50 of 429 ± 120 minutes at this catalyst loading. The 
slope was calculated as 0.11% min-1 or 0.0018% s-1. The turnover number of 0.04 molecules/s 
and a maximum conversion of 97%. This is comparatively slow compared to compound 4 
which had a turnover number of over 1 molecule/s and catalysts reported to be used 
industrially for the polymerisation of lactide with turnover numbers between 5-10 
molecules/s. 
 Conclusion 
Aims of this experiment were to attempt to find structure activity relationships between the 
electron donating or withdrawing properties of titanium chloride catalysts and their ability 
to catalyse the ring opening polymerisation of lactide, and to study the ability of titanium 
chloride complexes to polymerise lactide, given they have only recently been discovered 
to be active. 
All titanium (IV) chloride catalysts in this work are relatively slow, with very poor turnover 
numbers less than 0.1 molecule per second. The chloride ligand is not well known to initiate 
polymerisation, and further information about the conditions that affect the ligand’s ability 
to polymerise lactide may offer insight into other ligands which have previously been 
thought to be inactive to ring opening polymerisation. 
 Further Work 
Further work in this field should take the form of finding more well defined and pure 
examples of titanium chloride catalysts to continue to expand the data on the effect 
of subtle changes in sterics and electron donation or withdrawal from the metal 
centre and the ability of the metal to polymerise. Finding a method that allows in-situ 
measurements of the degree of polymerisation of the plastic without introducing air 
and moisture would be advantageous to allow studies of the polymerisation to occur 
with minimal intteruption to the reaction compared to an alliquot-removal method. 
Attempts to gain insights into whether the titanium(IV) chloride complexes maintain 
their cytoxic activity after polymerisation were made. In these attempts a polymer 
synthesised using bis(4-fluorophenylacetylacetonate)titanium(IV) chloride as a 
catalyst was exposed to air and exposed to the HT-29 human ovarian cancer cell line 
by Dr Aida Basri at the institute of cancer therapeutics, University of Bradford. After 
exposure to the plastic for 3 days there was found to be no increased cell death 
compared to the control cells. 
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This inactivity may be due to the limited volume of solvent used by the cell-line testing 
procedures and the purposeful insolubility of the resulting poly(lactic acid) plastics. 
The large amount of plastic required to collect significant concentrations of the 
titanium(IV) complex within the plastic means that the solvents used in the cell line 
testing must be changed to become more solublising to the plastics. These changes 
to the solvent system would remove the in vitro method further from realistic conditions 
found within a multi-organ system. It may be that the plastic requires a different 
environment to break down and release the drug and expose the cells to the titanium 
centres. The titanium(IV) complex may also simply be inactive once the plastic has 
been formed. New methods would need to be identified which would allow exposure 
of cancer cells to the metal-dispersed plastics over a larger amount of time than is 
usual in in vitro assays, and give a measure of cytotoxic ability. 
  
90 
 
 Chapter Three References 
1. Crossley, B.D. Ph.D. Thesis, University Of Leeds, 2011. 
2. Hebden, A.J. Ph.D. Thesis, University Of Leeds, 2010. 
3. Mannion, J.J. Ph.D. Thesis, University Of Leeds, 2009. 
4. Kim, Y. And Verkade, J.G. Novel Titanatranes With Different Ring Sizes:  Syntheses, 
Structures, And Lactide Polymerization Catalytic Capabilities. Organometallics. 
2002, 21(12), pp.2395-2399. 
5. Kim, Y., Jnaneshwara, G.K. And Verkade, J.G. Titanium Alkoxides As Initiators For 
The Controlled Polymerization Of Lactide. Inorganic Chemistry 2003, 42(5), 
pp.1437-1447. 
6. Russell, S.K., Gamble, C.L., Gibbins, K.J., Juhl, K.C.S., Mitchell, W.S., Tumas, A.J. And 
Hofmeister, G.E. Stereoselective Controlled Polymerization Of D/L-Lactide With 
[Ti(Trisphenolate)O-iPr]2 Initiators. Macromolecules. 2005, 38(24), pp.10336-10340. 
7. Gregson, C.K.A., Blackmore, I.J., Gibson, V.C., Long, N.J., Marshall, E.L. And White, 
A.J.P. Titanium-Salen Complexes As Initiators For The Ring Opening Polymerisation 
Of Rac-Lactide. Dalton Transactions. 2006, (25), pp.3134-3140. 
8. Gowda, R.R., Chakraborty, D. And Ramkumar, V. Controlled Hydrolysis Of [Ti(O-
2,4,6-Br3C6H2)2(O-IPr)2]2: Synthesis, Structural Characterization And Studies On Bulk 
Polymerization Of Cyclic Esters And Lactide. Inorganic Chemistry 
Communications. 2011, 14(11), pp.1777-1782. 
9. Takashima, Y., Nakayama, Y., Hirao, T., Yasuda, H. And Harada, A. 
Bis(Amido)Titanium Complexes Having Chelating Diaryloxo Ligands Bridged By 
Sulfur Or Methylene And Their Catalytic Behaviors For Ring-Opening Polymerization 
Of Cyclic Esters. Journal Of Organometallic Chemistry. 2004, 689(3), pp.612-619. 
10. Chen, H.Y., Liu, M.Y., Sutar, A.K. And Lin, C.C. Synthesis And Structural Studies Of 
Heterobimetallic Alkoxide Complexes Supported By Bis(Phenolate) Ligands: 
Efficient Catalysts For Ring-Opening Polymerization Of L-Lactide. Inorganic 
Chemistry. 2009, 49(2), pp.665-674. 
11. Jeong Go, M., Min Lee, J., Mun Lee, K., Hwa Oh, C., Park, K.H., Kim, S.H., Kim, M., 
Park, H.-R., Park, M.H., Kim, Y. And Lee, J. Titanium Complexes Containing 
Bidentate Benzotriazole Ligands As Catalysts For The Ring Opening Polymerization 
Of Lactide. Polyhedron. 2014, 67, pp.286-29 
12. Takashima, Y., Nakayama, Y., Watanabe, K., Itono, T., Ueyama, N., Nakamura, A., 
Yasuda, H., Harada, A. And Okuda, J. Polymerizations Of Cyclic Esters Catalyzed 
By Titanium Complexes Having Chalcogen-Bridged Chelating Diaryloxo Ligands. 
Macromolecules. 2002, 35(20), pp.7538-7544. 
13. Lee, J., Kim, Y. And Do, Y. Novel Chlorotitanium Complexes Containing Chiral 
Tridentate Schiff Base Ligands For Ring-Opening Polymerization Of Lactide. 
Inorganic Chemistry. 2007, 46(19), pp.7701-7703. 
14. Frediani, M., Sémeril, D., Mariotti, A., Rosi, L., Frediani, P., Rosi, L., Matt, D. And 
Toupet, L. Ring Opening Polymerization Of Lactide Under Solvent-Free Conditions 
91 
 
Catalyzed By A Chlorotitanium Calix[4]arene Complex. Macromolecules Rapid 
Communication. 2008, 29(18), pp.1554-1560. 
15. Ovitt, T.M. And Coates, G. W. Stereoselective Ring-Opening Polymerization Of Rac-
Lactide With A Single-Site, Racemic Aluminum Alkoxide Catalyst: Synthesis Of 
Stereoblock Poly(Lactic Acid). Journal Of Polymer Science Part A: Polymer 
Chemistry. 2000, 38(S1), pp.4686–4692. 
16. Thakur, K.A.M., Kean, R.T., Hall, E.S., Kolstad, J.J. And Munson, E.J. Stereochemical 
Aspects Of Lactide Stereo-Copolymerization Investigated By 1H NMR: A Case Of 
Changing Stereospecificity. Macromolecules. 1998, 31(5), pp.1487-1494. 
17. Thakur, K.A.M., Kean, R.T., Zell, M.T., Padden, B.E. And Munson, E.J. An Alternative 
Interpretation Of The HETCOR NMR Spectra Of Poly(Lactide). Chem. Commun. 
1998, (17), pp.1913-1914. 
18. Kricheldorf, H.R., Kreiser-Saunders, I., Jürgens, C. And Wolter, D. Polylactides - 
Synthesis, Characterization And Medical Application. Macromolecular Symposia. 
1996, 103(1), pp.85-102. 
19. Kricheldorf, H.R., Boettcher, C. And Tönnes, K.-U. Polylactones: 23. Polymerization 
Of Racemic And MesoD,L-Lactide With Various Organotin Catalysts—
Stereochemical Aspects. Polymer. 1992, 33(13), pp.2817-2824. 
20. Schindler, A. And Harper, D. Poly (Lactic Acid). I. Stereosequence Distribution In 
The Polymerization Of Racemic Dilactide. Journal Of Polymer Science: Polymer 
Letters Edition. 1976, 14(12), pp.729-734. 
21. Chabot, F., Vert, M., Chapelle, S. And Granger, P. Configurational Structures Of 
Lactic Acid Stereocopolymers As Determined By 13C∙{1H} NMR Polymer. 1983, 24(1), 
pp.53-59. 
22. Lillie, E. And Schulz, R.C. 1H- And 13C-{1H}-NMR Spectra Of Stereocopolymers Of 
Lactide. Die Makromolekulare Chemie. 1975, 176(6), pp.1901-1906. 
23. H. Chisholm, M., S. Iyer, S. And E. Matison, M. Concerning The Stereochemistry Of 
Poly(Lactide), PLA. Previous Assignments Are Shown To Be Incorrect And A New 
Assignment Is Proposed. Chemical Communications. 1997, 0(20), pp.1999-2000. 
24. Kasperczyk, J.E. HETCOR NMR Study Of Poly(rac-lactide) And Poly(meso-lactide). 
Polymer. 1999, 40(19), pp.5455-5458. 
25. Yamaji, T.S. Hayamizu, K. Yanagisawa, M. And Yamamoto, O. Spectral Database 
For Organic Compounds. [Online]. 2013. [Accessed 30/03/2016]. Available From: 
http://sdbs.db.aist.go.jp/sdbs/cgi-bin/cre_index.cgi 
26. Yamaji, T.S. Hayamizu, K. Yanagisawa, M. And Yamamoto, O. Spectral Database 
For Organic Compounds SDBS No.:15004. [Online]. 2013. [Accessed 30/03/2016]. 
Available From: http://sdbs.db.aist.go.jp/sdbs/cgi-bin/cre_index.cgi 
92 
 
 
 
 
4. TITANIUM ETHOXIDE COMPLEXES 
 Titanium complexes in the McGowan group 
 
Figure 4.1-1 – General structure of titanium (IV) complexes synthesised by the McGowan group. 
 
Titanium (IV) complexes in this chapter have been synthesised towards two aims: 
1. For the polymerisation of lactide 
2. For use as anti-cancer drugs 
 
Previous work in the McGowan group has focussed on the synthesis of titanium(IV) complexes with 
the aim to further improve our understanding of the structure/activity relationship of metallodrugs 
of the type shown in Figure 4.1-1. The group has synthesised a large library of compounds varying 
the symmetry of the β-diketonate ligand, the position and strength of the electron donating and 
withdrawing groups on the chelating ligand and the nature of the labile monodentate ligand, X.[1] 
Thus far, complexes with halide ligands have been researched with chloride and bromide 
complexes being the lead compounds of interest. However titanium β-diketonates containing 
ethoxide labile groups are known to be cytotoxic with one example, Budotitane, progressing to 
Phase II trials.[2]  
 
Scheme 4.1-1 – Synthesis of titanium ethoxide complexes 
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Bis-acetylacetonate titanium ethoxide complexes are synthesised using the procedure outlined in 
Scheme 4.1-1, a synthetic pathway used previously in the McGowan group.[3] Due to the asymmetry 
of the β-diketonate ligand and the inclusion of two monodentate ligands each structure can exist 
in 5 structural isomers (Figure 4.1-2), which are named first according to the monodentate ligands, 
then the benzoyl-adjacent oxygen atom of the acetylacetonate ligand, and finally by the methyl-
adjacent oxygen atom of the acetylacetonate ligand using similar methods to the Cahn-Ingold-
Prelog priority rules.[4, 5] Keppler et al reported that titanium β-diketonate halide complexes adopt 
only those structures with the monodentate ligand in the cis position in solution.[6]  These three forms 
are known to interconvert in solution giving rise to broad 1H NMR signals, This process is purported to 
be acid catalysed.[4, 7, 8]  
Unlike titanium chloride or bromide complexes, titanium ethoxide complexes form basic solutions, 
and so the interconversion between the structural isomers is expected to be slow, or not observed. 
Fay et al. have  suggested rate constants for the exchange between isomers containing three 
halide ligands to be between 6.7 x 102 and 1.6 x 104 s-1, the fastest conversion happening when 
chloride ligands are occupying the cis positions, and with activation energies around +11.3 ± 0.5 
kcalmol-1 or +47.31 kJmol-1.[8]  
 
 
Figure 4.1-2 – Possible structural isomers of β-diketonate ethoxide complexes 
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This chapter will investigate the methods of conversion of the titanium ethoxide complexes, and 
investigate whether there is structural stability benefit to using an ethoxide complex over a chloride 
or bromide complex. 
Chapter 3 of this work describes the use of well-studied titanium chloride complexes as catalysts for 
the polymerisation of lactide, and discusses the evidence that the initiating ligand is incorporated 
into the chain. Alkoxide ligands are much more traditional initiators for the polymerisation of 
lactide.[9-16] This chapter will also investigate the use of titanium ethoxide complexes for 
polymerisation of lactide, as well as trying to gather evidence of the efficiency of the 
polymerisation. 
Firstly this chapter reports the synthesis and characterisation of a series of novel titanium (IV) 
ethoxide complexes, then reports on a series of experiments to investigate the mechanism of the 
transition of the titanium (IV) ethoxide complexes between the five isomers shown in Figure 4.2-1. 
 Synthesis of bis-(4-fluorophenylacetylacetonate)titanium(IV) ethoxide [Ti(4’F-
Phacac)2(OEt)2] (Compound 5) 
 
Compound 5 - bis-(4’fluoroacetylacetonate)titanium(IV) ethoxide 
Figure 4.2-1 – Structure of compound 5 
Bis-(4’fluorophenylacetylacetonate)titanium(IV) ethoxide (compound 5) was synthesised via the 
scheme outlined in Scheme 4.1-1. To a solution of titanium(IV) ethoxide under anhydrous conditions, 
2 equivalents of 4-fluorophenylacetylacetone was added drop wise with vigorous stirring. The 
mixture was stirred for 16 hours. The resulting cream precipitate was isolated by filtration, washed 
with pentane and remaining organic solvent removed in vacuo. The compound was recrystallised 
from hot ethanol to give crystals suitable for X-ray diffraction. The compound was further analysed 
by microanalysis, 1H and 13C NMR spectroscopy and mass spectrometry.  
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4.2.1. Crystallographic analysis of bis-(4-fluorophenylacetylacetonate)titanium(IV) 
ethoxide  (Compound 5) 
 
Figure 4.2-2 – ORTEP diagram of Compound 5 with displacement ellipsoids showing 50% probability  
 
Compound 5 was found to crystallise in a monoclinic unit cell in the space group P21/n. The 
asymmetric unit contains one molecule with a total of four molecules in the unit cell. Bond lengths 
and selected angles from the crystal structure can be viewed in  
Table 4.2-1 and Table 4.2-2. The β-diketonate ligand is planar as expected, with C-O bond lengths 
of 1.311(3) Å, 1.284(3) Å, 1.296(3) Å and 1.288(3) Å, giving an average of 1.295 Å. As expected this 
bond length is between the normal bond length for a C-O single and double bond, confirming, 
along with the planar nature of the ligand, the aromaticity of the chelate. The ethoxide ligand 
oxygen atoms (O5 and O6) are in a cis configuration, as are the oxygen atoms closest to the phenyl 
rings of the β-diketonate ligand (O2 and O4). The oxygen atoms closest to the methyl groups (O1 
and O3) are in an trans position around the titanium centre. The complex is, therefore, in the cis-cis-
trans configuration. The ellipsoids of the ethoxide carbon atoms (C21-C24) are slightly larger than 
the more rigidly cooridnated acetylacetoneate carbon atoms, showing increased motion of the 
ethoxide chains. 
Additionally there is a difference between the Ti-O bond lengths for the chelating oxygen atoms 
and the monodentate ethoxide Ti-O bond length. The monodentate Ti-OEt bond lengths are 
1.827(2)Å and 1.833(2) Å, giving an average value of 1.830 Å. The chelating oxygen-metal bonds 
are significantly longer with values of 2.018(2) Å, 2.092(2) A, 2.030(2)Å and 2.098(2)Å. This gives an 
average value of 2.064 Å, or a 12 % increase in bond length for chelating oxygen atoms. 
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Figure 4.2-3 – Capped stick diagram showing the distorted octahedral geometry of the titanium centre 
of compound 5 
The geometry of the titanium metal centre shows significant distortion, with the ethoxide-ethoxide 
bond angle of 100.36(7)°, a significant widening caused by the steric bulk of the two ethyl chains 
(Figure 4.2-4). Figure 4.2-3 also shows the pinched angles between the two chelating oxygen atoms 
in the acetylacetonate ligand. In this case the angle is much smaller than the expected 90°, due 
to the strain of the chelating ring. 
 
 
  
97 
 
 
 
 
 
Table 4.2-1 – Interatomic distances for compound 5 with standard uncertainties listed in parentheses 
 
 
 
  
 
Ti(1)-O(5) 1.8278(18) Å Ti(1)-O(6) 1.8335(17) Å 
 Ti(1)-O(1) 2.0189(17) Å Ti(1)-O(3) 2.0301(16) Å 
 Ti(1)-O(4) 2.0925(17) Å Ti(1)-O(2) 2.0987(17) Å 
 O(2)-C(4) 1.284(3) Å O(3)-C(12) 1.311(3) Å 
 O(5)-C(21) 1.434(3) Å C(3)-C(2) 1.412(4) Å 
 C(3)-C(4) 1.428(3) Å C(4)-C(5) 1.511(3) Å 
 O(1)-C(2) 1.296(3) Å O(4)-C(14) 1.288(3) Å 
 C(2)-C(1) 1.525(3) Å C(15)-C(20) 1.418(3) Å 
 C(15)-C(16) 1.425(3) Å C(15)-C(14) 1.515(3) Å 
 C(14)-C(13) 1.423(3) Å C(13)-C(12) 1.419(3) Å 
 O(6)-C(23) 1.456(3) Å F(4)-C(18) 1.375(3) Å 
 C(5)-C(10) 1.417(3) Å C(5)-C(6) 1.419(3) Å 
 C(21)-C(22) 1.533(5) Å C(23)-C(24) 1.509(5) Å 
 C(18)-C(19) 1.398(4) Å C(18)-C(17) 1.404(3) Å 
 C(16)-C(17) 1.402(3) Å C(9)-C(10) 1.390(4) Å 
 C(9)-C(8) 1.416(4) Å C(20)-C(19) 1.408(4) Å 
 C(7)-C(8) 1.385(4) Å C(7)-C(6) 1.401(4) Å 
 C(12)-C(11) 1.516(3) Å C(8)-F(1) 1.384(3) Å 
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Table 4.2-2 – Selected bond angles for compound 5 with standard uncertainties listed in parentheses 
  
    
 O(5)-Ti(1)-O(6) 100.19(8)° O(5)-Ti(1)-O(1) 93.18(8)° 
 O(6)-Ti(1)-O(1) 100.74(8)° O(5)-Ti(1)-O(3) 100.36(7)° 
 O(6)-Ti(1)-O(3) 89.50(7)° O(3)-Ti(1)-O(4) 82.05(6)° 
 O(5)-Ti(1)-O(4) 88.19(7)° O(6)-Ti(1)-O(2) 90.98(8)° 
 O(1)-Ti(1)-O(4) 85.65(7)° O(3)-Ti(1)-O(2) 82.47(7)° 
 O(1)-Ti(1)-O(2) 81.82(7)° C(4)-O(2)-Ti(1) 130.09(15)° 
 O(4)-Ti(1)-O(2) 81.10(7)° C(21)-O(5)-Ti(1) 141.34(19)° 
 C(2)-C(3)-C(4) 122.0(2)° O(2)-C(4)-C(3) 122.6(2)° 
 C(2)-O(1)-Ti(1) 131.43(16)° C(3)-C(4)-C(5) 121.6(2)° 
 O(1)-C(2)-C(3) 124.6(2)° O(1)-C(2)-C(1) 114.8(2)° 
 C(7)-C(6)-C(5) 121.0(2)° O(6)-C(23)-C(24) 111.8(2)° 
 F(1)-C(8)-C(9) 117.4(2)° F(1)-C(8)-C(7) 119.5(2)° 
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Figure 4.2-4 – Space filling diagram showing the Van der Waals radii of the ligands around the titanium 
centre of compound 5. Hydrogen atoms omitted for clarity. 
 
 
Figure 4.2-5 – Capped stick representation of compound 5 showing the planes of the acetylacetonate 
backbone (lighter grey layer) and the plane of the 4’fluorophenyl ring (darker blue layer) 
 
The 4’fluorophenyl ring was found to twist slightly out of the plane of the acetylacetonate ligand, 
as can be seen in Figure 4.2-5, displaying a torsion angle of 10.22(8)°. The observed torsion may be 
due to the hydrogen bonds in the solid state as seen in Figure 4.2-6.  
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Figure 4.2-6 - Hydrogen bonding of the fluorophenyl fluorine atom with the adjacent hydrogen atom of 
the nearest molecule 
 
 
Figure 4.2-7 – Crystal packing of compound 5 viewed down the a axis of the crystal structure 
 
When viewed down the a axis of the crystal structure, compound 5 packs in an interesting 
herringbone structure as seen in Figure 4.2-7, showing each molecule stacking on top of each other 
in the vertical direction and an alternating orientation of the molecules along the horizontal axis. 
This mirrors the findings of the group with the analogous titanium complexes with chloride bridging 
ligands which often form a herringbone structure. [3, 17, 18] 
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4.2.2. NMR spectroscopic analysis of bis-(4-fluorophenylacetylacetonate)titanium(IV) 
ethoxide  (compound 5) 
 
Figure 4.2-8 – Labelled structure of compound 5 
 
Figure 4.2-6 shows a labelled structure of compound 5 which will be used for the assignments of the 
1H, 1H-1H COSY and 13C NMR spectrum in Figure 4.2-9 and Figure 4.2-10 . 
 
Figure 4.2-9 - 500MHz 1H NMR spectrum of compound 5 in CDCl3 showing chemical shifts and integrals 
at 300K 
At room temperature the spectrum is broad, suggesting that the interconversion between the 
structural isomers is occurring and is rapid. All of the signals arising from the acetylacetonate 
protons, except the methine proton, split into two separate peaks. Peak assignments are listed in 
Table 4.2-3.  
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Figure 4.2-10 – 500MHz 1H-1H COSY spectrum in CDCl3 collected at room temperature
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1H Chemical 
Shift (σ) 
Integration, 
multiplicity 
Assignment 
Chemical 
Shift 
13C 
Assignment 
1.24 ppm 3H, s HL 18.51 ppm l 
2.07 ppm 
2.26 ppm 3H, s HA 33.62 ppm a 
4.52 ppm 2H, as HK 72.38 ppm k 
6.20 ppm 1H, s HC 
111.48 
ppm 
f 
7.00 ppm 
7.12 ppm 2H, as HG  
130.17 
ppm 
g 
7.77 ppm 
8.04 ppm 2H, as HF 
133.41 
ppm 
h 
   
140.00 
ppm 
e 
   
164.03 
ppm 
d 
   
166.05 
ppm 
b 
 
Table 4.2-3 – NMR spectroscopic assignments for compound 5 
One explanation for the appearance of two signals for each expected proton 
environment of the acetylacetonate ligand in the 1H NMR spectrum is some form of 
coupling to the fluorine atom in the structure. If this were correct, H-C-C-F coupling values 
observed for the protons labelled Hg are calculated to be 135 Hz, which is two orders of 
magnitude larger than the expected coupling constant of 1-4 Hz.[19] Like the aromatic 
acetylacetonate protons, the methyl acac protons labelled Ha are split between two 
significantly different signals. It is unlikely that this is a splitting effect from the fluorine atom 
of 95 Hz over 9J. 
Another possibility is that compound 5 forms two products in solution, but crystallises with 
the ethoxide ligands in the cis position in the solid state. If this were the case, two different 
methine peaks would be expected, assuming that the structures have significant enough 
magnetic difference to cause the protons within the phenyl ring and methyl group of the 
acetylacetonate ligand to have such differences in the chemical shifts of the protons. 
Additionally the signals belonging to HK and HL, the ethoxide ligand signals, would also be 
split into two defined signals, assuming significant magnetic difference. The signals at 7.77 
ppm and 8.04 ppm each integrate with an area of one proton within error, suggesting that 
if there were two products they are present at a 1:1 ratio. This finding is mirrored in the 
integrations of the signals at 7.00 ppm and 7.12 ppm and with the methyl protons of the 
acetylacetonate ligand (HL) where the upfield signal at 2.07 ppm integrates to the same 
area as the signal at 2.26 ppm. 
A third possibility is that the hydrogen bonding shown in the solid state in Figure 4.2-6 also 
exists in solution, restricting the ability of the phenyl ring to rotate, causing the apparently 
equivalent phenyl protons labelled HG to be locked into position, and so stopping these 
protons experiencing equivalent magnetic environments. This would account for the 1:1 
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integration ratio observed between each of the phenyl signals within the 1H NMR 
spectrum. 
The final possibility is the formation in solution of isomers of the compound which have two 
inequivalent actylacetonate ligands. This would also explain the approximately equal 
signal area for the two signals observed for proton environments HA, HF and HG, however it 
would suggest that all of the isomers formed in situ within the NMR spectrometer have 
inequivalent acetylacetonate ligands, even when very symmetrical. 
The 1H-1H COSY spectrum in Figure 4.2-10 confirms the assignment of the protons HA as 
these protons do not couple to any other signal in the spectrum. The protons HK ad HL are 
found to couple as expected, and do not couple to any other signals, again confirming 
the assignment of these signals. In the expansion (right) we can see that only the two 
signals 8.04 ppm 7.77 ppm couple on the phenyl ring, and in this case they only couple to 
one another. The aromatic signals at 7.00 ppm and 7.12 ppm are found not to couple to 
any other proton in the spectrum which is unusual, but indicates that these protons are 
undergoing additional coupling to the fluorine atom and confirms the assignment as the 
protons closest to the fluorine atom. 
 Synthesis of bis-(4-bromophenylacetylacetonate)titanium(IV) ethoxide 
[Ti(4’Br-Phacac)2(OEt)2]  (Compound 6) 
 
Compound 6 - bis-(4-bromophenylacetylacetonate)titanium(IV) ethoxide 
Figure 4.3-1- Structure of compound 6 
  
Bis-(4’bromophenylacetylacetonate)titanium(IV) ethoxide was synthesised using the 
synthesis in Scheme 4.1-1. two equivalents of 4’bromophenylacetylacetone was slowly 
added to a solution of titanium(IV)ethoxide in ethanol under rigorous anhydrous 
conditions. The resulting precipitate was filtered, washed with pentane and all remaining 
solvent removed in vacuo. The cream solid was then recrystallised from hot ethanol in 
anhydrous conditions to yield single crystals suitable for X-ray diffraction. 
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4.3.1. Crystallographic analysis of bis-(4-
bromophenylacetylacetonate)titanium(IV) ethoxide  (compound 6) 
 
Figure 4.3-2 – ORTEP diagram of the asymmetric unit only of compound 6 with ellipsoids 
displayed at the 50% probability level 
 
Compound 6 crystallised in an orthorhombic unit cell in the space group Ccc2. The 
asymmetric unit contains half a molecule with 4 molecules in the unit cell.  The molecule is 
arranged in a cis-cis-trans arrangement with the ethoxide ligands showing a cis 
arrangement, the oxygen atoms closest to the phenyl ring of the β-diketonate ligand (O2 
and O2(a)) taking a cis arrangement. The oxygen atoms of the β-diketonate closest to the 
methyl groups of the ligand (O1 and O1(a)) take a trans-configuration.  Figure 4.3-3 shows 
the arrangement of the ethyl chains of the ethoxide groups. In compound 6 the chains 
take a Z shape arrangement, with each ethyl chain pointing in an opposite direction. In 
compound 5 the ethoxide groups take a C-shape arrangement in the solid-state as seen 
in Figure 4.2-4. Bond lengths and selected angles of compound 6 can be seen in Table 
4.3-1and Table 4.3-2 respectively. The acetylacetonate ligand is planar with average 
aromatic C=O bond length of 1.292 Å.  
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Figure 4.3-3 – Space-filling representation of the structure of compound 6 showing a Z-shape 
arrangement of the ethyl chains of the ethoxide ligand 
 
      
 Br(1)-C(8) 1.9148(17) Å Ti(1)-O(2) 2.0897(12) Å 
 Ti(1)-O(3) 1.8264(12) Å Ti(1)-O(1) 2.0119(9) Å 
 O(2)-C(4) 1.2894(18) Å O(3)-C(11) 1.409(2) Å 
 C(6)-C(7) 1.402(3) Å O(1)-C(2) 1.2946(17) Å 
 C(7)-C(8) 1.405(3) Å C(6)-C(5) 1.419(2) Å 
 C(5)-C(4) 1.504(2) Å C(8)-C(9) 1.391(3) Å 
 C(1)-C(2) 1.519(2) Å C(5)-C(10) 1.409(2) Å 
 C(3)-C(4) 1.418(2) Å C(2)-C(3) 1.410(2) Å 
 C(11)-C(12) 1.527(3) Å C(9)-C(10) 1.408(2) Å 
      
 
Table 4.3-1 – Average bond lengths of compound 6 with standard uncertainties listed in 
parentheses 
 
      
 O(3)(a)-Ti(1)-O(3) 99.44(8)°   O(2)(a)-Ti(1)-O(3) 169.12(5)° 
 O(2)(a)-Ti(1)-O(3)(a) 90.11(5) °   O(2)-Ti(1)-O(3)(a) 169.12(5)° 
 O(2)-Ti(1)-O(3) 90.11(5) °   O(2)(a)-Ti(1)-O(2) 80.89(7)° 
 O(1)(a)-Ti(1)-O(3) 91.06(4) °   O(1)(a)-Ti(1)-O(3)(a) 98.77(4)° 
 O(1)-Ti(1)-O(3)(a) 91.06(4) °   O(1)-Ti(1)-O(3) 98.77(4)° 
 O(1)(a)-Ti(1)-O(2) 86.15(4) °   O(1)(a)-Ti(1)-O(2)(a) 82.30(4)° 
 O(1)-Ti(1)-O(2)(a) 86.15(4) °   O(1)-Ti(1)-O(2) 82.30(4)° 
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 O(1)(a)-Ti(1)-O(1) 164.81(6)°   C(11)-O(3)-Ti(1) 145.30(14)° 
 C(4)-O(2)-Ti(1) 131.18(9)°   C(2)-O(1)-Ti(1) 132.40(9)° 
 C(5)-C(6)-C(7) 120.87(15)°   C(8)-C(7)-C(6) 119.06(16)° 
 C(7)-C(8)-Br(1) 119.45(14)°   C(9)-C(8)-Br(1) 119.36(14)° 
 C(9)-C(8)-C(7) 121.19(17)°   C(4)-C(5)-C(6) 118.78(13)° 
 C(10)-C(5)-C(6) 118.65(14)°   C(10)-C(5)-C(4) 122.57(13)° 
 C(1)-C(2)-O(1) 115.22(14)°   C(3)-C(2)-O(1) 124.58(13)° 
 C(3)-C(2)-C(1) 120.19(14)°   C(4)-C(3)-C(2) 121.79(14)° 
 C(5)-C(4)-O(2) 116.28(12)°   C(3)-C(4)-O(2) 123.47(14)° 
 C(3)-C(4)-C(5) 120.19(13)°   C(10)-C(9)-C(8) 119.60(16)° 
 C(9)-C(10)-C(5) 120.58(16)°   C(12)-C(11)-O(3) 113.37(16)° 
      
Table 4.3-2 – Bond angles of compound 6 with standard uncertainties listed in parentheses 
(a)
 – Indicates a symmetry generated atom in the second half of the molecule 
The Ti-OEt bond lengths in compound 6 are significantly shorter than the Ti-O bonds of the 
acetylacetonate chelating ligand, with chelating Ti-O bond lengths measuring 2.0119(9) 
Å and 2.0897(12) Å and Ti-OEt bond length measuring 1.826 Å. This continues to confirm 
the aromaticity of the acetylacetonate ligand as the electrons responsible for bonding 
are spread across the ligand and so the bonds to titanium are weaker as expected. 
The geometry of the titanium centre is distorted. The steric bulk of the ethoxide groups 
causes a widening of the ethoxide-ethoxide bond angles measuring 99.44(8)° as opposed 
to the usual 90° expected. There is also a significant pinching effect of the chelating ligand 
with acetylacetone O-Ti-O bond angles measuring 82.30(4)°. These two factors leave the 
titanium centre with a large angle for approach of the lactide molecule to the titanium 
centre and ligand exchange reactions as can be seen in Figure 4.3-3, the space filling 
diagram of compound 6. Due to the small bite angle of the chelating ligands and the 
otherwise normal unconstrained angle in between the acetylacetonate ligands, once 
there is exchange of the ethoxide ligands, nearly half of the coordination sphere of the 
titanium atom is exposed. This is ideal for a catalyst for the ring opening polymerisation of 
lactide. 
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Figure 4.3-4 – Capped stick diagram of compound 6 showing the distorted octahedral 
geometry of the titanium metal centre (hydrogen atoms omitted for clarity) 
 
 
Figure 4.3-5 – Capped stick representation of compound 6 showing the planes of the 
acetylacetonate backbone (light grey layer) and the plane of the 4’bromophenyl ring of the 
ligand. 
The phenyl ring of the acetylacetonate ligand is slightly out of plane, with the torsion angle 
between the ring and the acetylacteonate backbone measuring 11.78° (Figure 4.3-5).  
The compound was found to pack in layers, with each molecule oriented in the same 
direction when viewed down the a-axis. There was no hydrogen bonding, T-stacking or π-
π stacking found in this structure, leading to an untemplated structure as seen in Figure 
4.3-6. 
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Figure 4.3-6 – Crystal packing of compound 6 viewed down the a-axis of the crystal structure. 
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4.3.2. NMR spectroscopic analysis of bis-(4-
bromophenylacetylacetonate)titanium(IV) ethoxide  (Compound 6) 
 
 
Figure 4.3-7 – Labelled structure of compound 6 
Figure 4.3-7 shows a structure of compound 6 showing the labels which will be used for the 
assignments of the 1H, 13C{1H} and correlation NMR spectra.  
 
 
Figure 4.3-8 – 500MHz 1H NMR spectrum of compound 6 in CDCl3 showing chemical shifts and 
integrals at 300K 
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The proton NMR spectrum of the crystals of compound 6 confirmed successful 
complexation of the 4-bromoacetylacetonate ligand with a shift in the methine proton of 
0.05ppm downfield over the free ligand. Due to the broad signals of the NMR splitting 
patterns cannot be used to assign the NMR resonances, so correlation spectroscopy offers 
information on connectivity. 
The most upfield shift at 1.24 ppm arises from the terminal methyl group of the ethoxide 
ligand, and the COSY spectrum along with the integration shows the expected correlation 
with the ethoxide CH2 peak at 4.52 ppm (Figure 4.3-9). A HMBC spectrum shows coupling 
over several bonds, and the HMBC spectrum of compound 6 in Figure 4.3-11 shows the 
signals at 4.52 ppm and 1.25 ppm to only couple with each other over 2-3 bonds, 
confirming the assignment of these protons as the carbon atoms in the ethoxide ligand. 
The aromatic peaks at 7.48 ppm, 7.60 ppm and 7.89 ppm collectively arise from the four 
aromatic protons. Instead of the two expected signals, the peaks split into three signals, 
with each signal integrating to represent 1:2:1 protons respectively. The 1H-1H COSY 
spectrum (Figure 4.3-9) shows that the signal at 7.49 ppm couples to the signal at 7.60 ppm, 
but not the signal at 7.89 ppm.  
The NOESY spectrum (Figure 4.3-12) shows the same pattern where the protons responsible 
for the signal at 7.48 ppm are close in physical space to those at 7.60 ppm but not the one 
responsible for the peak at 7.89 ppm.  
 
1H Chemical 
Shift (σ) 
Integration, 
multiplicity 
Assignment 
13C Chemical 
Shift (σ) 
Assignment 
1.24 6H, s HL 18.49 l 
2.07 3H, as HA 27.01 a 
2.26 3H, as HA 27.69 a 
4.52 4H, as HK 72.46 k 
6.20 2H, as HC 98.86 c 
7.48 2H, as HF 99.33 c 
7.60 4H, as HI and HG 126.49 h 
7.89 2H, as HJ 129.12 f or j 
   131.60 g and i 
   136.09 e 
   178.70 d 
   181.70 d 
   181.78 d 
   190.63 b 
   193.55 b 
 
Table 4.3-3 – NMR spectroscopic assignments of compound 6 
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Figure 4.3-9 – 500 MHz 1H-1H COSY spectrum in CDCl3
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The HMQC spectrum (Figure 4.3-10) shows the carbon signals with their corresponding 
proton signals. The spectrum shows the signals at 129.1 ppm and 131.6 ppm on the 13C 
vertical axis each appear to couple to more than one proton signal. Equally, the broad 1H 
signal at 7.60 ppm encompasses signals which correlate with more than one significantly 
different 13C environment.  
 
 
Figure 4.3-10 – 500 MHz HMQC spectrum of compound 6 collected in CDCl3 at 298 K 
 
 The HMBC spectrum (Figure 4.3-11) shows that the most downfield aromatic proton signal 
at 7.89 ppm is coupled to the other two aromatic signals at 7.48 ppm and 7.60 ppm over 
several bonds. The most deshielded aromatic proton peak is attached to a carbon atom 
which couples over several bonds to the methine proton. None of the other carbon atoms 
couple to the methine proton as strongly. In aromatic systems the maximum coupling 
expected to be observed in HMBC spectroscopy is coupling over 4J.  This signal also shows 
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weak signal in the NOESY spectrum (Figure 4.3-12) with the methine proton, suggesting the 
proton responsible for the signal at 7.89 ppm to be close in physical space to the methine 
acetylacetonate proton, suggesting that the proton is on the phenyl ring in a position 
closest to the ketone and has been assigned as Hj 
The remaining 1H signals to be assigned, Hf, Hg and Hi were resolved by variable 
temperature studies in section 4.3.3. 
 
Figure 4.3-11 – 500 MHz HMBC spectrum of compound 6 collected at 253 K 
 
The HMBC spectrum allows us to assign the identity of the 13C{1H} NMR spectroscopic 
signals arising at 178.7 ppm and 190.6 ppm. The more upfield shift at 190.6 ppm is coupled 
over several bonds with the diagnostic methine proton at 6.20 ppm and the 
acetylacetonate methyl proton at 2.07 ppm and 2.26 ppm confirming these signals to be 
assigned to the ketone carbonyl carbon on the methyl side of the acetylacteonate ligand. 
The more downfield shift at 181.7 ppm couples with the aromatic signals mentioned before 
at 7.48 ppm, 7.60 ppm and 7.89 ppm, showing this shift to be assigned to the carbonyl 
carbon closest to the phenyl ring.   
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Figure 4.3-12 – 500 MHz NOESY spectrum of compound 6 collected at 253 K 
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4.3.3. Variable temperature studies of bis-(4-
bromophenylacetylacetonate)titanium(IV) ethoxide  (Compound 6) 
Figure 4.3-13 shows the 500 MHz 1H NMR spectrum of compound 6 collected at several 
temperatures. At room temperature only one broad methine proton (Hc, Figure 4.2-8) is 
observed. The methine proton is isolated from any other protons in the system by two 
ketone carbon atoms. As such it is not expected to exhibit any coupling. As the sample is 
cooled to 213 K, the single broad methine peak caused by rapid interconversion of the 
isomers of the complex is isolated into four sharp peaks as the interconversion processes 
decrease in rate. The structural isomers of bis(acetylacetonate) titanium ethoxide 
complexes are shown in Figure 4.1-2. The cis-cis-trans and cis-trans-cis isomers have 
equivalent methine protons on the acetylacetonate backbone. However, the cis-cis-cis 
isomer contains two non-equivalent acetylacetoneate ligands. Therefore the cis-cis-cis 
isomer would be responsible for two methine peaks in the 1H NMR spectrum. [8] A similar 
increase in the resolution of the acetylacetonate methyl group is also observed, with 
peaks arising in the region of 2.10 – 2.30 ppm. The presence of four peaks gives strong 
evidence of the existence of 3 structural isomers in solution at a time, and the apparent 
thermodynamic stability of the isomers with cis monodentate ligand indicated by the 
collection of all crystal structures of titanium (IV) β-diketonate complexes within the group 
so far exhibiting this arrangement, suggests that those three isomers may be the cis-cis-
trans, cis-cis-cis and cis-trans-cis isomers.   
All other broad peaks are also resolved at 213 K to confirm the original assignments of the 
protons. The aromatic peaks between 7.48 – 7.90 ppm resolve into several doublet peaks, 
confirming the para substitution of the halide on the phenyl ring of the acetyl acetonate 
ligand. This finding suggests that the proton environment Hf is inequivalent to Hj which could 
only with restricted rotation of the phenyl ring of the acetylacetonate ligand.  
The peak at 4.52 ppm resolves into a series of quartets confirming the assignment of the 
CH2 group of the ethoxide ligand and the peaks between 1.15 – 1.25 ppm resolve into a 
series of overlapping triplets corresponding to the CH3 group of the ethoxide ligand. 
The changes in the 13C{1H} NMR spectra in Figure 4.3-14 are less subtle, with 
acetylacetonate carbonyl resonances 178.7 and 193.6 ppm splitting into only two 
separate resonances, but with the methine 13C{1H} resonances at 98.86 and 99.3 ppm 
splitting into four well defined resonances at 99.4, 99.6, 99.9, and 100.2 ppm, mirroring the 
1H NMR spectroscopic experimental results. 
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Figure 4.3-13 – Variable temperature 500 MHz 1H NMR spectra of compound 6 in CDCl3. Expansions provided (right) Temperatures listed against the spectra.
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Figure 4.3-14 – 175 MHz 13C{1H} NMR spectra of compound 6 collected in CDCl3 at 298 K (top) 
and at 253 K (bottom) 
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 Synthesis of bis-(4-iodophenylacetylacetonate)titanium(IV) ethoxide [Ti(4’I-
Phacac)2(OEt)2]  (Compound 7) 
      v 
Compound 7 - bis-(4-iodophenylacetylacetonate)titanium(IV) ethoxide 
Figure 4.4-1 - Structure of compound 7 
Bis-(4-iodophenylacetylacetonate)titanium(IV) ethoxide was synthesised via the synthesis 
outlined in Scheme 4.1-1. 2 equivalents of 4’iodophenylacetylacetone was slowly added 
to a solution of titanium(IV) ethoxide in ethanol under rigorous anhydrous conditions. The 
resulting precipitate was filtered, washed with pentane and all remaining solvent removed 
in vacuo. The solid was then recrystallised from hot ethanol to yield an analytically pure 
brown powder. 
 
4.4.1. NMR spectroscopic analysis of bis-(4-
iodophenylacetylacetonate)titanium(IV) ethoxide (Compound 7) 
 
Figure 4.4-2 – Labelled structure of compound 7 
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The 1H NMR spectrum of compound 7 shows a similar pattern to the other titanium ethoxide 
complexes with para-substituted acetylacetonate ligands, with significant signal 
broadening observed within the spectrum at 298 K. The acetylactetonate methyl proton 
signal splits into two peaks at 2.07 and 2.26 ppm, while the diagnostic methine proton 
remains a single broad peak. In the aromatic region there are two signals at 7.46 and 7.74 
ppm with signals integrating to 3 and 1 proton respectively.  The 13C{1H} spectrum echoes 
the findings of the 1H spectrum, with signals for the acetylacetonate methyl and methine 
protons showing two separate peaks at 27.03 ppm and 27.67 ppm and 98.89 ppm and 
99.31 ppm respectively. 
  
Figure 4.4-3 – 500 MHz 1H NMR spectrum of compound 7 collected at 298 K in CDCl3 
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1H Chemical 
Shift (σ) 
Integration, 
multiplicity 
Assignment 
13C Chemical 
Shift (σ) 
Assignment 
1.23 ppm 3H, s HL 18.55 ppm l 
2.07 ppm 
2.26 ppm 
3H, s HA 
27.03 ppm 
27.67 ppm a 
4.51 ppm 2H, as HK 72.42 ppm k 
6.19 ppm 1H, as HC 98.89 ppm c 
7.46 ppm 1H, as HI 99.31 ppm c' 
7.74 ppm 3H, multiplet HF, HG and HJ 129.13 ppm g and i 
   136.68 ppm f  
   137.62 ppm j 
   178.91 ppm h 
   182.07 ppm e 
   190.77 ppm b 
   193.67 ppm d 
 
Table 4.4-1 – 1H and 13C{1H} assignments of compound 7 
 
The 1H spectrum in Figure 4.4-3 mirrors earlier findings with the methyl group of the 
acetylacetonate ligand again separating into two signals which integrate to three protons 
only when added together. The 1H NMR spectrum exhibits only one signal for the methine 
proton at 6.19 ppm suggesting, again, that there is only one type of compound present 
(i.e a centre containing the same number of bidentate and monodentate ligands), 
switching rapidly between stereochemical isomers as the broadening of the signals of the 
1H NMR spectrum indicates. The aromatic region shows a similar pattern observed in 
compound 5 and compound 6 where each aromatic proton exists in a different magnetic 
environment and, in this case, there is severe overlap of the signals. 
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Figure 4.4-4 – 175 MHz 13C{1H} NMR spectrum collected at 298 K in CDCl3. The CDCl3 peak has 
been truncated 
 
Figure 4.4-4 shows the 13C{1H} NMR spectrum of compound 7. In the spectrum collected at 
room temperature we see two separate signals at 99.3 ppm caused by the methine 
carbon, suggesting two distinct magnetic environments and possibly two distinct 
stereoisomers within the solution, or perhaps both cis and trans binding modes of the 
monodentate ligand which causes the methine carbon atoms to experience such 
different magnetic environments. The integration of the methine peaks of the 
acetylacetonate ligand of the 1H NMR spectrum again show a 1:1 ratio between the two 
peaks, suggesting either a ratio close to 1:1 of two different isomers or a methyl group 
which interacts closely with another atom or group to allow the protons of the methyl 
group to experience two different magnetic environments. 
If the complex undergoes rapid interconversion between all five structural isomers of the 
complex equally, this may explain these observations, as there are two structural isomers 
with monodentate ligands in the trans arrangement and three with monodentate ligands 
in the cis arrangement as seen in Figure 4.1-2. The significant difference in structure 
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between the cis and trans arrangement of the monodentate ligands may cause two 
distinct signals in the NMR spectrum, while allowing for many 1H signals to overlap in the 
NMR spectrum into the broad singlet we observe at room temperature. 
Assuming equal distribution of isomers, there is a 2:3 ratio of isomers with dissimilar magnetic 
environments, which correlates with an approximately equal integrations of the methyl 
acetylacetonate signals in the 1H NMR spectrum. The activation energy for rearrangement 
of titanium complexes with chloride monodentate ligands was found to be +47.31 kJmol-
1.[8]  If the activation energy for these ethoxide complexes is of a similar magnitude it could 
be feasible to suggest that this rapid interconversion between all forms of the isomers may 
be possible. 
  Synthesis of bis-(di-1,3-methoxyphenylpropan-1,3-diketonate)titanium(IV) 
ethoxide [Ti(4’OEtPhacacPh4’OEt)2(OEt)2] (Compound 8) 
 
Compound 8 - bis-(di-1,3-methoxyphenylpropan-1,3-diketonate)titanium(IV) ethoxide 
Figure 4.5-1 - Structure of compound 8 
Compound 8 was synthesised using the scheme shown in Scheme 4.5-1. Two equivalents 
of bis(4’methoxydiphenyl)acetylacetone was slowly added to a solution of titanium(IV) 
ethoxide in ethanol under rigorously anhydrous conditions. The resulting precipitate was 
filtered, washed with pentane and all remaining solvent removed in vacuo. The cream 
solid was then recrystallised from hot ethanol in anhydrous conditions to yield an 
analytically pure yellow powder. 
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Scheme 4.5-1 – Synthesis of symmetrical bis-(acetylacetonate)titanium(IV) ethoxide 
complexes. 
4.5.1. NMR spectroscopic analysis of bis-(di-1,3-methoxyphenylpropan-1,3-
diketonate)titanium(IV) ethoxide (Compound 8) 
 
 
Figure 4.5-2 – Labelled structure of compound 8 
Figure 4.5-4 shows the 1H NMR spectrum of compound 8. Due to the high symmetry of this 
molecule the spectrum is remarkably clear and even with slight broadening, the symmetry 
of the molecule is such that the expected triplet and quartet structure can be observed 
on the ethoxide proton signals at 1.26 ppm 4.57 ppm respectively, with normal coupling of 
around 7 Hz measured. 
There are two signals at 3.78 ppm and 3.91 ppm arising from the acetylacetonate methoxy 
group protons. The two expected aromatic proton signals each split into two signals, one 
pair at 8.16 ppm and 7.78 ppm and one pair at 7.01 ppm and 6.78 ppm. The COSY 
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spectrum (Figure 4.5-5) shows that only one of the signal in each identified pair couples to 
one another, both upfield peaks at 7.78 ppm and 6.78 ppm couple and both peaks at 
8.16 and 7.01 ppm couple. This may suggest that the phenyl rings of the ligand become 
inequivalent on formation of the complex, or that there is restricted rotation of the phenyl 
groups, making the protons pointing towards the titanium centre inequivalent to those 
pointing out.  
Due to the symmetry of the acetylacetonate ligand there are now only two possible 
isomers of the compound. (Figure 4.5-3) So far, every bis-acetylacetonate complex 
synthesised by the McGowan group has crystallised with monodentate ligands in the cis 
position, indicating a thermodynamic stability of the cis isomers. The 13C{1H} NMR spectrum 
in Figure 4.5-6 shows a single signal for the methine proton of the acetylacetonate ligand 
at room temperature, which suggests that there is only one configuration of the 
monodentate ligands, so the duplication of peaks within the 1H NMR spectrum might be 
explained by restricted rotation of the phenyl groups once complexed.  
 
 
Figure 4.5-3 – Possible isomers of compound 8 
 
The results of the 1H-1H COSY suggest most prominently that there is restricted rotation 
about the phenyl rings, and those rings on the inside experience increased deshielding 
from interaction with overlapping Van der Waals radii, and exhibit downfield chemical 
shifts in the 1H NMR spectrum. The two downfield shifts couple together, meaning they are 
next to each other in physical space, leading to an assignment of these atoms as HC’ and 
HD’ to their counterparts pointing to the outside of the complex HC and HD, which 
experience less deshielding from the interference of the Van der Waals radii, and so exhibit 
upfield chemical shifts, and couple together as seen in the COSY.  
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The idea of restricted rotation does not explain the inequivalent OMe proton signals in the 
1H NMR spectrum at 3.78 ppm and 3.91 ppm. In the cis arrangement of ethoxide ligands 
shown in Figure 4.5-3, the two phenyl methoxy groups on the left of the drawing are forced 
close to one another by the cis arrangement of the Ti-O bonds to the β-diketonate ligand, 
while the methoxy groups where the Ti-O bonds to the β-diketonate are trans to one 
another, the groups point out into space. Again those groups which experience 
interference of the Van der Waals radii shift downfield, and their counterparts remain 
upfield. This evidence further supports the notion that the molecule retains the cis 
arrangement of monodentate ligands in solution, as the trans equivalent would not exhibit 
inequivalent OMe groups. 
 
 
Figure 4.5-4 - 500 MHz 1H NMR spectrum of compound 8 collected at 298 K in CDCl3 
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1H Chemical 
Shift (σ) 
Integration, 
multiplicity 
Splitting 
Frequency 
Assignment 
13C Chemical 
Shift (σ) 
Assignment 
1.26 ppm 3H, t 6.9 Hz HI 18.70 ppm i 
3.77 ppm 
3.91 ppm 
6H, s 
  HA 55.44 ppm a 
4.57 ppm 2H, q 7.1 Hz HH 71.55 ppm f 
6.78 ppm 2H, s  HC 94.50 ppm g 
6.81 ppm 1H, s  HG 113.54 ppm d 
7.01 ppm 2H, s  HC’ 113.70 ppm d' 
7.78 ppm 2H, s  HD 129.66 ppm c 
8.15 ppm 2H. s  HD’ 130.47 ppm b 
    162.52 ppm e 
 
Table 4.5-1 – NMR spectroscopic assignments of the 1H and 13C{1H} spectra of compound 8  
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Figure 4.5-5 – 500 MHz 1H COSY NMR spectrum of compound 8 collected at 298K in CDCl3 
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Figure 4.5-6 – DEPT-135 (top) and 13C{1H} (bottom) NMR spectra of compound 8 collected at 298 K on a 175 MHz spectrometer.
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 Titanium(IV) Ethoxide complexes for polymerisation of lactide 
Compound 5, compound 6 and compound 7 were found not to polymerise lactide in 
solution. In all three cases a solution of the compound with 200 equivalents of lactide in 
chloroform was unchanged after being stirred at 60 °C for 2 days and in toluene at 110 °C 
reflux for 1 day. 
However, all three compounds were found to efficiently polymerise lactide in dry-melt 
conditions. A small amount of each sample was dissolved in 200 equivalents of molten 
lactide and stirred under anhydrous conditions at 150 °C. Each complex yielded a slightly 
yellow polymer after four hours of stirring and polymerisation was confirmed by 1H NMR 
spectroscopy with all three compounds generating excellent percentage conversions 
over 95%.  
Attempts to measure the efficiency of titanium (IV) ethoxide catalysts were made by 
completing polymerisations in dry melt at several temperatures. Compound 5 was mixed 
with 210 equivalents of L-lactide and the mixture crushed with a pestle and mortar. 10 mg 
samples of the mixture were added to glass vials with aluminium/PTFE crimped caps and 
were submerged in agitated oil at various temperatures. Three vials were removed from 
the oil during the polymerisation, cooled quickly and the reaction quenched with wet 
deuterated chloroform. This was repeated several times during the experiment. 
The sample vials were stripped of identifiers and a 1H NMR spectrum was collected for 
each sample. The area of the peaks of the 1H NMR spectrum belonging to poly(lactic acid) 
were integrated against those belonging to unreacted lactide in a blind experiment, 
ensuring no influence from the author, in order to calculate a degree of conversion, and 
the results of the experiment are plotted in  Figure 4.6-1.  
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Figure 4.6-1 – Logarithmic curves of best fit showing degree of polymerisation of samples of 
lactide at 150 °C, 160 °C, 170 °C, 185 °C and 200 °C with a 1:210 equivalents catalyst loading 
of compound 5. 
At all of the temperatures used in this experiment, compound 5 polymerises lactide to give 
final degrees of conversion around 97 % (Table 4.6-1).  
As the temperature of the polymerisation conditions is increased, the time taken for the 
catalyst to convert 50% of the lactide into poly(lactic acid) (EC50) decreases, indicating 
an increased rate of polymerisation with increasing temperature. Figure 4.6-2 shows the 
change in EC50 as temperature increases, showing an exponential decrease in the amount 
of time taken to convert 50% of the lactide into poly(lactic acid) and so a logarithmic 
increase in rate of polymerisation with temperature. 
Temperature EC50 
Degree of 
conversion 
(%) 
 Error 
 
150 °C 66.4 min 97.90 ± 0.09 % 
160 °C 35.8 min 96.67 ± 0.19 % 
170 °C 27.6 min 96.28 ± 0.16 % 
185 °C 12.0 min 96.40 ± 0.02 % 
200 °C 9.3 min 96.01 ± 0.25 % 
 
Table 4.6-1 – EC50 Time taken for a 1:200 equivalents catalyst loading of compound 5 to 
lactide to reach 50% conversion at a range of temperatures. 
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Figure 4.6-2 – Change in the rate of polymerisation with varying temperature of compound 5 
with 210 equivalents of lactide. 
At the fastest rate, compound 5 was found to have a turnover number of 0.13 
molecules/second for the polymerisation of lactide, which represents moderate catalytic 
ability. The best organic catalysts in the literature generating turnover numbers of up to 
1,000,000 molecules/second,[20] but most good catalysts having a turnover number of 10-
50 molecules per second.  
While titanium (IV) ethoxide complexes might seem to have poor performance for the 
polymerisation of lactide, the intersection of this ability with the anti-cancer activity of the 
complexes may enhance the desirability of using titanium (IV) ethoxide complexes to 
synthesise metal dispersed polymers.  
 In vitro cell line testing of para-substituted budotitane derivatives 
Recent work in the McGowan group has focussed on finding relationships between the 
structure of group IV β-diketonate drugs and their in vitro efficacy against many cancer 
cell lines.  
Work undertaken by Dr. Benjamin Crossley and Dr. James Mannion in the group found that 
titanium(IV) complexes containing halide and bis-β-diketonate ligands to be particularly 
effective in causing cell death of the A2780 human ovarian carcinoma cell-line, with 
bromide ligands being seemingly the most effective for titanium metallodrugs containing 
para-substituted acetylacetonate ligands, and ethoxide ligands performing equally well 
within error of the experiment.[3, 18] 
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Tshuva et al recently reported that source titanium alkoxide and chloride compounds, 
Ti(OiPr)4 and TiCl4(THF)2, were not active against cancer cell lines due to the high rate of 
aggregate formation in normoxic and aqueous conditions in vitro.[21]  
A series of para-substituted drugs were synthesised by the author and tested for cytotoxic 
activity against the HT-29 ovarian cancer cell line by Dr Aida Basri at the institute of cancer 
therapeutics, University of Bradford, with low IC50 values representing complexes which are 
able to cause effective cell death at low concentrations. (Table 4.7-1) 
Drug IC50 
Cis-platin 3.2 ± 0.3 μM 
 
Budotitane 
Compound 9 – Budotitane 
25.6 ± 0.3 μM 
 
IC50 test compound/ IC50 cis-platin 
= 8.0 
 
Somewhat active 
 
Bis-4’chlorophenylacetylacetonatetitanium(IV) 
ethoxide first prepared by Benjamin Crossley at 
the University of Leeds. 
30.73 ± 0.9 μM 
 
IC50 test compound/ IC50 cis-platin 
=9.6 
 
Somewhat active 
 
 
Bis-4’bromophenylacetylacetonatetitanium(IV) 
ethoxide 
Compound 6 
27.5± 0.8 μM 
 
IC50 test compound/ IC50 cis-platin 
= 8.6 
 
Somewhat active 
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Bis-4’iodophenylacetylacetonatetitanium(IV) 
ethoxide 
Compound 7 
25.7± 0.2 μM 
 
IC50 test compound/ IC50 cis-platin 
= 8.0 
 
Somewhat active 
 
Compound 8 
> 100 μM 
 
Inactive  
 
Table 4.7-1 – IC50 values of a series of para-substituted Budotitane derivatives. 
During cell line testing, a series of wells of cells are exposed to varying concentrations of 
the compound under investigation, with row of wells untreated to act as a control against 
the drug. The cells are provided growth medium and are incubated for 3 days while 
exposed to the drug. After exposure the cells undergo the MTT assay, described in section 
1.3.1. Cells which are alive convert yellow MTT into a purple formazan compound. A UV/vis 
spectrometer is used to calculate the degree of conversion of the MTT compared to the 
control wells, and the concentration of the drug exposure can be plotted against the 
degree of cell death to find the IC50 value of the drug.  The cell line results show that there 
is little electronic contribution to the activity of the titanium ethoxide complexes, as adding 
withdrawing halides in the para position of the phenylacetylacetonate ligand seems to 
have had very little effect on the IC50 values of these complexes  when compared to a 
non-substituted drug like Budotitane (compound 9). There is also no observable trend in 
the activity of the drugs against the decreasing withdrawing strength of the para-
substituted chlorine, bromine and iodine complexes as you might expect if electronics 
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were to play a large part activating or deactivating the activity of the drug, nor the steric 
effects of the larger halides atoms on the phenyl ring. The complexity of even this basic 
biological system makes it difficult to hypothesise as to the efficacy of the shape and 
electronics of the complex, and so further work to continue building a library to obtain 
large amounts of data is needed. 
Compound 6 and compound 7 were found to have moderate anti-cancer activity, with 
required dosages around 8 times the required dosage of cis-platin to cause cell death of 
50% of the population exposed. 
Compound 8 was found to be inactive against the HT-29 human ovarian cancer cell line 
with concentrations of compound 8 exceeding 100 μmoldm-3 and exhibiting essentially no 
cytotoxic activity. This may be due to the sensitivity of the complex to oxygen, or this may 
be an indication of an unusual configuration of compound 8 causing it to have reduced 
activity compared to the asymmetrical phenylacetylacetonate ligands.  
 Mechanistic studies of the interconversion of isomers of the titanium 
ethoxide complexes 
The broad signals of the 1H NMR spectra of the titanium (IV) ethoxide complexes in this 
chapter raises the questions;  
- How many isomers exist in solution? 
- During the mechanism of interconversion of the structural isomers of the 
complexes, does the acetylacetonate ligand partially or completely dissociate?  
 
 Mechanism of interconversion of titanium ethoxide complexes 
The McGowan group has previously studied the interconversion of the different possible 
isomers of asymmetrical biacetylacetonatetitanium halide complexes. Work undertaken 
by Dr Andrew Hebden found that when bis-(phenylacetylacetonate)titanium(IV) chloride 
and bis-(4-fluorophenylacetylacetonate)titanium(IV) chloride were mixed in CDCl3, a 
ligand exchange reaction occurred during which the two separate compounds formed 
(phenylacetylacetonate)(4-chlorophenylacetylacetonate)titanium(IV) chloride. The 
reaction was observed by NMR spectroscopy in situ. [17]  
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Figure 4.9-1 – Ligand exchange reactions of bis-(acetylacetonate) titanium chloride 
complexes. Bis-(4-chlorophenylacetylacetonate)titanium(IV) chloride (top left) and bis-
(phenylacetylacetonate)titanium(IV) chloride (bottom left) are mixed together in deuterated 
chloroform to form a cross-product  (right)  
During the experiment the methine protons of the two complexes initially exhibited two 
separate, well defined chemical shifts, separated by 0.06 ppm. During the course of the 
experiment the two methine signals were found to coalesce into one single signal with a 
chemical shift halfway between the two original chemical shifts. This proves that, for bis-
acetylacetonate titanium chloride complexes, the mechanism for interconversion can 
include complete dissociation of the acetylacetonate ligand from the metal centre. The 
group have suggested that this process is acid-catalysed, which can be formed from 
photolysis of the CDCl3. Equally, any trace acetylacetone ligands left from the synthesis 
can also act as weak acids and may allow the catalysis of the ligand exchange reaction. 
In order to further investigate this phenomenon bis(phenylacetylacetonate)titanium(IV) 
ethoxide (compound 9) and bis-(4’fluorophenylacetylacetonate)titanium(IV) ethoxide 
(compound 5) were mixed together in distilled, dry deuterated chloroform in a Young’s 
NMR tube as described in Scheme 4.9-1. Several 1H NMR spectra of the mixture were 
recorded as the mixture was left for 3 days to react (Figure 4.9-2). 
As the titanium ethoxide complexes are basic, the concentration of acid available to 
catalyse a ligand exchange reaction is low.  Over the course of several days there is no 
cross product methine peak observed upon mixing of the ethoxide complexes, unlike the 
effect which is observed with the analogous titanium chloride complexes. However, the 
peaks of the spectrum remain broad, suggesting rapid intramolecular conversion of the 
compounds between isomers. This suggests that the mechanism of interconversion does 
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not require that a β-diketonate completely dissociate from the complex in order to allow 
the interconversion of the complexes, and instead may only require a single oxygen atom 
to dissociate. 
 
Scheme 4.9-1 – Ligand exchange reactions of bis-(acetylacetonate) titanium ethoxide 
complexes. Bis-(4-fluorophenylacetylacetonate)titanium(IV) ethoxide (left) and bis-
(phenylacetylacetonate)titanium(IV) chloride (right) are mixed and no reaction is observed 
It can also be observed that the intensity of the peaks reduces over time even when the 
number of scans in the experiment remains constant. The solution was found to change 
colour, beginning a light yellow colour and ending a light green. 
The loss of intensity may be caused by a process by which the titanium(IV) is reduced to 
titanium (III) and becomes paramagnetic. This causes the chemical shifts of the protons of 
the magnetic complex to move into much higher chemical shifts. A spectrum with broad 
scan width was collected, however no additional peaks to those displayed in Figure 4.10-1 
were observed. As time elapses an additional peak forms in the spectrum at 9.80 ppm 
suggesting the formation of an aldehyde, with the peak having a quartet structure. This 
suggests that during the process the ethoxide ligand is oxidised to ethanal. A low sweep 
scan of the mixture showed that there is no hydride formed during the process. 
Similar experiments were performed with the pure complexes and the same phenomenon 
of colour change and reduced signal intensity in 1H NMR spectra was observed. 
compound 5, compound 6 and compound 7 were all found to exhibit similar behaviour 
when left in sunlight, with no change in the spectra observed when the sample was kept 
in the dark for several weeks, but when the compound was exposed to sunlight the 
indicative change in colour was observed and formation of the aldehyde observed in the 
1H spectra. It is not suggested that sunlight may initiate the interconversion of isomers of 
the complexes, as even in the dark, the titanium ethoxide complexes exhibit broad shifts 
in their 1H NMR spectra. 
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Figure 4.9-2 – In situ 1H NMR spectroscopy mechanistic study of a mixture of compound 5 and compound 9
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4.9.1. Attempted polymerisation with reduced titanium (IV) species 
An anhydrous solution of compound 5 in deuterated chloroform was exposed to sunlight 
for 1 day until a colour change was observed. One thousand equivalents of lactide were 
added to the solution, maintaining the anhydrous conditions in the solution. The solution 
was further exposed to sunlight for two days and a 1H NMR spectrum was collected.  
 
Figure 4.9-3 - 1H NMR spectrum of a UV exposed mixture of compound 5 and lactide (bottom) 
and 1H NMR spectrum of lactide (top) in CDCl3 collected at 300 MHz 
The 1H NMR in Figure 4.9-3 shows that despite UV ‘activation’, the resulting titanium 
complex remains inactive for the polymerisation of lactide at room temperature in solution.  
 Possible oxygenated products  
Titanium alkoxide complexes are well known to the group to degrade in aqueous or 
normoxic conditions. The complexes are prepared in rigorously anhydrous conditions, but 
in vitro cell line testing is carried out in a normoxic atmosphere, usually exposing the drugs 
to water and oxygen for several days. As such, if a drug shows activity even in these 
environments the oxygenated product may also be reactive. Compound 8 was exposed 
to oxygen during recrystallisation. Crystals of the oxygen-exposed product of compound 
8 were collected and stored under oil. A crystal structure of the crystals was obtained, 
though the quality of the crystals were such that it was not possible to resolve the initial 
solution fully. However the data was of sufficient quality to solve, and can give some idea 
of the connectivity of the product of the oxidation of compound 8. 
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 Figure 4.10-1 – Structure solution of the oxygenated product of compound 8. (Hydrogen 
atoms omitted for clarity) 
 
Figure 4.10-1 shows the initial solution of the crystal data. The product is a trimer comprising 
of three titanium centres with three oxide bridges to form a six-membered ring of Ti-O 
bonds. Each titanium centre remains chelated to two β-diketonate ligands, suggesting 
that the coordination of the chelating ligands is air and water stable. The metal centre has 
a cis configuration with respect to the oxide bridge, leaving each metal centre reasonably 
protected by the steric bulk of the ligands around the metal centre. This result suggests 
that when titanium (IV) ethoxide complexes are exposed to air and water in vivo they may 
not necessarily form large aggregate structures, and instead could form small molecules.  
While the structure is not resolved enough to measure bond angles with accuracy, an idea 
of the magnitude of the angles can be obtained. Figure 4.10-2 shows an expansion of a 
view of the crystal structure, showing the central 6 membered Ti-O-Ti ring and typical bond 
angles around the oxygen atoms and aluminium atoms. In this case the oxygen atom is 
expected to bond in an sp3 hybridised manner, to give an expected Ti-O-Ti bond angle of 
109°. In this structure this angle is much wider than expected, measuring around 143°. The 
structure exhibits Ti-O bonds of approximate length 1.80 Å, which is similar to the Ti-OEt 
bond lengths observed in the crystal structures of compound 5 and compound 6 without 
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any particular constraints on the bond lengths. The O-Ti-O bond length measures 
approximately 99 ° which is significantly larger than the expected 90 ° for an octahedral 
complex. This large deviation from typical bond angles in the geometries found in this 
structure must be driven by the required bond lengths, which seem to be typical of Ti-O 
single bond lengths. 
 
 
Figure 4.10-2 – Truncated view of the Ti-O-Ti ring of the oxygenated product of compound 8. 
Titanium – light grey   Oxygen - red 
 
 Attempted syntheses 
During this project many target compounds were identified and many syntheses were 
attempted. During purification, it was often found that solids of the target molecules would 
form glasses, solids which appear crystalline, but have no long range order, or into 
powders. Several solvent systems were identified as likely candidates for recrystallisation 
systems, with medium polarity solvents such as ethanol and chloroform achieving the most 
success. The following two compounds crystallised within oils of the compound, and as 
such while the compounds were successfully synthesised, additional characterisation of 
the compounds was not possible due to the small amount of product isolated. 
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4.11.1. Synthesis of bis-(4-methylphenylacetylacetone)Titanium(IV) ethoxide 
[Ti(4’MePhacac)2(OEt)2] - compound 10 
 
Compound 10 - bis-(4-methylphenylacetylacetone)Titanium(IV) ethoxide 
Figure 4.11-1 - Structure of compound 10 
Bis-(4’methylphenylacetylacetonate)titanium(IV) ethoxide (compound 10) was 
synthesised via the scheme outlined in Scheme 4.1-1. To a solution of titanium(IV) ethoxide 
under anhydrous conditions, 2 equivalents of 4-methylphenylacetylacetone was added 
drop wise in ethanol solution with vigorous stirring. The mixture was stirred for 16 hours. The 
resulting oil was isolated in vacuo. Attempts to purify the compound by recrystallisation 
from ethanol, chloroform, diethylether and vapour diffusion of pentane into chloroform at 
- 20 °C were unsuccessful. An aliquot of the pure oil of the compound was left in the fridge 
for several months. On returning inspection of the flask small brown crystals suitable for X-
ray had formed in the oil. 
The crystal structure was collected and solved by Dr. Christopher Pask using an Agilant 
SuperNova diffractometer at 250 K. The reason for the relatively high temperature 
collection is that the crystals of compound 10 were found to fracture at the usual 
collection temperature of 100 K. The crystal structure of the compound shows significant 
disorder around the ethoxide ligands, with one of the ethoxide ligands being solved in two 
parts, and the other being solved in three parts. The asymmetric unit contains one whole 
molecule, and the unit cell is monoclinic, in the P21/C space group, leading to four whole 
molecules in the unit cell. There is very little disorder around the acetylacetonate ligand, 
and the overall structure solution has an R1 of 6.97 % and Rint of 5.99 % 
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Figure 4.11-2 - ORTEP diagram of the asymmetric unit of with ellipsoids displayed at the 50% 
probability level 
The crystal structure of compound 10 exhibits a very large ethoxide-ethoxide angle of 
100.87°, comparable to those already observed from cis-ethoxide complexes earlier in this 
chapter. The bite angle of the acetylacetonate ligand is 82.62° suggesting a relatively 
strained ligand interaction with the titanium centre in the solid state. The remaining 
unconstrained angle around the titanium centre, the angle between the ethoxide oxygen 
atom and the nearest acetylacetonate oxygen atom, is fairly large at 98.14° compared 
with the expected 90° angles expected in a true octahedral complex. Again this complex 
exhibits a large empty coordination sphere, and the complex exhibits cis-trans-cis 
configuration. 
 
Figure 4.11-3 – Capped stick model of compound 10 with annotated bite angles of the 
acetylacetonate ligand 
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Figure 4.11-4 - Crystal packing of compound 10 viewed down the a-axis of the crystal 
structure. 
In the solid state, compound 10 exhibits a steep herringbone packing when viewed down 
the a-axis of the unit cell, but seems not to have any π or T-stacking interactions (Figure 
4.11-4). This finding mirrors the crystal packing of compound 5 despite the lack of hydrogen 
bonding interactions.  
 Ti(1)-O(1) 2.060(2) Å Ti(1)-O(2) 1.9939(19) Å 
 Ti(1)-O(3) 2.057(2) Å Ti(1)-O(4) 2.006(2) Å 
 Ti(1)-O(5) 1.795(2) Å Ti(1)-O(6) 1.790(2) Å 
 O(1)-C(2) 1.268(3) Å C(1)-C(2) 1.498(4) Å 
 O(2)-C(4) 1.289(3) Å C(2)-C(3) 1.394(4) Å 
 O(3)-C(13) 1.253(4) Å C(3)-C(4) 1.387(4) Å 
 O(4)-C(15) 1.268(3) Å C(4)-C(5) 1.491(4) Å 
 O(5)-C(23a) 1.406(9) Å O(5)-C(23b) 1.412(11) Å 
 C(5)-C(6) 1.391(4) Å C(5)-C(10) 1.394(4) Å 
 O(6)-C(25a) 1.419(15) Å O(6)-C(25b) 1.405(11) Å 
 O(6)-C(25c) 1.509(12) Å C(6)-C(7) 1.380(4) Å 
 C(7)-C(8) 1.382(5) Å C(8)-C(9) 1.381(4) Å 
 C(8)-C(11) 1.510(4) Å C(9)-C(10) 1.380(4) Å 
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 C(12)-C(13) 1.500(4) Å C(13)-C(14) 1.393(4) Å 
 C(14)-C(15) 1.389(4) Å C(15)-C(16) 1.500(4) Å 
 C(16)-C(17) 1.377(4) Å C(16)-C(21) 1.370(4) Å 
 C(17)-C(18) 1.371(4) Å C(18)-C(19) 1.372(5) Å 
 C(19)-C(20) 1.368(5) Å C(19)-C(22) 1.505(4) Å 
 C(20)-C(21) 1.399(5) Å C(23a)-C(24a) 1.512(13) Å 
 C(23b)-C(24b) 1.463(13) Å C(25a)-C(26a) 1.489(17) Å 
 C(25b)-C(26b) 1.40(2) Å C(25c)-C(26c) 1.451(18) Å 
 
Table 4.11-1 - Interatomic distances for compound 10 with standard uncertainties listed in 
parentheses 
Table 4.11-1 shows bond lengths within the structure. The structure shows the aromatic C-
O bonds in the acetylacetonate ligand to have lengths of 1.268(3) Å, 1.253(4) Å, 1.289(3) 
Å and 1.268(3) Å. These lengths are much shorter than the single C-O sigma bonds in the 
OEt ligands whose lengths are reported to be 1.406(9) Å, 1.419(15) Å, 1.509(12) Å, 1.412(11) 
Å and 1.405(11) Å. 
4.11.2. Crystallographic analysis of bis-(1,3-diphenylpropan-1,3-
diketonate)titanium(IV) ethoxide [Ti(1,3-diphenylpropan-
1,3,diketonate)2(OEt)2] (Compound 11) 
 
Compound 11 - bis-(1,3-diphenylpropan-1,3-diketonate)titanium(IV) ethoxide 
Figure 4.11-5 – Structure of bis-(1,3-diphenylpropan-1,3-diketonate)titanium(IV) ethoxide 
Bis-(1,3-diphenylpropan-1,3-diketonate)titanium(IV) ethoxide (compound 11) was 
synthesised via the scheme outlined in Scheme 4.1-1. To a solution of titanium(IV) ethoxide 
under anhydrous conditions, 2 equivalents of 1,3-diphenylpropan-1,3-dione was added 
drop wise in ethanol solution with vigorous stirring. The mixture was stirred for 36 hours. The 
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resulting oil was isolated in vacuo. Attempts to purify the compound by recrystallisation 
from ethanol, and chloroform were unsuccessful. An aliquot of the pure oil of the 
compound was left at - 20 °C for two days yielding crystals suitable for X-ray diffraction. 
 
Figure 4.11-6 – ORTEP diagram of compound 11 with displacement ellipsoids showing 50% 
probability 
Compound 11 crystallised in a monoclinic unit cell in the space group P21/c. The 
asymmetric unit contains one molecule, with a total of four molecules in the unit cell. 
Selected bond lengths and angles are included in Table 4.11-2 and Table 4.11-3 
respectively. As we have seen earlier with similar complexes, the Ti-O bond lengths of the 
ethoxide ligand oxygen atoms O(6) and O(5) are significantly shorter than those of the 
oxygen atoms of the acetylacetonate ligand O(2), O(3), O(4) and O(5), where the 
ethoxide Ti-O bond lengths measure an average of 1.827 Å compared to the 
acetylacetonate Ti-O bond lengths measuring an average of 2.062 Å. With standard 
uncertainties measuring 0.07 % of the bond lengths this is a significant difference between 
the bonding modes. 
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Ti(1)-O(2) 2.0194(16) Å  Ti(1)-O(3) 2.0960(16) Å 
 Ti(1)-O(6) 1.8189(16) Å  Ti(1)-O(4) 2.0293(16) Å 
 Ti(1)-O(5) 1.8349(17) Å  Ti(1)-O(1) 2.1036(16) Å 
 O(2)-C(9) 1.305(3) Å   O(3)-C(22) 1.284(3) Å 
O(1)-C(7) 1.290(3) Å  O(4)-C(24) 1.306(3) Å 
 O(6)-C(33) 1.435(3) Å  C(26)-C(25) 1.417(3) Å 
 O(5)-C(31) 1.431(3) Å  C(9)-C(8) 1.413(3) Å 
 C(22)-C(21) 1.516(3) Å  C(6)-C(7) 1.514(3) Å 
 C(25)-C(30) 1.423(3) Å  C(23)-C(24) 1.414(3) Å 
 C(10)-C(11) 1.420(3) Å  C(8)-C(7) 1.425(3) Å 
C(10)-C(9) 1.520(3) Å  C(31)-C(32) 1.521(5) Å 
 
Table 4.11-2 – Selected interatomic distances for compound 11 with standard uncertainties 
listed in parentheses 
 
O(3)-Ti(1)-O(2) 86.77(6) °   O(6)-Ti(1)-O(2) 100.46(7) ° 
 O(6)-Ti(1)-O(3) 168.62(7) °   O(4)-Ti(1)-O(2) 166.17(7) ° 
 O(4)-Ti(1)-O(3) 82.75(6) °   O(4)-Ti(1)-O(6) 88.63(7) ° 
 O(5)-Ti(1)-O(2) 90.84(7) °   O(5)-Ti(1)-O(3) 88.55(7) ° 
 O(5)-Ti(1)-O(6) 100.01(8) °   O(5)-Ti(1)-O(4) 97.87(7) ° 
 O(1)-Ti(1)-O(2) 83.22(6) °   O(1)-Ti(1)-O(3) 80.28(7) ° 
 O(1)-Ti(1)-O(6) 91.78(7) °   O(1)-Ti(1)-O(4) 86.12(6) ° 
 O(1)-Ti(1)-O(5) 167.61(7) °   C(24)-C(23)-C(22) 122.8(2) ° 
 C(31)-O(5)-Ti(1) 137.82(16) °   O(4)-C(24)-C(25) 115.47(18) ° 
 C(12)-C(11)-C(10) 121.1(2) °   C(7)-C(8)-C(9) 123.0(2) ° 
 C(6)-C(7)-O(1) 117.44(18) °     
 
Table 4.11-3 – Selected bond angles for compound 11 with standard uncertainties listed in 
parentheses 
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Figure 4.11-7 – Space filling diagram showing the Van der Waals radii of the atoms of the 
ligands around the complex and showing significant bowing of the acetylacetonate ligand. 
Figure 4.11-7 shows a space filling diagram of compound 11 viewed with the ethoxide 
ligands pointing towards the viewer. In this arrangement it is clear the complex exhibits a 
cis configuration with regards to the ethoxide ligands as usual, however the 
acetylacetonate backbone of the molecule is unusually bowed, with significant torsion of 
one of the phenyl rings of the ligand 29.29 ° away from the plane of each the ligands 
(Figure 4.11-8). This finding is interesting as this molecule does not form hydrogen bonds 
between molecules. The molecules do not exhibit π – π stacking nor form T-bonding 
interactions. This suggests that the torsion is caused only by the steric strain around the 
molecule, possibly due to interaction with the ethoxide ligands of the complex, which in 
this molecule are asymmetrical.  
 
Figure 4.11-8 – Capped stick representation of compound 11 showing the planes of the 
acetylacetonate ligand (grey) and the plane of the twisted phenyl ring of the ligand (blue) 
Twisted phenyl 
ring 
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 Dimeric analogues of bridging aluminium sec-butoxide dimers 
Several attempts were made to prepare dimeric titanium analogues of the bridged 
aluminium complexes synthesised in Chapter 2. Attempts to synthesise molecules with the 
target structure shown in Figure 4.12-1 were made by adding only one equivalent of the 
acetylacetonate ligand to titanium(IV) ethoxide in anhydrous conditions at -78 °C and 35 
°C. The solutions were stirred for 2 hours, at which point a precipitate formed. The 
precipitates were isolated by filtration and washed with pentane. The precipitates were 
often found to contain several products, with the bulk of the material being the normal 
bis-acetylacetonatetitanium(IV) ethoxide complexes and unreacted titanium(IV) 
ethoxide. 
 
Figure 4.12-1 – Target bridged titanium dimer compounds 
 
The filtrate was reduced in vacuo and the remaining residue was found to consist of 
unreacted titanium(IV) ethoxide in all cases. 
 Conclusion 
This chapter reports the synthesis and characterisation of several novel titanium (IV) 
ethoxide complexes, and contributes structural information about these complexes to the 
library of compounds made by the McGowan group. 
The ability for titanium (IV) ethoxide complexes to polymerise has been studied, and an in-
depth study into the effect of temperature on the rate of polymerisation for one 
compound has been conducted. 
The anti-cancer activity of a small range of these compounds has been assessed and the 
complexes have been found to show moderate activity against human ovarian cancer 
cell lines. Attempts to test the ability of a polymer produced using titanium (IV) ethoxide 
complexes has been attempted, however these attempts were unsuccessful due to the 
nature of the cell line assay. 
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The mechanism for interconversion of titanium (IV) ethoxide complexes between the 
structural isomers has been studied, and it was found that titanium (IV) ethoxide complexes 
are able to interconvert between isomers without complete dissociation of the β-
diketonate ligand, which indicates that it is possible to switch on and off the ability for the 
chelating ligand to dissociate by swapping the nature of the monodentate ligands. 
The nature of the decomposition of titanium (IV) ethoxide complexes has also been 
investigated, and a crystal structure of a complex exposed to oxygen has been collected. 
 Further Work 
The focus of future work in this field might investigate further the nature of the photo-
reduction of the titanium (IV) complexes, possibly to titanium (III) complexes, and isolating 
the structure of the reduced species. 
Titanium (IV) complexes have been of interest to the McGowan group in order to build up 
a library of structure-activity relationships and further work in this regard would be to 
attempt to synthesise meta and ortho substituted phenyl β-diketonate complexes to 
investigate whether increased asymmetry has any effect on the anti-cancer activity of the 
complexes. 
The potential of titanium (IV) ethoxide complexes for a combined polymerisation/anti-
cancer application seems ripe. A delivery system based on titanium dispersed poly(lactic 
acid) implants could be developed into a potentially low-cost continual delivery system 
of localised drugs to a tumor site, reducing the whole body exposure to anti-cancer active 
compounds in the future. One current barrier to this testing procedure is the DMSO solvent 
system used in in vitro cell line testing, and alternative methods of exposing cells to the 
decomposing plastic would have to be identified.  
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5. EXPERIMENTAL 
  Apparatus 
All syntheses stated as being performed under N2 or under anhydrous conditions were 
performed using Schlenk line techniques under an atmosphere of N2 which was passed 
over a dual column of phosphorus pentoxide and activated 4Å molecular sieves.  
All glassware, canulae and filter canulae used in the above syntheses stated as being 
performed “under N2” or “under anhydrous conditions” were stored in an oven at 160 °C 
prior to use. Volumes of liquid reagents were measured using N2 purged needles and 
syringes.  
Unless otherwise stated, all ligands used in this project were synthesised by the author using 
a modified synthesis originally reported by Hollick et al.[1] All solid ligands were recrystallised 
and dessicated before use. Acetylacetone was purified by distillation and stored over 3Å 
molecular sieves under dry nitrogen. Titanium starting materials including titanium(IV) 
ethoxide and titanium(IV) chloride were stored under dry nitrogen in a sealed ampoule 
and were purchased from Sigma-Aldrich Chemical Company. All other reagents were 
purchased from Sigma-Aldrich Chemical Company, Acros Organics, Fisher Scientific, VWR 
International or the in-house stores in the School of Chemistry, University of Leeds. 
Ethanol, hexane, methanol, toluene, dichloromethane, tetrahydrofuran and diethylether 
were dried by passing solvents over a copper catalyst and activated alumnia columns 
using a Pure Solvent MD Solvent Purification System. Pentane, petrol 40-60°, petrol 60-80°, 
petrol 80-100° and petrol 100-120° were distilled over wired sodium and stored under dry 
nitrogen after degassing using three freeze-pump-thaw cycles. Chloroform was dried by 
refluxing over calcium hydride and stored under dry nitrogen after degassing using three 
freeze-pump-thaw cycles. After drying all solvents were stored in Young’s tapped glass 
ampoules. 
 Analysis and instrumentation 
Deuterated NMR solvents were purchased from Sigma-Aldrich Chemical Company, Acros 
Organics or GOSS Scientific. All NMR solvents used in this project were distilled over calcium 
hydride under dry dinitrogen and stored under nitrogen with 4 Å molecular sieves in an 
ampoule fitted with a Young’s tap, except deuterated benzene which was degassed 
using three freeze-pump-thaw cycles and stored over a sodium mirror. 
All NMR, microanalysis and mass spectrometry samples were prepared in a Braun 
Labmaster 100 glove box and sealed under oxygen free nitrogen. 
NMR spectra were collected by the author or Mr. Simon Barrett using Bruker DRX 500 MHz 
spectrometers or a Bruker DPX 300 MHz spectrometer.  
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Microanalyses were collected by Mr. Ian Blakeley and Ms. Tanya Marinko-Covell at the 
University of Leeds microanalysis service. 
Mass spectra were collected by Ms. Tanya Marinko-Covell at the University of Leeds mass 
spectrometry service, with electrospray being the source of ionisation unless otherwise 
stated. 
X-ray diffraction data was collected by the author, Dr Christopher Pask or Miss Rianne Lord 
on a Bruker X8 diffractometer using monochromated Mo-Kα (graphite) X-ray radiation of 
wavelength 0.71073 Å.  Diffraction data was detected using a Kappa Apex II CCD 
detector. Suitable crystals were mounted on a MiTeGen micromesh and cooled to 150K 
using an Oxford cryostream low temperature device.[2] 
The data was scaled and prepared using APEX2 software and error calculations were 
found using SADABS. The data was solved by direct methods using the Olex2 GUI[3] and 
ShelXL or SuperFlip[4] packages. Structure refinement was achieved using ShelXS[5] or 
olex.refine packages.[3] 
 Aluminium Complexes 
5.3.1. Attempted synthesis of bis(acetylacetonate)aluminium chloride – 
(Compound 1)  
Anhydrous aluminium(III) chloride (0.5g, 3.7 mmol) was added to toluene (30 ml). The 
solution was heated and stirred until full desolution. Acetylacetone (0.73 ml, 0.75 g, 7.5 
mmol) was added under an atmosphere of N2. The resulting forest green solution was 
stirred for 10 hours. 
Characterisation data: 
Compound was found to have 0 % chlorine by elemental analysis. Mass spectrometry 
found a major peak of Na[Al(acetylacetonate)3]2 at 671.22 gmol-1. 
5.3.2. Attempted synthesis of bis(acetylacetonate)aluminium chloride – 
(Compound 1)  
Anhydrous aluminium(III) chloride (0.5 g) was added to petrol 60 - 80° (30 ml). The solution 
was stirred for three days until full desolution. Acetylacetone (0.74 ml, 0.75 g, 7.5 mmol) 
was added under an atmosphere of N2 to yield a milky white precipitate. The filtrate was 
isolated and the remaining solvent removed in vacuo to yield a white solid. 
Characterisation data 
Compound was found to contain large amounts of Na[Al(acetylacetonate)3]2  by mass 
spectrometry, major peak at 671.22 gmol-1. The compound was found to have 0% chlorine 
by elemental analysis. 
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5.3.3. Attempted synthesis of bis-(phenylacetylacetonate)aluminium chloride 
dimer – (Compound 2)  
To a solution of anhydrous aluminium(III) chloride (0.75 g, 5.6 mmol)  in chloroform (~40 ml) 
was added a solution of phenylacetylacetone (1.81 g, 11.2 mmol ) in DCM dropwise. A 
colour change was observed from orange to green. The crude product was dissolved in 
chloroform and allowed to recrystallise in an atmosphere of pentane under anhydrous 
conditions. 
Characterisation data 
 
Figure 5.3-1 – Lettered structure of compound 2 used for the assignment of 1H NMR peaks 
500 MHz, 298 K, CDCl3, 1H NMR: (See Figure 5.3-1) 
2.20 ppm 3H, s, [[PhCOCHCOCH3]2AlCl]2] Ha 
6.25 ppm 1H, s, [PhCOCHCOCH3]2AlCl]2 Hc  
7.45 ppm 3.5H, m [[CH(C2H2)(C2H2)CHCOCHCOCH3]2AlCl]2 Overlapping signals He and Hd 
(and additional impurity) 
7.93 ppm 2H, m [[CH(C2H2)(C2H2)CHCOCHCOCH3]2AlCl]2 Hc 
 
5.3.4. Attempted synthesis of bis(acetylacetonate)aluminium chloride dimer – 
(Compound 3) 
To a solution of anhydrous aluminium(III) chloride (0.5 g, 3.7 mmol) in DCM was added a 
solution of 4’chlorophenylacetylacetonate (1.46 g, 7.4 mmol) in petrol 60-80 °. The 
solution was stirred for 16 hours to yield 1.2 g, 2.6 mmol of white solid (70 % yield). 
Characterisation data 
500 MHz, 298 K, CDCl3, 1H NMR: 
2.18 ppm 6H, s, [[H3CCOCHCOCH3]2AlCl]2] 
5.79 ppm 1H, s, [H3CCOCHCOCH3]2AlCl]2 
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Suggested synthesis of the desired product, but significant impurities of Al(acac)3 
[H3CCOCHCOCH3]3Al]: 500 MHz, 298 K, CDCl3, 1H NMR:  
2.01 ppm (0.2 Equivalents) 6H, s, [H3CCOCHCOCH3]3Al] 
5.79 ppm (0.2 Equivalents) 1H, s, [H3CCOCHCOCH3]3Al] 
 
5.3.5. Successful Synthesis of bis-(acetylacetonate)aluminium secbutoxide dimer 
- (Compound 4) 
Aluminium secbutoxide (1.82 g, 7.4 mmol) was dissolved in petrol (60 – 80 °) and cooled 
to -78 °C in a cardice/acetone slurry bath. To which a solution of acetylacetone (1.48 g, 
14.8 mmol) in chloroform was added slowly with vigorous stirring under nitrogen. The 
solution was allowed to warm to 0 °C under dynamic nitrogen flow to yield colourless 
crystals suitable for X-ray diffraction.  (0.52 g, 0.87 mmol 23 % yield) 
Characterisation data: 
500 MHz, 298 K, CDCl3, 1H NMR:  
0.76 ppm [3H, bs, H3CCH2CHOCH3] butoxide  
0.93 ppm [2H, bs, H3CCH2CHOCH3] butoxide 
1.08 ppm [3H, H3CCH2CHOCH3]  butoxide 
1.80 ppm [6H, bs, CH3COCHCOCH3] acac 
1.94 ppm [6H, bs, CH3COCHCOCH3]  
3.69 ppm [1H, bs, CH3COCHCOCH3]  
5.35/5.49 ppm [2H, ad, CH3COCHCOCH3] 
 
175 MHz, CDCl3, 13C NMR:  
11.34 ppm [alkyl H3CCH2CHOCH3]  
20.87 ppm [alkyl H3CCH2CHOCH3] 
26.50 ppm [methyl, H3CCOCHCOCH3] 
30.56 ppm [alkyl, H3CCH2CHOCH3] 
69.16 ppm [H3CCOCHCOCH3] 
100.02 ppm [H3CCH2CHOCH3] 
187.89 ppm [H3CCOCHCOCH3] 
191.57 ppm [H3CCOCHCOCH3] 
 
Microanalysis: Calculated - C: 56.37%, H: 7.77% Found – C: 55.80%, H: 7.55% 
ES-MS (CHCl3, m/z) : 425.1 – ((M+Al) – 2 x acac) – C18H32Al3O6+ 
5.3.6. Polymerisation of L-Lactide using bis-(acetylacetonate)aluminium chloride 
dimer – (Compound 2)  
Recrystallised sample of compound 2 (0.014 g, 0.032 mmol) was added to L-lactide (0.91 
g, 6.3 mmol, 200 equivalents per aluminium centre) in an atmosphere of N2. The reaction 
mixture was heated to 150 °C for 4 hours and solidified leaving a slightly yellow plastic. 
Degree of conversion – 87.1 %, measured by integration of lactide methine proton 
against unreacted lactide methine proton. 
Characterisation 
Poly(lactic acid) 
500 MHz, CDCl3, 298 K 1H NMR:  
1.58 ppm [3H, t, [OCH(CH3)CO]n] 
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5.17 ppm [1H, q, [OCH(CH3)CO]n] 
 
Lactide 
1.67 ppm [3H, t, [OCH(CH3)CO]2] 
5.04 ppm [1H, q, [OCH(CH3)CO]2] 
 
5.3.7. Polymerisation of L-Lactide using bis-(acetylacetonate)aluminium 
secbutoxide - (Compound 4) 
Recrystallised sample of compound 4 (0.002 g, 0.033 mol) was added to L-lactide (1.56 g, 
10.831 mmol, 200 equivalents per aluminium centre) in an atmosphere of N2. The 
reaction mixture was heated to 150 °C for 10 minutes and solidified leaving a white solid. 
Degree of conversion – 94.49 %, measured by integration of lactide methine proton 
against unreacted lactide methine proton. 
Characterisation 
Poly(lactic acid) 
500 MHz, CDCl3, 298 K 1H NMR:  
1.58 ppm [3H, t, [OCH(CH3)CO]n] 
5.17 ppm [1H, q, [OCH(CH3)CO]n] 
Lactide 
1.67 ppm [3H, t, [OCH(CH3)CO]2] 
5.04 ppm [1H, q, [OCH(CH3)CO]2] 
 
 Titanium Complex Synthesis 
5.4.1. Bis-(4’Fluorophenylacetylacetonate)titanium(IV) ethoxide - compound 5 
2 equivalents of 4’fluorophenylacetylactone (2.37 g, 13.1 mmol) was dissolved in ethanol 
and added to titanium(IV) ethoxide (1.5 g, 6.57 mmol) solution. The mixture was allowed 
to stir for 16 hours and the resulting cream precipitate was isolated by filtration. The 
powder was then recrystallised from hot ethanol to yield light yellow crystals suitable for 
X-ray diffraction (2.61 g, 5.26 mmol, 80% yield). 
500 MHz, CDCl3, 298 K 1H NMR:  
1.24 ppm [3H, s, TiOCH2CH3]  
2.07/2.26 ppm [3H, s 4’FPhCOCHCOCH3] 
4.52 ppm [2H, as, TiOCH2CH3] 
6.20 ppm [1H, s, 4’FPhCOCHCOCH3]  
7.00/7.12 ppm [2H, as, H-ortho to fluorine atom on phenyl ring] 
7.77/8.04 ppm [2H, d, H-meta to fluorine atom on phenyl ring]. 
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175 MHz, CDCl3, 298K, 13C{1H} NMR:  
18.5 ppm [alkyl, TiOCH2CH3] 
33.6 ppm [alkyl,  4’FPhCOCHCOCH3] 
72.4 ppm [alkoxide, TiOCH2CH3] 
111.4 ppm [aromatic, C-meta to fluorine atom on phenyl ring] 
130.2 ppm [aromatic, C-ortho to fluorine atom in phenyl ring] 
133.4 ppm [aromatic, F-C of phenyl ring] 
140.0 ppm [aromatic, quaternary PhC-C=O of acetylacetonate] 
164.0 ppm [carbonyl, 4’FPhCOCHCOCH3] 
166.0 ppm [carbonyl, 4’FPhCOCHCOCH3]. 
Microanalysis: Calculated - C: 57.84%, H:5.66% Found – C:57.70%, H:5.25% 
ES-MS (CHCl3, m/z) : 519.1 (M+Na) - C24H26F2NaO6Ti+ 
See Appendix for crystallographic data 
5.4.2. Bis-(4-bromophenylacetylacetonate)titanium(IV) ethoxide  (Compound 6) 
2 equivalents of 4’bromophenylacetylactone (0.50 g, 2.09 mmol) was dissolved in 
ethanol and added to titanium(IV) ethoxide (0.24 g, 1.05 mmol) solution. The mixture was 
allowed to stir for 16 hours and the resulting cream precipitate was isolated by filtration. 
The powder was then recrystallised from hot ethanol to yield light yellow crystals suitable 
for X-ray diffraction. 
500 MHz, CDCl3, 298 K 1H NMR:  
1.24 ppm [6H s, TiOCH2CH3] 
2.07 ppm [3H, as, 4’BrPhCOCHCOCH3] 
2.26 ppm [3H, s, 4’BrPhCOCHCOCH3] 
4.52 ppm [4H, as, TiOCH2CH3] 
6.20 ppm [2H, s, 4’BrPhCOCHCOCH3] 
7.48 ppm [2H, as, H-meta to bromine atom on phenyl ring] 
7.60 ppm [4H, as, H-ortho to bromine atom on phenyl ring] 
7.89 ppm [2H, d, H-meta to bromine atom on phenyl ring] 
175 MHz, CDCl3, 298K, 13C{1H} NMR:  
18.5 ppm [alkyl, TiOCH2CH3] 
27.0 ppm [alkyl,  4’FPhCOCHCOCH3] 
27.7 ppm [alkyl, 4’BrPhCOCHCOCH3] 
72.5 ppm [alkoxide, TiOCH2CH3] 
98.9/99.3 ppm [methine, 4’BrPhCOCHCOCH3] 
131.6 ppm [aromatic, C-ortho to bromine atom in phenyl ring] 
129.1 ppm [aromatic, C-meta to bromine atom on phenyl ring] 
126.5 ppm [aromatic, Br-C of phenyl ring] 
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140.0 ppm [aromatic, quaternary C-C=O of acetylacetonate] 
178.7/181.7/181.8 ppm [carbonyl, 4’BrPhCOCHCOCH3] 
190.6/193.6 ppm [carbonyl, 4’BrPhCOCHCOCH3]. 
See Appendix for crystallographic data 
5.4.3. Bis-(4-iodophenylacetylacetonate)titanium(IV) ethoxide (Compound 7) 
2 equivalents of 4’iodophenylacetylactone (0.50 g, 1.74 mmol) was dissolved in ethanol 
and added to titanium(IV) ethoxide (0.20 g, 0.88 mmol) in ethanol. The mixture was 
allowed to stir for 16 hours and the resulting brown precipitate was isolated by filtration. 
The powder was then recrystallised from hot ethanol to yield a dark brown solid. 
500 MHz, CDCl3, 298 K 1H NMR:  
1.23 ppm [3H, s, TiOCH2CH3] 
2.07/2.26 ppm [3H, s, 4’IPhCOCHCOCH3] 
4.51 ppm [2H, as, TiOCH2CH3] 
6.19 ppm [4’IPhCOCHCOCH3] 
7.46 ppm [1H as, H-ortho to the iodine atom of the phenyl ring] 
7.74 ppm [3H, m, H-ortho to the iodine atom of the phenyl ring, H-meta to the iodine 
atom of the phenyl ring]. 
175 MHz, CDCl3, 298K, 13C{1H} NMR:  
18.6 ppm [alkyl, TiOCH2CH3] 
27.0/27.7 ppm [methyl, 4’IPhCOCHCOCH3] 
72.4 ppm [alkoxide, TiOCH2CH3] 
98.9 ppm [methine, 4’IPhCOCHCOCH3] 
129.1 ppm [aromatic, C atoms-ortho to the iodine atom of the phenyl ring] 
136.7/137.6 ppm [aromatic, C atoms – meta to the iodine atoms of the phenyl ring], 
178.9 ppm [aromatic quaternary, C-I] 
182.1 ppm [aromatic quaternary, C-C=O] 
190.8 ppm [carbonyl, 4’IPhCOCHCOCH3] 
193.7 ppm [carbonyl, 4’IPhCOCHCOCH3]. 
Microanalysis – Calculated – C: 40.48%, H: 3.68%. Found – C: 40.80% H: 3.55% 
5.4.4. Synthesis of Bis-(1,3-di-4-methoxyphenylpropan-1,3-
diketonate)titanium(IV) ethoxide (Compound 6) 
1 equivalent of bis-4’methoxyphenylacetylactone (0.3 g, 1.01 mmol) was dissolved in 
ethanol and added to titanium(IV) ethoxide (0.24 g, 1.05 mmol) in ethanol. The mixture 
was allowed to stir for 16 hours and the resulting white precipitate was isolated by 
filtration. The powder was then recrystallised from hot ethanol to yield a white powder. 
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500 MHz, CDCl3, 298 K 1H NMR:  
1.26 ppm [3H, t, 2J = 6.9 Hz, TiOCH2CH3] 
3.77/3.91 ppm [6H, s, H3COPhCOCHCOPhOCH3] 
4.57 ppm [2H, q, 2J = 7.1 Hz, TiOCH2CH3] 
6.78 ppm [2H, s, H-atoms ortho to the methoxy group of the phenyl ring] 
6.81 ppm [1H, s, H3COPhCOCHCOPhOCH3] 
7.01 ppm [2H, s, H-atoms ortho to the methoxy group of the phenyl ring] 
7.78 ppm [2H, s, H-atoms meta to the methoxy group of the phenyl ring] 
8.15 ppm [2H, s, H-atoms meta to the methoxy group of the phenyl ring] 
175 MHz, CDCl3, 298K, 13C{1H} NMR:  
18.7 ppm [alkyl, TiOCH2CH3] 
55.4 ppm [methoxy, H3COPhCOCHCOPhOCH3] 
71.6 ppm [alkoxy, TiOCH2CH3] 
94.5 ppm [methine, H3COPhCOCHCOPhOCH3] 
113.5 ppm [aromatic, C-atoms meta to the methoxy group of the phenyl ring] 
113.7 ppm [aromatic, C-atoms meta to the methoxy group of the phenyl ring] 
129.7 ppm [aromatic, C-atoms ortho to the methoxy group of the phenyl ring] 
130.5 ppm [aromatic, C-OCH3] 
162.5 ppm [carbonyl, H3COPhCOCHCOPhOCH3] 
Elemental Analysis – Calculated – C:64.78%, H:5.72%, Found – C:64.75%, H:5.65% 
ES-MS (CHCl3, m/z) : 673.2 (M+H) - C38H41O8Ti 
 Bulk polymerisations 
5.5.1. Bulk polymerisation of lactide with bis-(acetylacetonate)titanium chloride 
(Compound 2) 
200 equivalents of rac-lactide was mixed with one equivalent of bisacetylacteonate 
titanium chloride. The mixture was ground in a pestle and mortar and sealed in a round 
bottomed flask with a suba seal. The flask was then submerged in oil at 150°C. 
Degree of conversion – 80 %, measured by integration of lactide methine proton against 
unreacted lactide methine proton. 
Characterisation 
Poly(lactic acid) 
500 MHz, CDCl3, 298 K 1H NMR:  
1.58 ppm [3H, t, [OCH(CH3)CO]n] 
5.17/5.19 ppm [1H, m, [OCH(CH3)CO]n] 
Lactide 
1.67 ppm [3H, t, [OCH(CH3)CO]2] 
5.04 ppm [1H, q, [OCH(CH3)CO]2] 
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5.5.2. Bulk polymerisation of lactide with bis-(4’methoxyphenylacetylacetonate) 
titanium(IV) chloride 
200 equivalents of rac-lactide was mixed with one equivalent of bis-
4’methoxyphenylacetylacteonate titanium chloride. The mixture was ground in a pestle 
and morter and sealed in a round bottomed flask with a suba seal. The flask was then 
submerged in oil at 150°C. 
Degree of conversion – 54 %, measured by integration of lactide methine proton against 
unreacted lactide methine proton. 
Characterisation 
Poly(lactic acid) 
500 MHz, CDCl3, 298 K 1H NMR:  
1.58 ppm [3H, t, [OCH(CH3)CO]n] 
5.17/5.19 ppm [1H, m, [OCH(CH3)CO]n] 
Lactide 
1.67 ppm [3H, t, [OCH(CH3)CO]2] 
5.04 ppm [1H, q, [OCH(CH3)CO]2] 
5.5.3. In situ polymerisation of lactide with bis-
(4’methoxyphenylacetylacetonate) titanium(IV) chloride 
A bulk mixture of 200 equivalents of L-lactide was mixed with one equivalent of bis-
4’methoxyphenylacetylacteonate titanium chloride. The mixture was ground in a pestle 
and mortar and sealed into glass crip-cap vials with aluminium caps and PTFE plugs. The 
vials were submerged into rigorously stirred oil at 150°C. Three sample vials were removed 
at 5 minutes, 10 minutes, 20 minutes, 40 minutes, 60 minutes, 3 hours, 4 hours,13 hours and 
15 hours. Each sample vial was exposed to air and the polymer inside analysed by 1H NMR. 
The NMR spectra were randomised and each data set was given a random number. The 
degree of polymerisation was calculated by single-blind integration of the area under the 
peaks of polymerised lactide against total area of unreacted and polymerised lactide 
and the percentage conversion calculated for each of the vials. The average was 
calculated and plotted using orgin pro 8. 
Degree of conversion – 14%, measured by integration of lactide methine proton against 
unreacted lactide methine proton. 
Characterisation 
Poly(lactic acid) 
500 MHz, CDCl3, 298 K 1H NMR:  
1.58 ppm [3H, t, [OCH(CH3)CO]n] 
5.17/5.19 ppm [1H, m, [OCH(CH3)CO]n] 
Lactide 
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1.7 ppm [3H, t, [OCH(CH3)CO]2] 
5.0 ppm [1H, q, [OCH(CH3)CO]2] 
5.5.4. In-Situ polymerisation studies of lactide with compound 5 
A bulk mixture of 210 equivalents of L-lactide was mixed with one equivalent of compound 
5. The mixture was ground in a pestle and mortar and sealed into glass crip-cap vials with 
aluminium caps and PTFE plugs. The vials were submerged into rigorously stirred oil at 150 
°C. Three sample vials were removed at 5 minutes, 10 minutes, 20 minutes, 40 minutes, 60 
minutes, 90 minutes, 150 hours, 4 hours, 5 hours and 8.5 hours and 12 hours. Each sample 
vial was exposed to air and the polymer inside analysed by 1H NMR in wet CDCl3. This 
process was repeated in oil baths at 160 °C, 170 °C, 185 °C and 200 °C. The NMR spectra 
were randomised and each data set was given a random number. The degree of 
polymerisation was calculated by single-blind integration of the area under the peaks of 
polymerised lactide against total area of unreacted and polymerised lactide and the 
percentage conversion calculated for each of the vials. The average was calculated and 
plotted using Origin pro 8. Origin was further used to model appropriate lines of best fit for 
all of the data points, and a logarithmic fit was selected, using origin to interpolate 
variables for A1, A2, x, x0 and p which best fit the data set satisfying equations with general 
formula as shown in Equation 3.3-1. The general formula was rearranged to make x the 
subject of the equation and y=50 inserted with the variables interpolated by Origin Pro 
(Equation 3.3-2). Full calculations are included in the appendix. 
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6. APPENDICES 
 Crystallographic information for compound 4 
Table 1 Crystal data and structure refinement for DC46_0M. 
Identification code DC46_0M 
Empirical formula C28H39Al2O10 
Formula weight 589.55 
Temperature/K 150 
Crystal system tetragonal 
Space group I41 
a/Å 14.8759(2) 
b/Å 14.8759(2) 
c/Å 29.5961(6) 
α/° 90 
β/° 90 
γ/° 90 
Volume/Å3 6549.4(2) 
Z 8 
ρcalcmg/mm3 1.196 
m/mm-1 0.138 
F(000) 2504.0 
Crystal size/mm3 0.06 × 0.02 × 0.01 
Radiation MoKα (λ = 0.71073) 
2Θ range for data collection 3.064 to 56.714° 
Index ranges -19 ≤ h ≤ 19, -19 ≤ k ≤ 19, -39 ≤ l ≤ 39 
Reflections collected 59082 
Independent reflections 8169 [Rint = 0.0459, Rsigma = 0.0275] 
Data/restraints/parameters 8169/1/373 
Goodness-of-fit on F2 1.055 
Final R indexes [I>=2σ (I)] R1 = 0.0705, wR2 = 0.1717 
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Final R indexes [all data] R1 = 0.1101, wR2 = 0.2085 
Largest diff. peak/hole / e Å-3 0.38/-0.45 
Flack parameter 0.48(13) 
 
Table 2 Fractional Atomic Coordinates (×104) and Equivalent Isotropic 
Displacement Parameters (Å2×103) for DC46_0M. Ueq is defined as 1/3 of of the 
trace of the orthogonalised UIJ tensor. 
Atom x y z U(eq) 
Al1 -14305.8(17) -9308.6(15) -11105.2(8) 49.2(5) 
O5 -15565(4) -9432(3) -11107(2) 47.8(11) 
O2 -14207(4) -9311(3) -10464.5(19) 50.7(14) 
O3 -13036(3) -9308(3) -11116.5(17) 54.1(13) 
O4 -14307(4) -9201(4) -11748(2) 55.4(15) 
O1 -14298(4) -8030(3) -11095.2(17) 52.7(13) 
C1 -14088(6) -6519(6) -10885(3) 67(2) 
C9 -13685(7) -8991(6) -12007(3) 59(2) 
C2 -14114(5) -7492(6) -10778(3) 55.7(19) 
C7 -12499(5) -9072(5) -11437(3) 53.3(19) 
C10 -13967(7) -8854(8) -12498(3) 84(3) 
C8 -12789(6) -8925(6) -11875(3) 64(2) 
C4 -14008(6) -8654(7) -10202(3) 61(2) 
C3 -13919(6) -7779(6) -10342(3) 66(2) 
C6 -11525(6) -9056(6) -11314(3) 71(2) 
C5 -13840(7) -8907(7) -9708(3) 78(3) 
Al2 -19303.8(17) -5693.2(16) -11105.7(9) 49.2(5) 
O6 -18035(4) -5692(4) -11116.0(19) 58.5(14) 
O8 -19205(4) -5686(4) -10467(2) 54.2(14) 
O10 -20554(4) -5559(4) -11107(3) 53.1(12) 
O7 -19313(4) -5803(4) -11744(2) 60.1(16) 
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O9 -19294(4) -6972(3) -11095.2(19) 58.6(14) 
C24 -19084(6) -8485(5) -10890(3) 64(2) 
C19 -18963(8) -6132(8) -12491(3) 86(3) 
C23 -19113(6) -7498(5) -10777(3) 54.7(19) 
C16 -17509(5) -5925(5) -11442(3) 52.9(19) 
C18 -18691(6) -6011(5) -12008(3) 54.6(19) 
C17 -17785(7) -6085(6) -11875(3) 68(2) 
C22 -18909(6) -7224(7) -10340(3) 69(3) 
C21 -19001(6) -6341(7) -10202(3) 59(2) 
C20 -18856(7) -6099(7) -9711(3) 80(3) 
C15 -16520(6) -5943(6) -11310(3) 66(2) 
C28 -21507(10) -6336(10) -10473(6) 164(7) 
C11 -16404(8) -8466(9) -11758(3) 117(5) 
C27 -21245(9) -6228(10) -11036(7) 137(6) 
C13 -16238(9) -8773(9) -11050(7) 141(6) 
C26 -21556(9) -6664(8) -11352(4) 129(4) 
C12 -16564(8) -8333(8) -11359(4) 129(5) 
C14 -16543(10) -8660(10) -10492(6) 146(6) 
C25 -21408(9) -6518(9) -11766(4) 115(5) 
  
Table 3 Anisotropic Displacement Parameters (Å2×103) for DC46_0M. The 
Anisotropic displacement factor exponent takes the form: -
2π2[h2a*2U11+2hka*b*U12+…]. 
Atom U11 U22 U33 U23 U13 U12 
Al1 59.9(14) 50.2(12) 37.4(9) 2.6(10) -0.6(10) 15.1(10) 
O5 56(3) 42(2) 45(2) 1(2) -4(2) 20(2) 
O2 62(3) 54(3) 36(3) 8(2) 4(2) 7(2) 
O3 60(3) 61(3) 42(3) 6(3) 4(3) 16(2) 
O4 65(4) 64(4) 38(3) 0(2) -3(2) 18(3) 
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O1 76(3) 45(3) 37(2) 2(2) -4(3) 12(2) 
C1 83(6) 54(5) 65(5) 3(4) 2(5) -14(4) 
C9 80(6) 53(5) 42(4) 0(4) -3(4) -10(4) 
C2 50(4) 72(5) 45(4) 8(4) 7(3) -1(3) 
C7 63(5) 46(4) 51(5) 7(3) 1(4) -9(3) 
C10 100(7) 117(9) 36(4) 11(5) 0(5) -19(6) 
C8 64(5) 77(6) 50(5) 6(4) 6(4) -15(4) 
C4 62(5) 86(6) 37(4) -2(4) 4(4) -1(4) 
C3 85(6) 69(6) 43(5) -10(4) -1(4) -17(5) 
C6 76(6) 69(6) 70(6) 2(5) 10(5) -7(4) 
C5 103(8) 88(7) 42(4) 10(5) 1(5) -16(5) 
Al2 58.3(14) 49.5(12) 39.9(9) -2.1(10) -0.3(10) -4.4(10) 
O6 64(3) 60(3) 52(3) -5(3) 4(3) 2(2) 
O8 60(3) 60(3) 42(3) -4(2) 2(2) 7(2) 
O10 60(3) 47(3) 53(3) -3(3) -4(3) -13(2) 
O7 72(4) 62(4) 46(4) -4(3) 3(3) -4(3) 
O9 79(4) 53(3) 44(3) -4(3) -4(3) 7(3) 
C24 79(6) 49(4) 63(5) -9(4) -5(4) 15(4) 
C19 109(8) 111(9) 38(4) -12(5) -3(5) 21(6) 
C23 53(4) 62(5) 49(4) 0(4) 12(3) 6(3) 
C16 53(4) 49(4) 57(5) -3(3) 7(4) 13(3) 
C18 66(5) 53(4) 46(4) 0(3) -6(4) 11(4) 
C17 78(6) 77(6) 49(5) -7(4) -1(4) 27(5) 
C22 83(6) 81(6) 43(5) 2(4) -2(4) 29(5) 
C21 63(5) 75(6) 38(4) 1(4) 3(4) 1(4) 
C20 102(8) 93(7) 46(5) -15(5) -1(5) 18(6) 
C15 70(6) 64(5) 64(5) -9(4) 1(4) 9(4) 
C28 143(12) 126(11) 223(17) 88(12) 43(13) -23(9) 
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C11 125(9) 157(11) 69(6) -21(6) 5(6) 82(8) 
C27 88(8) 92(9) 232(17) 14(10) -13(9) -50(6) 
C13 74(7) 80(7) 267(18) -12(9) -2(9) 55(5) 
C26 145(10) 126(9) 116(9) -34(7) 26(7) -81(8) 
C12 148(9) 130(9) 108(8) 31(7) 12(7) 96(8) 
C14 141(12) 119(10) 180(14) -55(10) 23(11) 45(9) 
C25 122(10) 154(12) 69(6) 22(6) -7(6) -61(8) 
  
Table 4 Bond Lengths for DC46_0M. 
Atom Atom Length/Å   Atom Atom Length/Å 
Al1 Al11 2.915(5)   Al2 O102 1.875(6) 
Al1 O51 1.883(6)   Al2 O10 1.870(6) 
Al1 O5 1.882(6)   Al2 O7 1.898(8) 
Al1 O2 1.902(7)   Al2 O9 1.902(6) 
Al1 O3 1.889(6)   O6 C16 1.288(9) 
Al1 O4 1.908(7)   O8 C21 1.288(11) 
Al1 O1 1.902(5)   O10 Al22 1.875(6) 
O5 Al11 1.883(6)   O10 C27 1.447(11) 
O5 C13 1.412(9)   O7 C18 1.249(10) 
O2 C4 1.283(11)   O9 C23 1.254(9) 
O3 C7 1.288(9)   C24 C23 1.507(10) 
O4 C9 1.241(10)   C19 C18 1.499(11) 
O1 C2 1.263(10)   C23 C22 1.389(11) 
C1 C2 1.481(11)   C16 C17 1.369(11) 
C9 C10 1.527(11)   C16 C15 1.523(11) 
C9 C8 1.393(12)   C18 C17 1.408(12) 
C2 C3 1.390(11)   C22 C21 1.382(13) 
C7 C8 1.384(11)   C21 C20 1.513(11) 
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C7 C6 1.494(12)   C28 C27 1.72(3) 
C4 C3 1.372(13)   C11 C12 1.222(13) 
C4 C5 1.531(11)   C27 C26 1.228(19) 
Al2 Al22 2.923(5)   C13 C12 1.223(19) 
Al2 O6 1.888(6)   C13 C14 1.72(2) 
Al2 O8 1.895(7)   C26 C25 1.264(14) 
1-3-X,-2-Y,+Z; 2-4-X,-1-Y,+Z 
  
Table 5 Bond Angles for DC46_0M. 
Atom Atom Atom Angle/˚   Atom Atom Atom Angle/˚ 
O5 Al1 Al11 39.28(16)   O8 Al2 Al22 92.95(18) 
O51 Al1 Al11 39.27(16)   O8 Al2 O7 173.8(3) 
O5 Al1 O51 78.5(2)   O8 Al2 O9 89.3(3) 
O51 Al1 O2 90.5(3)   O102 Al2 Al22 38.64(18) 
O5 Al1 O2 94.6(3)   O10 Al2 Al22 38.76(16) 
O5 Al1 O3 174.3(3)   O10 Al2 O6 173.7(3) 
O51 Al1 O3 95.9(3)   O102 Al2 O6 96.4(3) 
O5 Al1 O4 90.2(3)   O102 Al2 O8 90.4(3) 
O51 Al1 O4 94.6(3)   O10 Al2 O8 94.6(3) 
O5 Al1 O1 96.0(3)   O10 Al2 O102 77.4(2) 
O51 Al1 O1 174.5(3)   O10 Al2 O7 90.0(3) 
O2 Al1 Al11 93.08(19)   O102 Al2 O7 94.7(3) 
O2 Al1 O4 173.6(3)   O102 Al2 O9 173.9(3) 
O2 Al1 O1 89.2(2)   O10 Al2 O9 96.6(3) 
O3 Al1 Al11 135.1(2)   O7 Al2 Al22 93.2(2) 
O3 Al1 O2 86.6(3)   O7 Al2 O9 86.0(3) 
O3 Al1 O4 89.1(3)   O9 Al2 Al22 135.3(2) 
O3 Al1 O1 89.6(3)   C16 O6 Al2 128.2(6) 
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O4 Al1 Al11 93.4(2)   C21 O8 Al2 128.5(6) 
O1 Al1 Al11 135.2(2)   Al2 O10 Al22 102.6(2) 
O1 Al1 O4 86.1(3)   C27 O10 Al22 127.1(9) 
Al1 O5 Al11 101.5(2)   C27 O10 Al2 129.3(8) 
C13 O5 Al11 128.2(8)   C18 O7 Al2 129.6(6) 
C13 O5 Al1 129.6(8)   C23 O9 Al2 129.6(6) 
C4 O2 Al1 128.3(5)   O9 C23 C24 116.5(8) 
C7 O3 Al1 129.3(5)   O9 C23 C22 124.3(8) 
C9 O4 Al1 129.5(6)   C22 C23 C24 119.1(8) 
C2 O1 Al1 130.3(5)   O6 C16 C17 124.5(8) 
O4 C9 C10 114.6(9)   O6 C16 C15 113.6(7) 
O4 C9 C8 124.0(8)   C17 C16 C15 121.7(7) 
C8 C9 C10 121.3(8)   O7 C18 C19 115.1(8) 
O1 C2 C1 117.9(7)   O7 C18 C17 123.7(8) 
O1 C2 C3 122.7(8)   C17 C18 C19 121.0(8) 
C3 C2 C1 119.5(8)   C16 C17 C18 122.3(8) 
O3 C7 C8 122.6(7)   C21 C22 C23 122.1(8) 
O3 C7 C6 115.3(7)   O8 C21 C22 124.2(8) 
C8 C7 C6 121.9(8)   O8 C21 C20 116.1(8) 
C7 C8 C9 123.3(8)   C22 C21 C20 119.8(8) 
O2 C4 C3 124.2(8)   O10 C27 C28 111.6(13) 
O2 C4 C5 115.4(9)   C26 C27 O10 121.3(16) 
C3 C4 C5 120.4(8)   C26 C27 C28 127.1(11) 
C4 C3 C2 123.5(8)   O5 C13 C14 111.6(13) 
O6 Al2 Al22 135.1(2)   C12 C13 O5 124.3(17) 
O6 Al2 O8 86.5(3)   C12 C13 C14 124.1(10) 
O6 Al2 O7 89.5(3)   C27 C26 C25 125.6(12) 
O6 Al2 O9 89.6(3)   C11 C12 C13 123.9(12) 
1-3-X,-2-Y,+Z; 2-4-X,-1-Y,+Z 
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Table 6 Hydrogen Atom Coordinates (Å×104) and Isotropic Displacement 
Parameters (Å2×103) for DC46_0M. 
Atom x y z U(eq) 
H1A -13698 -6418 -11147 101 
H1B -13851 -6188 -10624 101 
H1C -14696 -6307 -10954 101 
H10A -14403 -9318 -12583 126 
H10B -13437 -8898 -12694 126 
H10C -14241 -8259 -12532 126 
H8 -12355 -8771 -12097 77 
H3 -13713 -7346 -10130 79 
H6A -11421 -8596 -11083 107 
H6B -11166 -8917 -11583 107 
H6C -11348 -9646 -11196 107 
H5A -14414 -8929 -9546 117 
H5B -13449 -8456 -9568 117 
H5C -13549 -9497 -9694 117 
H24A -19684 -8687 -10982 96 
H24B -18888 -8825 -10625 96 
H24C -18660 -8584 -11139 96 
H19A -19098 -6767 -12548 129 
H19B -18471 -5940 -12689 129 
H19C -19499 -5769 -12554 129 
H17 -17349 -6251 -12095 82 
H22 -18698 -7658 -10129 83 
H20A -18667 -5469 -9688 120 
H20B -18389 -6487 -9582 120 
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H20C -19418 -6183 -9543 120 
H15A -16339 -5348 -11200 99 
H15B -16157 -6102 -11575 99 
H15C -16426 -6390 -11072 99 
H28A -21048 -6035 -10290 246 
H28B -21529 -6975 -10393 246 
H28C -22094 -6061 -10415 246 
H11A -16728 -8025 -11942 176 
H11B -16599 -9074 -11841 176 
H11C -15757 -8407 -11812 176 
H27 -21724 -5762 -11074 165 
H13 -16713 -9242 -11092 169 
H26A -22217 -6645 -11315 155 
H26B -21374 -7295 -11297 155 
H12A -17224 -8375 -11324 154 
H12B -16402 -7698 -11299 154 
H14A -17118 -8964 -10441 220 
H14B -16602 -8021 -10418 220 
H14C -16081 -8932 -10300 220 
H25A -21717 -6972 -11948 172 
H25B -20760 -6548 -11824 172 
H25C -21632 -5919 -11846 172 
Experimental 
Single crystals of C28H39Al2O10 [DC46_0M] were [Recrystallised by slow evaporation from 
chloroform]. A suitable crystal was selected and [MiTeGen Mesh] on a 'Bruker APEX-II 
CCD' diffractometer. The crystal was kept at 150 K during data collection. Using Olex2 [1], the 
structure was solved with the ShelXS [2] structure solution program using Direct Methods and refined 
with the ShelXL [3] refinement package using Least Squares minimisation. 
Dolomanov, O.V., Bourhis, L.J., Gildea, R.J, Howard, J.A.K. & Puschmann, H. (2009), J. Appl. Cryst. 
42, 339-341. 
Sheldrick, G.M. (2008). Acta Cryst. A64, 112-122 
Sheldrick, G.M. (2008). Acta Cryst. A64, 112-122 
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Crystal structure determination of [DC46_0M] 
Crystal Data for C28H39Al2O10 (M =589.55): tetragonal, space group I41 (no. 80), a = 
14.8759(2) Å, c = 29.5961(6) Å, V = 6549.4(2) Å3, Z = 8, T = 150 K, μ(MoKα) = 0.138 mm-1, Dcalc = 
1.196 g/mm3, 59082 reflections measured (3.064 ≤ 2Θ ≤ 56.714), 8169 unique (Rint = 0.0459, Rsigma = 
0.0275) which were used in all calculations. The final R1 was 0.0705 (I > 2σ(I)) and wR2 was 0.2085 
(all data). 
Refinement model description 
Number of restraints - 1, number of constraints - unknown. 
Details: 
1. Fixed Uiso 
 At 1.2 times of: 
  All C(H) groups, All C(H,H) groups 
 At 1.5 times of: 
  All C(H,H,H) groups 
2.a Ternary CH refined with riding coordinates: 
 C27(H27), C13(H13) 
2.b Secondary CH2 refined with riding coordinates: 
 C26(H26A,H26B), C12(H12A,H12B) 
2.c Aromatic/amide H refined with riding coordinates: 
 C8(H8), C3(H3), C17(H17), C22(H22) 
2.d Idealised Me refined as rotating group: 
 C1(H1A,H1B,H1C), C10(H10A,H10B,H10C), C6(H6A,H6B,H6C), C5(H5A,H5B,H5C), 
 C24(H24A,H24B,H24C), C19(H19A,H19B,H19C), C20(H20A,H20B,H20C), 
C15(H15A,H15B, 
 H15C), C28(H28A,H28B,H28C), C11(H11A,H11B,H11C), C14(H14A,H14B,H14C), 
C25(H25A, 
 H25B,H25C) 
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 Crystallographic information of compound 5 
Table 1 Crystal data and structure refinement for compound 5 
Identification code DC94 
Empirical formula C24H26F2O6Ti 
Formula weight 143.86 
Temperature/K 173.15 
Crystal system monoclinic 
Space group P21/n 
a/Å 11.2553(10) 
b/Å 19.6468(19) 
c/Å 11.3094(11) 
α/° 90 
β/° 90.178(5) 
γ/° 90 
Volume/Å3 2500.8(4) 
Z 4 
ρcalcmg/mm3 0.3821 
m/mm-1 0.328 
F(000) 281.4 
Crystal size/mm3 0.02 × 0.03 × 0.02 
Radiation Mo Kα (λ = 0.71073) 
2Θ range for data collection 4.14 to 69.6° 
Index ranges -17 ≤ h ≤ 13, -29 ≤ k ≤ 31, -17 ≤ l ≤ 12 
Reflections collected 46103 
Independent reflections 9026 [Rint = 0.0754, Rsigma = 0.1400] 
Data/restraints/parameters 9026/0/28 
Goodness-of-fit on F2 5.519 
Final R indexes [I>=2σ (I)] R1 = 0.5455, wR2 = 0.8418 
Final R indexes [all data] R1 = 0.6230, wR2 = 0.8677 
Largest diff. peak/hole / e Å-3 11.13/-16.20 
 
 
  
Table 2 Fractional Atomic Coordinates (×104) and Equivalent Isotropic 
Displacement Parameters (Å2×103) for DC94. Ueq is defined as 1/3 of of the 
trace of the orthogonalised UIJ tensor. 
Atom x y z U(eq) 
Ti2 9219(3) 2576.6(14) 1538(3) 21.4(9) 
O4 9180(20) 3374(13) 2700(20) 68(6) 
O8 8974(18) 3246(10) 324(19) 50(5) 
O10 9500(40) 2110(20) 2350(40) 130(13) 
O11 11033(18) 2831(11) 1200(20) 54(5) 
O18 9550(20) 1848(13) 160(20) 67(6) 
O38 7512(17) 2414(9) 1303(18) 46(4) 
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Table 3 Bond Lengths for DC94. 
Atom Atom Length/Å   Atom Atom Length/Å 
Ti2 O4 2.05(3)   Ti2 O11 2.14(2) 
Ti2 O8 1.92(2)   Ti2 O18 2.15(3) 
Ti2 O10 1.34(4)   Ti2 O38 1.96(2) 
  
Table 4 Bond Angles for DC94. 
Atom Atom Atom Angle/˚   Atom Atom Atom Angle/˚ 
O8 Ti2 O4 86.1(9)   O18 Ti2 O10 90(2) 
O10 Ti2 O4 95(2)   O18 Ti2 O11 81.7(9) 
O10 Ti2 O8 174.6(18)   O38 Ti2 O4 100.9(9) 
O11 Ti2 O4 87.7(9)   O38 Ti2 O8 82.9(8) 
O11 Ti2 O8 81.2(8)   O38 Ti2 O10 102.0(19) 
O11 Ti2 O10 93.6(19)   O38 Ti2 O11 161.4(9) 
O18 Ti2 O4 168.5(10)   O38 Ti2 O18 88.1(9) 
O18 Ti2 O8 87.8(10)           
Experimental 
Single crystals of C24H26F2O6Ti [DC94] were [obtained from recrystallisation from hot 
ethanol]. A suitable crystal was selected and [Crystal mounted on MiTeGen loop under 
flombilin] on a 'Bruker APEX-II CCD' diffractometer. The crystal was kept at 173.15 K during data 
collection. Using Olex2 [1], the structure was solved with the ShelXS [2] structure solution program 
using Patterson Method and refined with the ShelXL [3] refinement package using CGLS minimisation. 
1. Dolomanov, O.V., Bourhis, L.J., Gildea, R.J, Howard, J.A.K. & Puschmann, H. (2009), J. 
Appl. Cryst. 42, 339-341. 
2. Sheldrick, G.M. (2008). Acta Cryst. A64, 112-122 
3. Sheldrick, G.M. (2008). Acta Cryst. A64, 112-122 
Crystal structure determination of [DC94] 
Crystal Data for C24H26F2O6Ti (M =143.86): monoclinic, space group P21/n (no. 14), a = 
11.2553(10) Å, b = 19.6468(19) Å, c = 11.3094(11) Å, β = 90.178(5)°, V = 2500.8(4) Å3, Z = 4, T = 
173.15 K, μ(Mo Kα) = 0.328 mm-1, Dcalc = 0.3821 g/mm3, 46103 reflections measured (4.14 ≤ 2Θ ≤ 
69.6), 9026 unique (Rint = 0.0754, Rsigma = 0.1400) which were used in all calculations. The final R1 was 
0.5455 (I>=2u(I)) and wR2 was 0.8677 (all data). 
Refinement model description 
Number of restraints - 0, number of constraints - 0. 
Details: 
1. Fixed Uiso 
 At 1.2 times of: 
  All C(H) groups, All C(H,H) groups 
 At 1.5 times of: 
  All C(H,H,H) groups 
2.a Secondary CH2 refined with riding coordinates: 
 C22(H22A,H22B), C23(H23A,H23B) 
2.b Aromatic/amide H refined with riding coordinates: 
 C6(H6), C19(H19), C16(H16), C10(H10), C17(H17), C9(H9), C20(H20), C7(H7) 
2.c Idealised Me refined as rotating group: 
 C11(H11A,H11B,H11C), C1(H1A,H1B,H1C), C21(H21A,H21B,H21C), 
C24(H24A,H24B,H24C) 
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 Crystallographic information of compound 6 
Table 1 Crystal data and structure refinement for DC133. 
Identification code DC133 
Empirical formula C11H14O3TiBr 
Formula weight 309.07 
Temperature/K 150.0 
Crystal system orthorhombic 
Space group Ccc2 
a/Å 11.4688(12) 
b/Å 22.418(2) 
c/Å 10.6590(12) 
α/° 90 
β/° 90 
γ/° 90 
Volume/Å3 2740.5(5) 
Z 8 
ρcalcmg/mm3 1.4981 
m/mm-1 3.261 
F(000) 1239.6 
Crystal size/mm3 0.01 × 0.02 × 0.02 
Radiation Mo Kα (λ = 0.71073) 
2Θ range for data collection 3.64 to 67.1° 
Index ranges -17 ≤ h ≤ 17, -34 ≤ k ≤ 22, -16 ≤ l ≤ 16 
Reflections collected 19850 
Independent reflections 5371 [Rint = 0.0238, Rsigma = 0.0410] 
Data/restraints/parameters 5371/0/151 
Goodness-of-fit on F2 0.964 
Final R indexes [I>=2σ (I)] R1 = 0.0281, wR2 = N/A 
Final R indexes [all data] R1 = 0.0380, wR2 = 0.0714 
Largest diff. peak/hole / e Å-3 1.09/-0.46 
Flack parameter 0.016(7) 
 
 
  
Table 2 Fractional Atomic Coordinates (×104) and Equivalent Isotropic 
Displacement Parameters (Å2×103) for DC133. Ueq is defined as 1/3 of of the 
trace of the orthogonalised UIJ tensor. 
Atom x y z U(eq) 
Br1 2149.0(2) 4970.04(8) 9611.39(18) 48.27(7) 
Ti1 2500 7500 3142.8(3) 20.54(7) 
O3 2380.4(8) 6881.5(5) 2035.1(12) 27.2(2) 
O2 2219.9(9) 6912.5(5) 4634.8(12) 24.76(19) 
O1 791.5(8) 7665.6(5) 3392.3(9) 25.5(2) 
C10 2664.3(13) 6158.1(8) 6631.9(16) 28.9(3) 
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C9 2844.6(15) 5722.8(8) 7556.0(18) 33.5(3) 
C8 1926.8(16) 5579.0(7) 8374.7(16) 35.7(4) 
C5 1572.0(12) 6449.8(7) 6514.5(14) 24.7(3) 
C1 -1087.3(14) 7879.8(10) 4222.8(18) 44.8(5) 
C2 98.2(11) 7582.8(7) 4334.8(15) 26.2(3) 
C3 368.7(14) 7234.6(8) 5397.2(16) 30.1(3) 
C4 1404.0(12) 6890.4(6) 5465.7(13) 22.5(3) 
C7 857.7(18) 5869.7(8) 8301.0(19) 47.5(4) 
C6 680.5(16) 6308.2(8) 7374.5(17) 40.9(4) 
C11 2540.9(17) 6264.1(9) 1859(2) 44.1(5) 
C12 3800.3(18) 6062.3(9) 2051(3) 56.8(6) 
  
Table 3 Anisotropic Displacement Parameters (Å2×103) for DC133. The 
Anisotropic displacement factor exponent takes the form: -
2π2[h2a*2U11+2hka*b*U12+…]. 
Atom U11 U22 U33 U12 U13 U23 
Br1 83.92(15) 28.98(9) 31.91(9) -1.85(8) -8.18(11) 7.86(8) 
Ti1 17.09(11) 30.30(17) 14.23(13) -2.27(12) -0 0 
O3 25.8(5) 32.7(6) 23.2(5) -1.5(4) -2.4(4) -4.7(5) 
O2 21.9(4) 31.3(5) 21.1(5) -0.1(4) 2.7(4) 3.2(5) 
O1 19.7(4) 38.2(5) 18.7(5) -1.8(4) -0.5(3) 3.1(4) 
C10 32.1(8) 27.6(8) 27.1(8) -1.7(5) -1.8(6) 1.0(7) 
C9 39.2(8) 27.9(8) 33.3(9) 0.4(6) -8.3(7) 0.8(7) 
C8 59.2(10) 24.7(7) 23.1(8) -4.1(7) -6.0(7) 1.8(6) 
C5 29.6(7) 25.4(7) 19.2(6) -4.0(5) 0.1(5) -0.6(6) 
C1 29.7(8) 69.6(13) 35.0(9) 15.2(8) 8.1(7) 14.4(9) 
C2 20.4(5) 34.5(8) 23.8(8) -0.1(5) 1.8(5) 1.1(6) 
C3 27.8(6) 41.0(9) 21.5(7) 4.1(6) 6.6(6) 5.4(7) 
C4 25.1(6) 25.3(7) 17.0(6) -2.2(5) -0.2(5) -0.9(5) 
C7 57.6(10) 45.2(10) 39.6(11) 0.4(8) 14.9(9) 16.8(9) 
C6 39.2(9) 44.3(10) 39.1(10) 3.9(7) 12.0(8) 15.5(8) 
C11 41.5(9) 33.0(9) 58.0(14) -5.8(7) -6.8(9) -3.4(9) 
C12 45(1) 36.2(9) 89.1(18) 6.9(8) -7.4(12) -5.4(12) 
  
Table 4 Bond Lengths for DC133. 
Atom Atom Length/Å   Atom Atom Length/Å 
Br1 C8 1.9148(17)   C10 C5 1.419(2) 
Ti1 O3 1.8264(12)   C9 C8 1.405(3) 
Ti1 O31 1.8264(12)   C8 C7 1.391(3) 
Ti1 O21 2.0897(12)   C5 C4 1.504(2) 
Ti1 O2 2.0897(12)   C5 C6 1.409(2) 
Ti1 O1 2.0119(9)   C1 C2 1.519(2) 
Ti1 O11 2.0119(9)   C2 C3 1.410(2) 
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O3 C11 1.409(2)   C3 C4 1.418(2) 
O2 C4 1.2894(18)   C7 C6 1.408(2) 
O1 C2 1.2946(17)   C11 C12 1.527(3) 
C10 C9 1.402(3)         
11/2-X,3/2-Y,+Z 
  
Table 5 Bond Angles for DC133. 
Atom Atom Atom Angle/˚   Atom Atom Atom Angle/˚ 
O31 Ti1 O3 99.44(8)   C5 C10 C9 120.87(15) 
O2 Ti1 O3 90.11(5)   C8 C9 C10 119.06(16) 
O2 Ti1 O31 169.12(5)   C9 C8 Br1 119.45(14) 
O21 Ti1 O3 169.12(5)   C7 C8 Br1 119.36(14) 
O21 Ti1 O31 90.11(5)   C7 C8 C9 121.19(17) 
O21 Ti1 O2 80.89(7)   C4 C5 C10 118.78(13) 
O1 Ti1 O31 91.06(4)   C6 C5 C10 118.65(14) 
O1 Ti1 O3 98.77(4)   C6 C5 C4 122.57(13) 
O11 Ti1 O31 98.77(4)   C1 C2 O1 115.22(14) 
O11 Ti1 O3 91.06(4)   C3 C2 O1 124.58(13) 
O1 Ti1 O2 82.30(4)   C3 C2 C1 120.19(14) 
O1 Ti1 O21 86.15(4)   C4 C3 C2 121.79(14) 
O11 Ti1 O2 86.15(4)   C5 C4 O2 116.28(12) 
O11 Ti1 O21 82.30(4)   C3 C4 O2 123.47(14) 
O11 Ti1 O1 164.81(6)   C3 C4 C5 120.19(13) 
C11 O3 Ti1 145.30(14)   C6 C7 C8 119.60(16) 
C4 O2 Ti1 131.18(9)   C7 C6 C5 120.58(16) 
C2 O1 Ti1 132.40(9)   C12 C11 O3 113.37(16) 
11/2-X,3/2-Y,+Z 
  
Table 6 Hydrogen Atom Coordinates (Å×104) and Isotropic Displacement 
Parameters (Å2×103) for DC133. 
Atom x y z U(eq) 
H10 3281.7(13) 6259.1(8) 6077.0(16) 34.7(4) 
H9 3577.1(15) 5527.9(8) 7627.6(18) 40.2(4) 
H1a -986.5(17) 8313.3(11) 4174(16) 67.1(7) 
H1b -1480(6) 7737(6) 3463(9) 67.1(7) 
H1c -1561(6) 7781(6) 4959(8) 67.1(7) 
H3 -157.1(14) 7230.3(8) 6085.8(16) 36.1(4) 
H7 250.6(18) 5773.1(8) 8872.3(19) 57.0(5) 
H6 -46.3(16) 6510.4(8) 7328.7(17) 49.0(5) 
H11a 2033.4(17) 6045.7(9) 2454(2) 53.0(6) 
H11b 2293.0(17) 6157.1(9) 998(2) 53.0(6) 
H12a 4319(2) 6304(5) 1525(12) 85.2(9) 
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H12b 4016(5) 6112(7) 2934(4) 85.2(9) 
H12c 3875(4) 5641(2) 1816(15) 85.2(9) 
Experimental 
Single crystals of C11H14O3TiBr [DC133] were [obtained from recrystallisation with hot 
ethanol]. A suitable crystal was selected and [mounted on a MiTeGen crystal mount] on a Bruker 
X8 diffractometer. The crystal was kept at 150.0 K during data collection. Using Olex2 [1], the structure 
was solved with the Superflip [2] structure solution program using Charge Flipping and refined with 
the olex2.refine [3] refinement package using Gauss-Newton minimisation. 
1. Dolomanov, O.V., Bourhis, L.J., Gildea, R.J, Howard, J.A.K. & Puschmann, H. (2009), J. 
Appl. Cryst. 42, 339-341. 
2. Palatinus, L. & Chapuis, G. (2007). J. Appl. Cryst., 40, 786-790; Palatinus, L. & van der 
Lee, A. (2008). J. Appl. Cryst. 41, 975-984; Palatinus, L., Prathapa, S. J. & van Smaalen, S. 
(2012). J. Appl. Cryst. 45, 575-580 
3. Bourhis, L.J., Dolomanov, O.V., Gildea, R.J., Howard, J.A.K., Puschmann, H. (2013). in 
preparation 
Crystal structure determination of [DC133] 
Crystal Data for C11H14O3TiBr (M =309.07): orthorhombic, space group Ccc2 (no. 37), a = 
11.4688(12) Å, b = 22.418(2) Å, c = 10.6590(12) Å, V = 2740.5(5) Å3, Z = 8, T = 150.0 K, μ(Mo 
Kα) = 3.261 mm-1, Dcalc = 1.4981 g/mm3, 19850 reflections measured (3.64 ≤ 2Θ ≤ 67.1), 5371 unique 
(Rint = 0.0238, Rsigma = 0.0410) which were used in all calculations. The final R1 was 0.0281 (I>=2u(I)) 
and wR2 was 0.0714 (all data). 
Refinement model description 
Number of restraints - 0, number of constraints - 21. 
Details: 
1. Fixed Uiso 
 At 1.2 times of: 
  All C(H) groups, All C(H,H) groups 
 At 1.5 times of: 
  All C(H,H,H) groups 
2.a Secondary CH2 refined with riding coordinates: 
 C11(H11a,H11b) 
2.b Aromatic/amide H refined with riding coordinates: 
 C10(H10), C9(H9), C3(H3), C7(H7), C6(H6) 
2.c Idealised Me refined as rotating group: 
 C1(H1a,H1b,H1c), C12(H12a,H12b,H12c) 
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 Crystallographic data of compound 11 
Table 1 Crystal data and structure refinement for dc150. 
Identification code dc150 
Empirical formula C34H32O6Ti 
Formula weight 425.32 
Temperature/K 150 
Crystal system monoclinic 
Space group P21/c 
a/Å 11.2203(12) 
b/Å 15.8876(16) 
c/Å 20.1373(19) 
α/° 90 
β/° 121.131(6) 
γ/° 90 
Volume/Å3 3072.8(6) 
Z 4 
ρcalcmg/mm3 0.919 
m/mm-1 0.113 
F(000) 850.0 
Crystal size/mm3 0.083 × 0.072 × 0.011 
Radiation MoKα (λ = 0.71073) 
2Θ range for data collection 3.486 to 60.484° 
Index ranges -15 ≤ h ≤ 15, -22 ≤ k ≤ 22, -28 ≤ l ≤ 24 
Reflections collected 37033 
Independent reflections 8994 [Rint = 0.0621, Rsigma = 0.0646] 
Data/restraints/parameters 8994/0/378 
Goodness-of-fit on F2 1.021 
Final R indexes [I>=2σ (I)] R1 = 0.0612, wR2 = 0.1674 
Final R indexes [all data] R1 = 0.0932, wR2 = 0.1908 
Largest diff. peak/hole / e Å-3 1.16/-0.64 
 
 
  
Table 2 Fractional Atomic Coordinates (×104) and Equivalent Isotropic 
Displacement Parameters (Å2×103) for dc150. Ueq is defined as 1/3 of of the 
trace of the orthogonalised UIJ tensor. 
Atom x y z U(eq) 
Ti1 1966.9(4) 2223.5(3) 3486.6(2) 20.00(12) 
O3 711.0(17) 3112.8(11) 3607.1(9) 24.0(3) 
O2 474.3(17) 1416.3(11) 3479.5(9) 23.6(3) 
O1 585.4(17) 2274.8(10) 2333.6(9) 23.5(3) 
O4 2934.4(17) 2181.9(10) 4660.7(9) 22.9(3) 
O6 2964.7(17) 3095.9(11) 3413.6(10) 25.1(4) 
O5 3033.6(18) 1338.7(11) 3530.3(10) 27.6(4) 
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C21 -486(2) 3984.4(14) 4047.6(13) 21.5(4) 
C7 -727(2) 2070.9(14) 1908.0(13) 19.4(4) 
C26 5061(2) 2015.4(15) 6191.6(14) 22.5(5) 
C25 3736(2) 2330.6(13) 6006.6(13) 18.8(4) 
C29 4485(3) 2256.1(16) 7387.0(14) 27.6(5) 
C19 -1869(3) 5204.8(17) 3305.4(16) 35.0(6) 
C18 -2483(3) 5234.4(16) 3760.2(16) 33.1(6) 
C6 -1469(2) 2364.8(14) 1069.2(13) 20.3(4) 
C30 3461(3) 2450.1(15) 6612.0(13) 22.6(5) 
C22 600(2) 3328.3(14) 4188.0(13) 19.9(4) 
C11 -3142(2) 846.4(15) 2799.9(14) 25.1(5) 
C14 -1771(3) -311.0(16) 4018.6(15) 29.8(5) 
C15 -994(3) 181.8(15) 3798.5(14) 25.5(5) 
C24 2666(2) 2506.5(14) 5165.7(13) 18.3(4) 
C28 5791(3) 1942.4(17) 7559.8(15) 30.1(5) 
C9 -817(2) 1296.8(14) 2958.3(13) 20.2(4) 
C2 -1478(3) 3262.4(18) 82.0(16) 38.0(7) 
C4 -3514(3) 2407.7(18) -252.5(15) 30.8(6) 
C16 -1107(2) 4025.1(15) 4503.5(14) 25.1(5) 
C23 1494(2) 3019.0(15) 4958.2(14) 21.9(4) 
C8 -1462(3) 1617.7(16) 2187.7(14) 26.2(5) 
C10 -1679(2) 768.0(14) 3182.0(13) 20.6(4) 
C13 -3226(3) -220.2(16) 3641.4(16) 29.0(5) 
C5 -2830(3) 2090.7(16) 507.0(14) 26.2(5) 
C27 6087(2) 1827.2(16) 6967.7(15) 27.3(5) 
C20 -876(3) 4575.3(16) 3444.4(14) 28.3(5) 
C12 -3914(3) 359.8(16) 3031.0(15) 27.5(5) 
C17 -2113(3) 4643.7(17) 4355.3(16) 31.5(6) 
C1 -792(3) 2954.1(16) 849.9(15) 28.7(5) 
C33 2782(3) 3977.0(18) 3241.5(18) 39.1(7) 
C32 2828(4) -55(2) 3989(2) 60.7(10) 
C31 3752(3) 608(2) 3977(2) 48.6(8) 
C34 3556(5) 4487(2) 3987(3) 75.3(13) 
C3 -2838(3) 2996.5(18) -462.0(15) 34.9(6) 
  
Table 3 Anisotropic Displacement Parameters (Å2×103) for dc150. The 
Anisotropic displacement factor exponent takes the form: -
2π2[h2a*2U11+2hka*b*U12+…]. 
Atom U11 U22 U33 U23 U13 U12 
Ti1 15.38(19) 30.7(2) 12.3(2) 0.61(15) 5.97(15) 1.49(15) 
O3 20.4(8) 33.7(9) 15.2(8) 3.0(6) 7.3(7) 6.4(7) 
O2 19.3(8) 34.8(9) 14.0(8) 3.4(6) 6.8(7) 0.7(6) 
O1 18.1(8) 37.3(9) 12.9(8) 0.4(6) 6.5(7) -2.0(6) 
O4 17.8(8) 34.8(9) 13.6(8) 1.3(6) 6.2(6) 4.7(6) 
O6 20.7(8) 33.0(9) 18.7(8) 1.2(7) 8.2(7) -1.3(7) 
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O5 25.4(9) 34.6(9) 23.9(9) 1.7(7) 13.4(8) 6.0(7) 
C21 15.4(10) 26.1(11) 15.6(10) -1.1(8) 2.8(8) 1.2(8) 
C7 18.7(10) 26.6(11) 12.8(10) 0.1(8) 8.2(9) 3.1(8) 
C26 17.7(10) 29.4(11) 17.7(11) 5.5(8) 7.2(9) 2.2(8) 
C25 17.4(10) 23.6(10) 12.4(10) 2.7(8) 5.6(8) -0.8(8) 
C29 29.9(13) 35.7(13) 14.5(11) 1.5(9) 9.5(10) -3.3(10) 
C19 30.9(14) 32.7(13) 26.3(14) 5.7(10) 4.1(11) 8.3(10) 
C18 25.4(13) 29.6(12) 29.5(14) -4.5(10) 3.8(11) 8.7(10) 
C6 19.1(10) 28.7(11) 13.4(10) 1.0(8) 8.7(9) 2.5(8) 
C30 20.8(11) 29.7(11) 16.7(11) 2.5(8) 9.1(9) 0.2(9) 
C22 15(1) 25.3(10) 16.7(10) 0.0(8) 6.1(8) 0.3(8) 
C11 23.8(11) 29.1(11) 21.3(12) 2.1(9) 11(1) 1.4(9) 
C14 33.3(14) 29.9(12) 26.9(13) 5.5(10) 16.1(11) 1.6(10) 
C15 24.9(12) 29.3(12) 21.8(12) 3.7(9) 11.7(10) 3.3(9) 
C24 15.9(10) 23.2(10) 13(1) 0.8(8) 5.6(8) -2.5(8) 
C28 25.2(12) 38.5(13) 15.8(11) 6.8(10) 2.9(10) -0.3(10) 
C9 20.7(10) 25.7(11) 15.9(10) 0.5(8) 10.6(9) 2.1(8) 
C2 44.5(17) 39.4(15) 22.5(13) 5.9(11) 11.9(12) -10.6(12) 
C4 21.7(12) 46.8(15) 15.2(12) 0.3(10) 3.5(10) 1.6(10) 
C16 19.4(11) 28.7(11) 22.2(12) -0.3(9) 7.3(9) 1.3(9) 
C23 19.5(11) 30.3(11) 14.1(10) 1.3(8) 7.4(9) 4.7(8) 
C8 18.6(11) 40.1(13) 15.5(11) 4.7(9) 5.7(9) -1.9(9) 
C10 22.4(11) 24.2(10) 15.7(10) -1.2(8) 10.3(9) 0.2(8) 
C13 32.2(13) 28.5(12) 30.7(14) -0.9(10) 19.3(12) -6.2(10) 
C5 20.8(11) 40.6(14) 16.0(11) 1.8(9) 8.5(10) -1.7(9) 
C27 17.3(11) 35.8(13) 22.1(12) 6(1) 5.4(10) 3.1(9) 
C20 24.9(12) 34.6(13) 19.6(12) 2.8(9) 7.2(10) 3.8(10) 
C12 21.3(11) 34.4(13) 26.5(13) -0.4(10) 12.2(10) -3.4(9) 
C17 24.3(12) 36.9(13) 29.3(14) -7.1(11) 10.9(11) 3.7(10) 
C1 27.6(13) 35.4(13) 17.6(12) 1.7(9) 7.7(10) -6.6(10) 
C33 43.0(16) 38.1(15) 41.2(17) 11.3(12) 25.2(14) 4.5(12) 
C32 45(2) 46.8(19) 78(3) 25.2(18) 23(2) 16.3(15) 
C31 34.7(16) 51.5(18) 56(2) 22.2(16) 21.1(15) 20.5(14) 
C34 106(4) 34.8(17) 72(3) -11.3(18) 37(3) -5(2) 
C3 40.5(16) 39.1(14) 16.0(12) 7.9(10) 8.2(12) 4.1(12) 
  
Table 4 Bond Lengths for dc150. 
Atom Atom Length/Å   Atom Atom Length/Å 
Ti1 O3 2.0963(17)   C19 C18 1.403(4) 
Ti1 O2 2.1035(17)   C19 C20 1.413(4) 
Ti1 O1 2.0197(17)   C18 C17 1.405(4) 
Ti1 O4 2.0295(17)   C6 C5 1.420(3) 
Ti1 O6 1.8348(17)   C6 C1 1.413(3) 
Ti1 O5 1.8186(17)   C22 C23 1.430(3) 
O3 C22 1.285(3)   C11 C10 1.413(3) 
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O2 C9 1.290(3)   C11 C12 1.408(3) 
O1 C7 1.305(3)   C14 C15 1.403(3) 
O4 C24 1.306(3)   C14 C13 1.408(4) 
O6 C33 1.431(3)   C15 C10 1.419(3) 
O5 C31 1.434(3)   C24 C23 1.414(3) 
C21 C22 1.515(3)   C28 C27 1.405(4) 
C21 C16 1.412(3)   C9 C8 1.425(3) 
C21 C20 1.414(3)   C9 C10 1.515(3) 
C7 C6 1.520(3)   C2 C1 1.412(4) 
C7 C8 1.413(3)   C2 C3 1.407(4) 
C26 C25 1.423(3)   C4 C5 1.403(3) 
C26 C27 1.413(3)   C4 C3 1.400(4) 
C25 C30 1.417(3)   C16 C17 1.407(3) 
C25 C24 1.511(3)   C13 C12 1.405(4) 
C29 C30 1.413(3)   C33 C34 1.521(5) 
C29 C28 1.410(4)   C32 C31 1.486(5) 
  
Table 5 Bond Angles for dc150. 
Atom Atom Atom Angle/˚   Atom Atom Atom Angle/˚ 
O3 Ti1 O2 80.29(7)   C1 C6 C7 118.5(2) 
O1 Ti1 O3 86.76(7)   C1 C6 C5 119.0(2) 
O1 Ti1 O2 83.20(7)   C29 C30 C25 120.4(2) 
O1 Ti1 O4 166.16(7)   O3 C22 C21 117.43(19) 
O4 Ti1 O3 82.75(6)   O3 C22 C23 123.5(2) 
O4 Ti1 O2 86.13(7)   C23 C22 C21 119.0(2) 
O6 Ti1 O3 88.54(8)   C12 C11 C10 120.8(2) 
O6 Ti1 O2 167.60(7)   C15 C14 C13 120.6(2) 
O6 Ti1 O1 90.85(7)   C14 C15 C10 119.9(2) 
O6 Ti1 O4 97.86(7)   O4 C24 C25 115.48(19) 
O5 Ti1 O3 168.62(7)   O4 C24 C23 123.4(2) 
O5 Ti1 O2 91.77(8)   C23 C24 C25 121.1(2) 
O5 Ti1 O1 100.46(8)   C27 C28 C29 120.5(2) 
O5 Ti1 O4 88.64(7)   O2 C9 C8 123.9(2) 
O5 Ti1 O6 100.03(8)   O2 C9 C10 117.44(19) 
C22 O3 Ti1 132.24(14)   C8 C9 C10 118.6(2) 
C9 O2 Ti1 130.58(14)   C3 C2 C1 120.4(2) 
C7 O1 Ti1 132.83(14)   C3 C4 C5 119.5(2) 
C24 O4 Ti1 133.97(15)   C17 C16 C21 120.3(2) 
C33 O6 Ti1 137.85(17)   C24 C23 C22 122.8(2) 
C31 O5 Ti1 142.95(19)   C7 C8 C9 123.0(2) 
C16 C21 C22 122.0(2)   C11 C10 C15 119.0(2) 
C16 C21 C20 119.4(2)   C11 C10 C9 122.0(2) 
C20 C21 C22 118.6(2)   C15 C10 C9 119.0(2) 
O1 C7 C6 115.95(19)   C12 C13 C14 119.9(2) 
O1 C7 C8 123.9(2)   C4 C5 C6 121.1(2) 
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C8 C7 C6 120.1(2)   C28 C27 C26 119.7(2) 
C27 C26 C25 120.5(2)   C19 C20 C21 120.1(2) 
C26 C25 C24 118.4(2)   C13 C12 C11 119.7(2) 
C30 C25 C26 119.0(2)   C18 C17 C16 119.9(3) 
C30 C25 C24 122.6(2)   C2 C1 C6 119.7(2) 
C28 C29 C30 119.9(2)   O6 C33 C34 110.1(3) 
C18 C19 C20 119.8(2)   O5 C31 C32 114.4(2) 
C19 C18 C17 120.4(2)   C4 C3 C2 120.3(2) 
C5 C6 C7 122.5(2)           
  
Table 6 Hydrogen Atom Coordinates (Å×104) and Isotropic Displacement 
Parameters (Å2×103) for dc150. 
Atom x y z U(eq) 
H26 5256 1931 5790 27 
H29 4295 2337 7791 33 
H19 -2120 5607 2905 42 
H18 -3154 5656 3665 40 
H30 2582 2662 6496 27 
H11 -3611 1232 2382 30 
H14 -1311 -710 4426 36 
H15 -11 123 4062 31 
H28 6475 1808 8080 36 
H2 -1018 3652 -68 46 
H4 -4430 2224 -622 37 
H16 -844 3633 4913 30 
H13 -3743 -550 3799 35 
H5 -3285 1686 647 31 
H27 6973 1624 7089 33 
H20 -470 4549 3132 34 
H12 -4896 423 2775 33 
H17 -2541 4662 4657 38 
H1 121 3142 1218 34 
H33A 1778 4118 2966 47 
H33B 3140 4121 2898 47 
H32A 2099 -191 3455 91 
H32B 2398 150 4275 91 
H32C 3377 -560 4242 91 
H31A 4417 785 4518 58 
H31B 4298 363 3765 58 
H34A 3427 5088 3862 113 
H34B 4550 4349 4256 113 
H34C 3188 4350 4322 113 
H3 -3299 3217 -974 42 
H23 1360(30) 3220(20) 5371(19) 42 
H8 -2450(30) 1511(19) 1829(19) 42 
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Experimental 
Single crystals of C34H32O6Ti [dc150] were [obtained from recrystallisation from hot 
ethanol]. A suitable crystal was selected and [mounted on a MiTeGen mesh] on a 'Bruker APEX-II 
CCD' diffractometer. The crystal was kept at 150 K during data collection. Using Olex2 [1], the 
structure was solved with the olex2.solve [2] structure solution program using Charge Flipping and 
refined with the ShelXL [3] refinement package using Least Squares minimisation. 
1. Dolomanov, O.V., Bourhis, L.J., Gildea, R.J, Howard, J.A.K. & Puschmann, H. (2009), J. 
Appl. Cryst. 42, 339-341. 
2. Bourhis, L.J., Dolomanov, O.V., Gildea, R.J., Howard, J.A.K., Puschmann, H. (2013). in 
preparation 
3. Sheldrick, G.M. (2008). Acta Cryst. A64, 112-122 
Crystal structure determination of [dc150] 
Crystal Data for C34H32O6Ti (M =425.32): monoclinic, space group P21/c (no. 14), a = 
11.2203(12) Å, b = 15.8876(16) Å, c = 20.1373(19) Å, β = 121.131(6)°, V = 3072.8(6) Å3, Z = 4, T = 
150 K, μ(MoKα) = 0.113 mm-1, Dcalc = 0.919 g/mm3, 37033 reflections measured (3.486 ≤ 2Θ ≤ 
60.484), 8994 unique (Rint = 0.0621, Rsigma = 0.0646) which were used in all calculations. The 
final R1 was 0.0612 (I > 2σ(I)) and wR2 was 0.1908 (all data). 
Refinement model description 
Number of restraints - 0, number of constraints - unknown. 
Details: 
1. Fixed Uiso 
 At 1.2 times of: 
  All C(H) groups, {H3,H23,H8} of C3, All C(H,H) groups 
 At 1.5 times of: 
  {H32A,H32B,H32C} of C32, {H34A,H34B,H34C} of C34 
2.a Secondary CH2 refined with riding coordinates: 
 C33(H33A,H33B), C31(H31A,H31B) 
2.b Aromatic/amide H refined with riding coordinates: 
 C26(H26), C29(H29), C19(H19), C18(H18), C30(H30), C11(H11), C14(H14), 
 C15(H15), C28(H28), C2(H2), C4(H4), C16(H16), C13(H13), C5(H5), C27(H27), 
 C20(H20), C12(H12), C17(H17), C1(H1), C3(H3) 
2.c Idealised Me refined as rotating group: 
 C32(H32A,H32B,H32C), C34(H34A,H34B,H34C) 
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 Crystallographic information for compound 8 
Identification code dc150 
Empirical formula C34H32O6Ti 
Formula weight 584.50 
Temperature/K 150 
Crystal system monoclinic 
Space group P21/c 
a/Å 11.2203(12) 
b/Å 15.8876(16) 
c/Å 20.1373(19) 
α/° 90 
β/° 121.131(6) 
γ/° 90 
Volume/Å3 3072.8(6) 
Z 4 
ρcalcg/cm3 1.2634 
μ/mm-1 0.321 
F(000) 1225.8 
Crystal size/mm3 0.085 × 0.078 × 0.011 
Radiation Mo Kα (λ = 0.71073) 
2Θ range for data collection/° 4.44 to 60.48 
Index ranges -15 ≤ h ≤ 15, -22 ≤ k ≤ 22, -28 ≤ l ≤ 24 
Reflections collected 37033 
Independent reflections 8989 [Rint = 0.0621, Rsigma = 0.0646] 
Data/restraints/parameters 8989/0/371 
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Goodness-of-fit on F2 1.049 
Final R indexes [I>=2σ (I)] R1 = 0.0606, wR2 = 0.1616 
Final R indexes [all data] R1 = 0.0925, wR2 = 0.1860 
Largest diff. peak/hole / e Å-3 1.21/-0.87 
Table 6.5-1 - Crystal data and structure refinement for bis-(1,3-diphenylpropan-1,3-
diketonate)titanium(IV) ethoxide 
  
Atom x y z U(eq) 
Ti1 6966.8(4) 7776.6(3) 8486.6(2) 20.17(12) 
O2 5585.9(16) 7725.2(10) 7333.7(9) 23.6(3) 
C10 3530(2) 7635.1(14) 6069.2(13) 20.5(4) 
O3 5711.1(16) 6887.3(10) 8607.1(9) 24.2(3) 
C26 8461(2) 7550.2(15) 11612.4(13) 22.8(4) 
C22 5600(2) 6671.9(13) 9187.7(13) 20.0(4) 
C9 4273(2) 7929.0(13) 6908.1(12) 19.5(4) 
C25 8737(2) 7669.6(13) 11006.6(12) 18.8(4) 
O6 8033.9(17) 8661.4(10) 8530.4(10) 27.8(4) 
O4 7934.2(16) 7818.3(10) 9660.5(9) 23.0(3) 
O5 7964.9(17) 6904.3(10) 8413.6(9) 25.2(3) 
O1 5474.1(16) 8583.8(10) 8479.6(9) 23.6(3) 
C27 9485(3) 7743.9(15) 12386.9(14) 27.8(5) 
C6 3321(2) 9232.0(13) 8182.2(13) 20.6(4) 
C11 2169(2) 7908.6(16) 5506.9(14) 26.4(5) 
C23 6494(2) 6980.9(14) 9958.1(13) 22.0(4) 
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C21 4514(2) 6015.7(14) 9047.4(13) 21.7(4) 
C30 10061(2) 7984.9(14) 11191.6(13) 22.5(4) 
C28 10790(3) 8057.6(16) 12559.6(14) 30.3(5) 
C20 3892(2) 5975.0(14) 9502.9(14) 25.3(5) 
C8 3538(2) 8382.0(15) 7188.1(13) 26.2(5) 
C24 7666(2) 7494.1(13) 10165.5(12) 18.4(4) 
C7 4182(2) 8703.2(13) 7958.4(13) 20.3(4) 
C12 1485(3) 7591.9(17) 4747.6(14) 30.9(5) 
C29 11086(2) 8172.6(15) 11967.8(14) 27.5(5) 
C5 1858(2) 9153.7(14) 7800.7(14) 25.2(5) 
C1 4006(3) 9818.3(14) 8799.0(14) 25.6(5) 
C15 4207(3) 7045.6(15) 5849.7(14) 28.9(5) 
C2 3229(3) 10310.8(15) 9018.7(15) 30.0(5) 
C3 1774(3) 10220.1(15) 8641.8(15) 29.1(5) 
C4 1086(2) 9640.3(15) 8031.5(15) 27.6(5) 
C16 4124(3) 5424.8(15) 8444.3(14) 28.5(5) 
C13 2162(3) 7003.1(17) 4538.2(15) 35.1(6) 
C18 2516(3) 4765.8(16) 8759.6(16) 33.2(6) 
C14 3522(3) 6736.7(17) 5082.1(15) 38.3(6) 
C19 2887(3) 5356.5(16) 9355.2(15) 31.8(5) 
C17 3131(3) 4795.1(16) 8305.0(15) 35.1(6) 
C31 7781(3) 6023.2(17) 8240.6(17) 39.5(6) 
C33 8752(3) 9392(2) 8978(2) 49.4(8) 
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C34 7829(4) 10054(2) 8989(2) 61.3(10) 
C32 8554(5) 5513(2) 8986(2) 75.0(13) 
 Table 6.5-2 - Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement 
Parameters (Å2×103) for dc150. Ueq is defined as 1/3 of of the trace of the orthogonalised 
UIJ tensor. 
Atom U11 U22 U33 U12 U13 U23 
Ti1 15.53(19) 30.8(2) 12.5(2) -1.48(14) 6.05(15) -0.62(14) 
O2 18.4(8) 37.3(9) 13.0(8) 2.0(6) 6.6(6) -0.3(6) 
C10 19.4(10) 28.8(11) 13.4(10) -2.5(8) 8.6(9) -1.0(8) 
O3 20.8(8) 33.8(8) 15.2(8) -6.4(6) 7.4(7) -2.9(6) 
C26 20.8(10) 29.9(11) 16.9(11) -0.3(8) 9.2(9) -2.6(8) 
C22 15.0(9) 25.4(10) 16.8(10) -0.2(8) 6.2(8) 0.1(8) 
C9 19.2(10) 26.5(10) 12.8(10) -3.2(8) 8.2(8) -0.0(8) 
C25 17.4(10) 23.5(10) 12.6(10) 0.8(8) 5.7(8) -2.7(7) 
O6 25.6(8) 34.7(9) 23.9(9) -5.9(7) 13.4(7) -1.6(7) 
O4 17.8(8) 34.7(8) 13.7(7) -4.7(6) 6.3(6) -1.4(6) 
O5 20.9(8) 32.9(8) 18.7(8) 1.3(6) 8.2(7) -1.1(6) 
O1 19.4(8) 34.8(8) 14.0(8) -0.6(6) 6.7(6) -3.4(6) 
C27 30.0(13) 35.7(12) 14.7(11) 3.4(10) 9.6(10) -1.4(9) 
C6 22.4(11) 24.3(10) 15.8(10) -0.3(8) 10.3(9) 1.3(8) 
C11 21.0(11) 40.5(13) 16.4(11) 1.7(9) 8.8(9) -1.8(9) 
C23 19.3(10) 31.0(11) 14.3(10) -4.7(8) 7.7(9) -1.5(8) 
C21 15.6(9) 26.2(10) 15.6(10) -1.1(8) 2.6(8) 1.2(8) 
C30 17.7(10) 29.5(11) 17.7(11) -2.1(8) 7.2(9) -5.5(8) 
C28 25.6(12) 38.4(13) 15.9(11) 0.3(10) 2.9(10) -6.8(9) 
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C20 19.7(10) 28.9(11) 22.3(12) -1.3(8) 7.2(9) 0.2(9) 
C8 18.3(10) 40.4(13) 15.5(11) 2.0(9) 5.6(9) -4.6(9) 
C24 16.1(10) 23.2(9) 13.1(10) 2.6(7) 5.6(8) -0.8(7) 
C7 20.8(10) 25.8(10) 16(1) -2.1(8) 10.6(9) -0.5(8) 
C12 21.7(12) 46.9(14) 15.3(11) -1.6(10) 3.4(10) -0.2(10) 
C29 17.6(11) 35.9(12) 22.3(12) -3.2(9) 5.4(9) -6.1(9) 
C5 24.2(11) 29.1(11) 21.2(11) -1.5(9) 11(1) -2.0(9) 
C1 24.9(11) 29.3(11) 22.1(12) -3.2(9) 11.8(10) -3.5(9) 
C15 28.0(13) 35.2(12) 17.5(11) 6.7(9) 7.5(10) -1.7(9) 
C2 33.6(13) 30.1(12) 26.9(13) -1.7(10) 16.1(11) -5.4(10) 
C3 32.2(13) 28.5(12) 30.8(13) 6.1(9) 19.3(11) 0.9(10) 
C4 21.4(11) 34.5(12) 26.6(13) 3.4(9) 12.3(10) 0.5(10) 
C16 25.0(12) 34.7(12) 19.6(12) -3.6(9) 7.2(10) -2.8(9) 
C13 40.9(15) 39.4(13) 16.0(12) -4.1(11) 8.3(11) -8.1(10) 
C18 25.5(12) 29.7(12) 29.7(13) -8.8(9) 3.8(11) 4.4(10) 
C14 45.1(16) 39.3(14) 22.5(13) 10.6(12) 11.9(12) -5.9(10) 
C19 24.6(12) 37.0(13) 29.6(14) -3.6(10) 11.0(11) 7.3(10) 
C17 30.9(14) 32.8(13) 26.3(13) -8.2(10) 4.0(11) -5.5(10) 
C31 43.7(16) 38.2(14) 41.7(17) -4.6(12) 25.6(14) -11.5(12) 
C33 35.3(16) 52.1(17) 57(2) -20.8(13) 21.5(15) -22.4(15) 
C34 45.7(19) 47.2(18) 78(3) -16.7(15) 22.9(19) -25.6(18) 
C32 106(4) 34.6(16) 72(3) 5.3(19) 37(3) 11.0(17) 
 Table 6.5-3 - Anisotropic Displacement Parameters (Å2×103) for dc150. The Anisotropic 
displacement factor exponent takes the form: -2π2[h2a*2U11+2hka*b*U12+…]. 
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Atom Atom Length/Å   Atom Atom Length/Å 
Ti1 O2 2.0194(16)   C6 C7 1.514(3) 
Ti1 O3 2.0960(16)   C6 C5 1.413(3) 
Ti1 O6 1.8189(16)   C6 C1 1.419(3) 
Ti1 O4 2.0293(16)   C11 C12 1.402(3) 
Ti1 O5 1.8349(17)   C23 C24 1.414(3) 
Ti1 O1 2.1036(16)   C21 C20 1.412(3) 
O2 C9 1.305(3)   C21 C16 1.414(3) 
C10 C9 1.520(3)   C30 C29 1.413(3) 
C10 C11 1.420(3)   C28 C29 1.404(4) 
C10 C15 1.413(3)   C20 C19 1.407(3) 
O3 C22 1.284(3)   C8 C7 1.425(3) 
C26 C25 1.417(3)   C12 C13 1.400(4) 
C26 C27 1.412(3)   C5 C4 1.407(3) 
C22 C23 1.430(3)   C1 C2 1.402(3) 
C22 C21 1.516(3)   C15 C14 1.412(3) 
C9 C8 1.413(3)   C2 C3 1.408(3) 
C25 C30 1.423(3)   C3 C4 1.405(3) 
C25 C24 1.512(3)   C16 C17 1.413(3) 
O6 C33 1.435(3)   C13 C14 1.407(4) 
O4 C24 1.306(3)   C18 C19 1.406(4) 
O5 C31 1.431(3)   C18 C17 1.403(4) 
O1 C7 1.290(3)   C31 C32 1.521(5) 
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C27 C28 1.410(4)   C33 C34 1.485(5) 
 Table 6.5-4 - Bond Lengths for bis-(1,3-diphenylpropan-1,3-diketonate)titanium(IV) ethoxide. 
Atom Atom Atom Angle/˚   Atom Atom Atom Angle/˚ 
O3 Ti1 O2 86.77(6)   C5 C6 C7 122.01(19) 
O6 Ti1 O2 100.46(7)   C1 C6 C7 119.00(19) 
O6 Ti1 O3 168.62(7)   C1 C6 C5 119.0(2) 
O4 Ti1 O2 166.17(7)   C12 C11 C10 121.1(2) 
O4 Ti1 O3 82.75(6)   C24 C23 C22 122.8(2) 
O4 Ti1 O6 88.63(7)   C20 C21 C22 122.0(2) 
O5 Ti1 O2 90.84(7)   C16 C21 C22 118.6(2) 
O5 Ti1 O3 88.55(7)   C16 C21 C20 119.4(2) 
O5 Ti1 O6 100.01(8)   C29 C30 C25 120.4(2) 
O5 Ti1 O4 97.87(7)   C29 C28 C27 120.5(2) 
O1 Ti1 O2 83.22(6)   C19 C20 C21 120.4(2) 
O1 Ti1 O3 80.28(7)   C7 C8 C9 123.0(2) 
O1 Ti1 O6 91.78(7)   O4 C24 C25 115.47(18) 
O1 Ti1 O4 86.12(6)   C23 C24 C25 121.07(19) 
O1 Ti1 O5 167.61(7)   C23 C24 O4 123.4(2) 
C9 O2 Ti1 132.81(14)   C6 C7 O1 117.44(18) 
C11 C10 C9 122.5(2)   C8 C7 O1 123.9(2) 
C15 C10 C9 118.5(2)   C8 C7 C6 118.69(19) 
C15 C10 C11 118.9(2)   C13 C12 C11 119.5(2) 
C22 O3 Ti1 132.23(14)   C28 C29 C30 119.8(2) 
C27 C26 C25 120.4(2)   C4 C5 C6 120.8(2) 
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C23 C22 O3 123.52(19)   C2 C1 C6 119.9(2) 
C21 C22 O3 117.43(19)   C14 C15 C10 119.8(2) 
C21 C22 C23 118.94(19)   C3 C2 C1 120.6(2) 
C10 C9 O2 115.96(18)   C4 C3 C2 119.9(2) 
C8 C9 O2 123.9(2)   C3 C4 C5 119.7(2) 
C8 C9 C10 120.1(2)   C17 C16 C21 120.2(2) 
C30 C25 C26 119.0(2)   C14 C13 C12 120.4(2) 
C24 C25 C26 122.62(19)   C17 C18 C19 120.4(2) 
C24 C25 C30 118.39(19)   C13 C14 C15 120.4(2) 
C33 O6 Ti1 142.92(18)   C18 C19 C20 119.9(2) 
C24 O4 Ti1 133.97(14)   C18 C17 C16 119.8(2) 
C31 O5 Ti1 137.82(16)   C32 C31 O5 110.1(2) 
C7 O1 Ti1 130.59(14)   C34 C33 O6 114.4(2) 
C28 C27 C26 119.9(2)           
 Table 6.5-5 - Bond Angles for bis-(1,3-diphenylpropan-1,3-diketonate)titanium(IV) ethoxide 
Atom x y z U(eq) 
H26 7582(2) 7338.4(15) 11496.6(13) 27.3(5) 
H27 9295(3) 7663.0(15) 12790.6(14) 33.3(6) 
H11 1714(2) 8312.9(16) 5647.3(14) 31.7(6) 
H23 6293(2) 6835.1(14) 10347.3(13) 26.4(5) 
H30 10257(2) 8069.6(14) 10790.5(13) 27.1(5) 
H28 11475(3) 8192.4(16) 13080.3(14) 36.4(6) 
H20 4154(2) 6367.6(14) 9911.6(14) 30.4(6) 
H8 2570(2) 8476.7(15) 6847.1(13) 31.4(6) 
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H12 570(3) 7775.4(17) 4378.4(14) 37.1(6) 
H29 11973(2) 8375.9(15) 12089.0(14) 33.0(6) 
H5 1390(2) 8767.7(14) 7383.1(14) 30.2(6) 
H1 4989(3) 9877.0(14) 9062.8(14) 30.8(6) 
H15 5120(3) 6857.7(15) 6217.4(14) 34.6(6) 
H2 3690(3) 10709.5(15) 9425.9(15) 35.9(6) 
H3 1258(3) 10550.2(15) 8799.8(15) 34.9(6) 
H4 105(2) 9577.1(15) 7775.6(15) 33.1(6) 
H16 4530(3) 5451.1(15) 8131.8(14) 34.2(6) 
H13 1700(3) 6782.4(17) 4026.1(15) 42.2(7) 
H18 1845(3) 4344.3(16) 8664.3(16) 39.9(7) 
H14 3982(3) 6346.8(17) 4931.9(15) 46.0(8) 
H19 2460(3) 5338.0(16) 9657.4(15) 38.1(7) 
H17 2881(3) 4392.9(16) 7904.8(15) 42.1(7) 
H31a 6777(3) 5882.6(17) 7965.0(17) 47.5(8) 
H31b 8139(3) 5879.5(17) 7897.0(17) 47.5(8) 
H33a 9418(3) 9215(2) 9518(2) 59.3(10) 
H33b 9298(3) 9638(2) 8766(2) 59.3(10) 
H34a 7100(18) 10191(13) 8456(2) 91.9(15) 
H34b 7400(20) 9849(7) 9276(14) 91.9(15) 
H34c 8377(7) 10560(6) 9243(15) 91.9(15) 
H32a 9549(7) 5649(15) 9254(10) 112.5(19) 
H32b 8190(20) 5651(15) 9322(8) 112.5(19) 
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H32c 8420(30) 4912(2) 8861(3) 112.5(19) 
Table 6.5-6 - Hydrogen Atom Coordinates (Å×104) and Isotropic Displacement Parameters 
(Å2×103) for bis-(1,3-diphenylpropan-1,3-diketonate)titanium(IV) ethoxide. 
6.5.1. Experimental 
Single crystals of C34H32O6Ti [dc150] were [Sample recrystallised from ethanol]. A suitable 
crystal was selected and [] on a 'Bruker APEX-II CCD' diffractometer. The crystal was kept at 150 K 
during data collection. Using Olex2 [1], the structure was solved with the ShelXS [2] structure solution 
program using Direct Methods and refined with the olex2.refine [3] refinement package using Gauss-
Newton minimisation. 
1. Dolomanov, O.V., Bourhis, L.J., Gildea, R.J, Howard, J.A.K. & Puschmann, H. 
(2009), J. Appl. Cryst. 42, 339-341. 
6.5.1.1. Crystal structure determination of bis-(1,3-diphenylpropan-1,3-
diketonate)titanium(IV) ethoxide 
Crystal Data for C34H32O6Ti (M =584.50 g/mol): monoclinic, space group P21/c (no. 14), a = 
11.2203(12) Å, b = 15.8876(16) Å, c = 20.1373(19) Å, β = 121.131(6)°, V = 3072.8(6) Å3, Z = 4, T = 
150 K, μ(Mo Kα) = 0.321 mm-1, Dcalc = 1.2634 g/cm3, 37033 reflections measured (4.44° ≤ 2Θ ≤ 
60.48°), 8989 unique (Rint = 0.0621, Rsigma = 0.0646) which were used in all calculations. The 
final R1 was 0.0606 (I>=2u(I)) and wR2 was 0.1860 (all data). 
Refinement model description 
Number of restraints - 0, number of constraints - 58. 
Details: 
1. Fixed Uiso 
 At 1.2 times of: 
  All C(H) groups, All C(H,H) groups 
 At 1.5 times of: 
  All C(H,H,H) groups 
2.a Secondary CH2 refined with riding coordinates: 
 C31(H31a,H31b), C33(H33a,H33b) 
2.b Aromatic/amide H refined with riding coordinates: 
 C26(H26), C27(H27), C11(H11), C23(H23), C30(H30), C28(H28), C20(H20), 
C8(H8), 
 C12(H12), C29(H29), C5(H5), C1(H1), C15(H15), C2(H2), C3(H3), C4(H4), 
C16(H16), 
  C13(H13), C18(H18), C14(H14), C19(H19), C17(H17) 
2.c Idealised Me refined as rotating group: 
 C34(H34a,H34b,H34c), C32(H32a,H32b,H32c) 
This report has been created with Olex2, compiled on 2015.01.26 svn.r3150 for OlexSys. Please let us know if there are any errors or if 
you would like to have additional features. 
 Maple calculation methods of EC50 from the logarithmic fitting of data 
presented in section 4.6 
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